Universe宇宙的个人主页 - 老虎社区

Universe宇宙

Travelling around the universe

IP属地：未知

46关注

130粉丝

0主题

0勋章

2021-12-30

First post 😉

抱歉，原内容已删除

2021-12-29

First post 😉

JinkoSolar Holdings Up on Shanghai Listing

2021-12-28

Higher, higher and more higher than inflation and interest rates! 😉🎉

抱歉，原内容已删除

2021-12-28

First post 😉

Brace yourself for Big Tech correction in early 2022 - Loup Ventures' Gene Munster

2021-12-27

First post 😉

Plug Power Trades Like A Story Stock And Smells Like An Early-Stage Tesla

2021-12-26

First post 😉

1 Retail Stock That Can Go Head-to-Head With E-Commerce

2021-12-25

First post 😉

Electric boat developer Forza X1 files for a $29 million IPO

2021-12-24

Time to take your pills? [LOL]

Pfizer’s Covid Pill Gets Green Light. Investors Are Starting to Pay Attention to the Stock.

2021-12-24

[Spurting] [Facepalm]

United, Delta cancel more than 200 U.S. Christmas Eve flights amid COVID surge

2021-12-24

First post 😉

Hong Kong: Stocks rise in opening trade

2021-12-23

😉

U.S. adds Merck pill as 2nd easy-to-use drug against COVID-19

2021-12-23

First post 😉

Tesla shares rose nearly 2% in early trading

2021-12-22

$SINGAPORE AIRLINES LTD(C6L.SI)$going to drop to $2.50? [Surprised] [Doubt] Even vaccinated still restrict their travel plan? Lmao. [Spurting] [Facepalm] Democracy has died? [Onlooker]

Singapore to freeze new ticket sales for quarantine-free travel

2021-12-22

First post 😉

The IPOs to expect in 2022: Reddit, Instacart and others could hit Wall Street

2021-12-21

$SINGAPORE AIRLINES LTD(C6L.SI)$is over valued? [Doubt] Omicron covid virus roaming around us, and some policy makers wanted to lock down again, cancel public events, etc.The high inflation and high oil prices means higher cost to SIA. Did you also notice the high electricity bill too?No covid vaccine can help as they are NOT the silver bullet, and they cannot remove covid virus from this planet, and also cannot prevent covid mutation, and thus other countries will cancel travel oversea, since the covid virus will continue to roam with us and mutate.Please enlighten me and feel free to comment below.

2021-12-21

First post 😉

Let the Roblox Share Price Decline to $70, Then Start a Position

2021-12-20

@小虎活动 @TigerEvents, please come out with lots of events that have lots of rewards for us. Merry Christmas 2021. [YoYo] [YoYo]

@小虎活动:小虎活动账号搬迁通知，快来关注TigerEvents

2021-12-20

First post 😉

Summit Therapeutics Shares Fall nearly 30% After Failing to Meet Endpoint in Phase 3 Ri-CoDIFy Study

2021-12-19

😉

US IPO Week Ahead: The IPO market decks the halls with 1 IPO in the short holiday week

2021-12-17

U.S. stocks sink at Friday's open,Nasdaq Composite Index declines 0.9%

U.S. stocks sink at Friday's open,Nasdaq Composite Index declines 0.9%

去老虎APP查看更多动态

{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":"3585001294737518","uuid":"3585001294737518","gmtCreate":1621913938254,"gmtModify":1623508272458,"name":"Universe宇宙","pinyin":"universeyzuniverseyuzhou","introduction":"","introductionEn":"","signature":"Travelling around the universe","avatar":"https://static.laohu8.com/default-avatar.jpg","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":130,"headSize":46,"tweetSize":560,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":3,"name":"书生虎","nameTw":"書生虎","represent":"努力向上","factor":"发布10条非转发主帖,其中5条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":3,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"228c86a078844d74991fff2b7ab2428d-2","templateUuid":"228c86a078844d74991fff2b7ab2428d","name":"投资总监虎","description":"证券账户累计交易金额达到30万美元","bigImgUrl":"https://static.tigerbbs.com/9d20b23f1b6335407f882bc5c2ad12c0","smallImgUrl":"https://static.tigerbbs.com/ada3b4533518ace8404a3f6dd192bd29","grayImgUrl":"https://static.tigerbbs.com/177f283ba21d1c077054dac07f88f3bd","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.07.14","exceedPercentage":"80.45%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"35ec162348d5460f88c959321e554969-2","templateUuid":"35ec162348d5460f88c959321e554969","name":"宗师交易员","description":"证券或期货账户累计交易次数达到100次","bigImgUrl":"https://static.tigerbbs.com/ad22cfbe2d05aa393b18e9226e4b0307","smallImgUrl":"https://static.tigerbbs.com/36702e6ff3ffe46acafee66cc85273ca","grayImgUrl":"https://static.tigerbbs.com/d52eb88fa385cf5abe2616ed63781765","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.11.12","exceedPercentage":"80.15%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-1","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"出道虎友","description":"加入老虎社区500天","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.10.08","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":6,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":692138642,"gmtCreate":1640871344543,"gmtModify":1640871592905,"author":{"id":"3585001294737518","authorId":"3585001294737518","name":"Universe宇宙","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3585001294737518","idStr":"3585001294737518"},"themes":[],"htmlText":"First post 😉","listText":"First post 😉","text":"First post 😉","images":[],"top":1,"highlighted":2,"essential":1,"paper":1,"likeSize":2,"commentSize":17,"repostSize":0,"link":"https://laohu8.com/post/692138642","repostId":"2195495494","repostType":4,"isVote":1,"tweetType":1,"viewCount":1510,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":696468200,"gmtCreate":1640748819402,"gmtModify":1640748935261,"author":{"id":"3585001294737518","authorId":"3585001294737518","name":"Universe宇宙","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3585001294737518","idStr":"3585001294737518"},"themes":[],"htmlText":"First post 😉","listText":"First post 😉","text":"First post 😉","images":[],"top":1,"highlighted":2,"essential":1,"paper":1,"likeSize":3,"commentSize":16,"repostSize":0,"link":"https://laohu8.com/post/696468200","repostId":"1121384359","repostType":4,"repost":{"id":"1121384359","weMediaInfo":{"introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"media_name":"Dow Jones","id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"pubTimestamp":1640747921,"share":"https://www.laohu8.com/m/news/1121384359?lang=&edition=full","pubTime":"2021-12-29 11:18","market":"us","language":"en","title":"JinkoSolar Holdings Up on Shanghai Listing","url":"https://stock-news.laohu8.com/highlight/detail?id=1121384359","media":"Dow Jones","summary":"ADRs of JinkoSolar Holdings Co. Ltd. rose 4.58% on Tuesday after the solar module maker said the Chi","content":"<p>ADRs of JinkoSolar Holdings Co. Ltd. rose 4.58% on Tuesday after the solar module maker said the China Securities Regulatory Commission cleared the listing of its principal operating subsidiary on the Shanghai Stock Exchange's Sci-Tech innovation board. The company said it will soon enter the issuance process for its Shanghai IPO.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>JinkoSolar Holdings Up on Shanghai Listing</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nJinkoSolar Holdings Up on Shanghai Listing\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2021-12-29 11:18</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p>ADRs of JinkoSolar Holdings Co. Ltd. rose 4.58% on Tuesday after the solar module maker said the China Securities Regulatory Commission cleared the listing of its principal operating subsidiary on the Shanghai Stock Exchange's Sci-Tech innovation board. The company said it will soon enter the issuance process for its Shanghai IPO.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"JKS":"晶科能源"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1121384359","content_text":"ADRs of JinkoSolar Holdings Co. Ltd. rose 4.58% on Tuesday after the solar module maker said the China Securities Regulatory Commission cleared the listing of its principal operating subsidiary on the Shanghai Stock Exchange's Sci-Tech innovation board. The company said it will soon enter the issuance process for its Shanghai IPO.","news_type":1},"isVote":1,"tweetType":1,"viewCount":765,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":696891212,"gmtCreate":1640658030256,"gmtModify":1640658031502,"author":{"id":"3585001294737518","authorId":"3585001294737518","name":"Universe宇宙","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3585001294737518","idStr":"3585001294737518"},"themes":[],"htmlText":"Higher, higher and more higher than inflation and interest rates! 😉🎉","listText":"Higher, higher and more higher than inflation and interest rates! 😉🎉","text":"Higher, higher and more higher than inflation and interest rates! 😉🎉","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/696891212","repostId":"1137993417","repostType":4,"isVote":1,"tweetType":1,"viewCount":1259,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":696156872,"gmtCreate":1640653862375,"gmtModify":1640654057013,"author":{"id":"3585001294737518","authorId":"3585001294737518","name":"Universe宇宙","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3585001294737518","idStr":"3585001294737518"},"themes":[],"htmlText":"First post 😉","listText":"First post 😉","text":"First post 😉","images":[],"top":1,"highlighted":2,"essential":1,"paper":1,"likeSize":3,"commentSize":15,"repostSize":0,"link":"https://laohu8.com/post/696156872","repostId":"1151169779","repostType":4,"repost":{"id":"1151169779","pubTimestamp":1640653683,"share":"https://www.laohu8.com/m/news/1151169779?lang=&edition=full","pubTime":"2021-12-28 09:08","market":"us","language":"en","title":"Brace yourself for Big Tech correction in early 2022 - Loup Ventures' Gene Munster","url":"https://stock-news.laohu8.com/highlight/detail?id=1151169779","media":"seekingalpha","summary":"Loup Ventures analyst Gene Munster warned investors to \"brace yourself\" for a potential correction i","content":"<ul>\n <li>Loup Ventures analyst Gene Munster warned investors to \"brace yourself\" for a potential correction in Big Tech during the first three months&nbsp;of 2022, as the market comes to terms with the likelihood that higher interest rates will force valuations to contract.</li>\n <li>\"I think investors in Big Tech should enter 2022 with a healthy dose of caution,\" the Loup Ventures founder and managing partner told CNBC on Monday.</li>\n <li>Munster pointed to the Federal Reserve's next policy meeting as a potential catalyst for a correction in many of the high-flying tech names. The Fed is scheduled to conclude its next meeting on Jan. 26.</li>\n <li>The Loup Ventures founder predicted that Apple(NASDAQ:AAPL)would continue to outperform most of its peers, projecting that the iPhone maker could be a $250 stock \"in the next few years.\" (AAPL enters the last week of 2021 at just above $176.)</li>\n <li>However, Munster specifically highlighted high valuations for names like Amazon(NASDAQ:AMZN), Netflix(NASDAQ:NFLX), NVIDIA(NASDAQ:NVDA), Tesla(NASDAQ:TSLA)and Rivian(NASDAQ:RIVN).</li>\n <li>Munster quickly added that he believes in the long-term value of Big Tech but that earnings and revenue growth in 2022 will not be enough for most companies to overcome the contracting valuations that traditionally come with rising interest rates.</li>\n <li>Looking longer-term, the Loup Ventures managing partner argued that the metaverse will see some \"fits and starts in terms of investor enthusiasm\" in 2022 but will eventually \"capture the majority of our time in the future,\" making it a core tech theme for the next five years and beyond.</li>\n <li>In addition, Munster pointed to autonomy and self-driving cars as another major tech advance that will dominate the coming years.</li>\n <li>\"I'm a big believer in Big Tech,\" he said but added that for the near-term, investors needed a \"more sober\" thought process surrounding the impact of interest rates on valuation.</li>\n <li>Comparing some of the stocks that Munster mentioned, NVDA has outperformed the rest of the group, rising by about 127% over the course of 2021. TSLA also had an excellent year as well, notching a 51% advance.</li>\n <li>AAPL has slightly outpaced the S&amp;P 500, posting a gain of nearly 33%. NFLX and AMZN have significantly underperformed the broader market,posting gains of 14% and 5%, respectively:</li>\n</ul>\n<p><img src=\"https://static.tigerbbs.com/fc7123954b4d89ae78502400737b4d73\" tg-width=\"1200\" tg-height=\"408\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"></p>","source":"seekingalpha","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Brace yourself for Big Tech correction in early 2022 - Loup Ventures' Gene Munster</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBrace yourself for Big Tech correction in early 2022 - Loup Ventures' Gene Munster\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-28 09:08 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3783427-brace-yourself-for-big-tech-correction-in-early-2022-loup-ventures-gene-munster><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Loup Ventures analyst Gene Munster warned investors to \"brace yourself\" for a potential correction in Big Tech during the first three months of 2022, as the market comes to terms with the likelihood ...</p>\n\n<a href=\"https://seekingalpha.com/news/3783427-brace-yourself-for-big-tech-correction-in-early-2022-loup-ventures-gene-munster\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".DJI":"道琼斯",".SPX":"S&P 500 Index",".IXIC":"NASDAQ Composite"},"source_url":"https://seekingalpha.com/news/3783427-brace-yourself-for-big-tech-correction-in-early-2022-loup-ventures-gene-munster","is_english":true,"share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","article_id":"1151169779","content_text":"Loup Ventures analyst Gene Munster warned investors to \"brace yourself\" for a potential correction in Big Tech during the first three months of 2022, as the market comes to terms with the likelihood that higher interest rates will force valuations to contract.\n\"I think investors in Big Tech should enter 2022 with a healthy dose of caution,\" the Loup Ventures founder and managing partner told CNBC on Monday.\nMunster pointed to the Federal Reserve's next policy meeting as a potential catalyst for a correction in many of the high-flying tech names. The Fed is scheduled to conclude its next meeting on Jan. 26.\nThe Loup Ventures founder predicted that Apple(NASDAQ:AAPL)would continue to outperform most of its peers, projecting that the iPhone maker could be a $250 stock \"in the next few years.\" (AAPL enters the last week of 2021 at just above $176.)\nHowever, Munster specifically highlighted high valuations for names like Amazon(NASDAQ:AMZN), Netflix(NASDAQ:NFLX), NVIDIA(NASDAQ:NVDA), Tesla(NASDAQ:TSLA)and Rivian(NASDAQ:RIVN).\nMunster quickly added that he believes in the long-term value of Big Tech but that earnings and revenue growth in 2022 will not be enough for most companies to overcome the contracting valuations that traditionally come with rising interest rates.\nLooking longer-term, the Loup Ventures managing partner argued that the metaverse will see some \"fits and starts in terms of investor enthusiasm\" in 2022 but will eventually \"capture the majority of our time in the future,\" making it a core tech theme for the next five years and beyond.\nIn addition, Munster pointed to autonomy and self-driving cars as another major tech advance that will dominate the coming years.\n\"I'm a big believer in Big Tech,\" he said but added that for the near-term, investors needed a \"more sober\" thought process surrounding the impact of interest rates on valuation.\nComparing some of the stocks that Munster mentioned, NVDA has outperformed the rest of the group, rising by about 127% over the course of 2021. TSLA also had an excellent year as well, notching a 51% advance.\nAAPL has slightly outpaced the S&P 500, posting a gain of nearly 33%. NFLX and AMZN have significantly underperformed the broader market,posting gains of 14% and 5%, respectively:","news_type":1},"isVote":1,"tweetType":1,"viewCount":829,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":696978060,"gmtCreate":1640611791191,"gmtModify":1640611883951,"author":{"id":"3585001294737518","authorId":"3585001294737518","name":"Universe宇宙","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3585001294737518","idStr":"3585001294737518"},"themes":[],"htmlText":"First post 😉","listText":"First post 😉","text":"First post 😉","images":[],"top":1,"highlighted":2,"essential":1,"paper":1,"likeSize":4,"commentSize":17,"repostSize":0,"link":"https://laohu8.com/post/696978060","repostId":"1111088353","repostType":4,"repost":{"id":"1111088353","pubTimestamp":1640610579,"share":"https://www.laohu8.com/m/news/1111088353?lang=&edition=full","pubTime":"2021-12-27 21:09","market":"us","language":"en","title":"Plug Power Trades Like A Story Stock And Smells Like An Early-Stage Tesla","url":"https://stock-news.laohu8.com/highlight/detail?id=1111088353","media":"Seeking Alpha","summary":"Summary\n\nThe stock of Plug Power enjoyed some great appreciation during the last years, which seems ","content":"<p><b>Summary</b></p>\n<ul>\n <li>The stock of Plug Power enjoyed some great appreciation during the last years, which seems hard to explain when purely looking at the fundamentals.</li>\n <li>The stock performance of almost 2,000% over the last 5 years is an illustration of the increased momentum of the hydrogen market.</li>\n <li>Plug Power shows some important parallels with Tesla, on which I will elaborate in this article.</li>\n <li>If the sentiment can remain positive while growth continues, short-term fundamentals might not matter much.</li>\n</ul>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/80405c7f3988b402597ce18944c15c47\" tg-width=\"1536\" tg-height=\"683\" width=\"100%\" height=\"auto\"><span>http://www.fotogestoeber.de/iStock via Getty Images</span></p>\n<p>How can a company in a niche sector which has continuously burned cash over the years have a market capitalization of over $17B? Plug Power (PLUG) is a pure-play hydrogen company that has yet to run a profit. Still, the stock has returned a total of almost 2,000% over the last 5 years.</p>\n<p>In this article, I will investigate the promises and expectations behind Plug Power and compare the stock to another stock with large promises: Tesla (TSLA).</p>\n<p><b>Great stock performance, but a lofty valuation</b></p>\n<p>Plug Power has behaved somewhat like a battleground stock during the last couple of years. Ever since the&nbsp;2014 hydrogen rally, Plug Power has remained a stock that lured investors who believe in the technology, but also attracted quite some short-sellers, judged by its current short interest of almost 10 percent.</p>\n<p>More recently, the stock has experienced a huge liftoff, most likely fueled by the announcement of the&nbsp;Build Back Better Plan&nbsp;of president Biden. Since then, Plug Power's stock more or less came back to earth again, even though it is still trading at a very high price to sales ratio.</p>\n<p>Please review the following charts for illustration of these metrics:</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/3664f73c0fc1fcd1b2673c8df4701be5\" tg-width=\"635\" tg-height=\"478\" width=\"100%\" height=\"auto\"><span>Data by YCharts</span></p>\n<p><i>Plug Power development of share price, short interest, and price to sales ratio during the last 10 years. (source: YCharts)</i></p>\n<p>A true story stock</p>\n<blockquote>\n A story stock refers to a company's shares whose value reflects expected outperformance, the culmination of some new innovation, or favorable press coverage, rather than its market value being solely based on fundamentals like assets and income (Source:Investopedia)\n</blockquote>\n<p>A story can be a powerful backbone of stock performance. Though the hydrogen market is still somewhat of a niche, the story of Plug is one of great expectations.</p>\n<p>Hydrogen is indeed a promising market. Let us explore the&nbsp;potential benefits and promises&nbsp;of hydrogen:</p>\n<ul>\n <li>Green hydrogen can help to decarbonize multiple sectors in which it is difficult to reduce emissions, like long-haul transport, chemical industry, and iron and steel production.</li>\n <li>Green hydrogen can contribute to improvements in air quality and energy security.</li>\n <li>Hydrogen can be produced using a multitude of sources, such as renewables, nuclear energy, natural gas, oil, and even coal. Transportation can be done using pipelines or in liquefied form. It can be transformed into electricity very easily.</li>\n <li>Hydrogen can play an important role in coping with the variable outputs of renewable energy sources. Wind and solar energy output are not always in sync with electricity demand, and hydrogen can be used as a store or energy in times when renewable energy production outpaces demand. These storages can be used in times when renewable energy output is lower than demand, and can be saved for days, weeks, or even months, and can even be transported over long distances if needed.</li>\n <li>Clean hydrogen is currently used in an expanding number of projects worldwide, and it seems to be a matter of time before the technology is scaled up and costs are brought down.</li>\n <li>Currently, hydrogen is mostly used in oil refining processes and for the production of fertilizers. Sectors in which it is still hardly used, like transport, buildings, and power generation seem large untapped markets.</li>\n</ul>\n<p>As such, hydrogen could play an important supporting role in the renewable energy transition, supplying markets that are difficult or impractical to reach for batteries.</p>\n<p>Plug Power has a focused strategy, is already an established business in the hydrogen market, and has a large growing number of commercial relationships. This might mean that the company has the potential to become one of the first pure-play hydrogen companies which&nbsp;could transition&nbsp;from a story stock to a large positive cash flow company.</p>\n<p>The commercial relationships and collaborations which Plug is undertaking are among the most important future drivers of growth for the company, among which are collaborations with&nbsp;Airbus(OTCPK:EADSF),Phillips66(PSX),Acciona(OTCPK:ACXIF),BAE Systems(OTCPK:BAESF),Baker Hughes(BKR), and&nbsp;Brookfield Renewable(BEP).</p>\n<p><b>Parallels with early-stage Tesla</b></p>\n<p>I think it is very interesting to compare Plug Power with Tesla. This seems to make sense since they were both one of the largest first movers in big markets: EV for Tesla and hydrogen for Plug. Tesla also was (and might still be) a good example of a story stock, with their large promises of electrifying the automotive sector.</p>\n<p>Let us look at the share price development, short percentage, and PS ratio of Tesla during the period from 2010 to the end of 2019:</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/d9911b4514f3c0a566dffcd28c188e1c\" tg-width=\"635\" tg-height=\"478\" width=\"100%\" height=\"auto\"><span>Data by YCharts</span></p>\n<p><i>Tesla's development of share price, short interest, and price to sales ratio between 2010 and the end of 2019. (source: YCharts)</i></p>\n<p>There are some noticeable differences between the share price development of Plug Power and an earlier-stage Tesla. First of all, from 2012 to 2019, the percentage of Tesla's stock sold short has consistently oscillated around 20%. Plug Power is already under 10% and has moved around 15% for the largest part of the last couple of years. But the biggest difference between the two stocks is probably that the price to sales ratio of Tesla has trended down quickly between 2010 and the end of 2019. Since Plug Power's price to sales ratio is heavily influenced by its recent outlier, let us take a look at a graph comparing the two between 2010 and September of this year:</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/d46be5e658002b2f45b8c5ca43559b93\" tg-width=\"635\" tg-height=\"433\" width=\"100%\" height=\"auto\"><span>Data by YCharts</span></p>\n<p><i>Tesla and Plug Power development price to sales ratio between 2010 and September 2021. (source: YCharts)</i></p>\n<p>These two ratios look to have a lot more in common. But as we can already see, after the end of 2019, Tesla's price to sales ratio went sharply up again. The reason for this was, of course, the almost unprecedented skyrocketing of the Tesla stock starting from the end of 2019. This is illustrated in the following graph of what happened to Tesla shares from September 2019 until now:</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/d29232b1b3d9ff99e1edb6e4eac33901\" tg-width=\"635\" tg-height=\"478\" width=\"100%\" height=\"auto\"><span>Data by YCharts</span></p>\n<p><i>Development of Tesla share price, short interest, and price to sales ratio between September 2019 and now. (source: YCharts)</i></p>\n<p>As the stock price of Tesla skyrocketed, the short percentage went down sharply and the PS ratio went up.</p>\n<p>The million-dollar question is of course, could this happen to Plug Power as well? Technically, if we look solely at the metrics of Plug compared with the metrics of Tesla just before the stock price exploded, the P/S ratio of Plug is still much too high to expect that the stock could go in the same direction in short order. I also believe that fundamentally, Plug would need to experience some serious growth for the stock to be able to regain its recent upward momentum.</p>\n<p>Another similarity between Plug and Tesla is that negative earnings surprises have been many at Plug recently, this happened to Tesla as well&nbsp;in 2019. At the time, Tesla's stock price was not negatively impacted by those surprises. Currently, the market seems to shake off Plug Power's results as well, though the stock did drop by more than 50% since last year.</p>\n<p><b>Currently, expectations still beat metrics</b></p>\n<p>Like Tesla, Plug's share price seems to be governed more by growth expectations than by current stock metrics. This<i>could</i>mean that Plug would be able to go in the same direction as Tesla if enough investors remain convinced that their business model is profitable for the future and if growth can be expected to continue. Also, as for Tesla, in the long term, fundamental metrics will need to correspond with their lofty valuations. This means that the companies will need to deliver on their expectations.</p>\n<p><b>These are some very large ifs.</b></p>\n<p>Of course, the hydrogen market is different from the EV market. Since the energy density of hydrogen is very high, it will likely be able to compete in markets where batteries still have issues, like long-haul transport. On the other hand, on an energy efficiency level, batteries have some large benefits over hydrogen for smaller transport purposes. On aggregate, I am skeptical about hydrogen being able to be a strong competitor in the EV space, but it will likely play a large role in other modes of transport, as in energy storage.</p>\n<p>Plug Power has been trading like a stock for believers, which shows some strong parallels with Tesla. Theoretically, the stock could follow the same direction as Tesla did, but this is anyone's guess and I believe it would take more growth to continue its upward momentum.</p>\n<p>Plug Power is a promising business, but the company had some bad results recently. This did not impact the stock much during the last 2 years. In the short term, the stock price seems to be most impacted by sentiment and not by fundamentals. This makes it a wonderful stock for traders, but as a long-term investor, I am staying on the sidelines.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Plug Power Trades Like A Story Stock And Smells Like An Early-Stage Tesla</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPlug Power Trades Like A Story Stock And Smells Like An Early-Stage Tesla\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-27 21:09 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/article/4476789-plug-power-stock-promising-business-parallels-with-tesla><strong>Seeking Alpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Summary\n\nThe stock of Plug Power enjoyed some great appreciation during the last years, which seems hard to explain when purely looking at the fundamentals.\nThe stock performance of almost 2,000% over...</p>\n\n<a href=\"https://seekingalpha.com/article/4476789-plug-power-stock-promising-business-parallels-with-tesla\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://seekingalpha.com/article/4476789-plug-power-stock-promising-business-parallels-with-tesla","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1111088353","content_text":"Summary\n\nThe stock of Plug Power enjoyed some great appreciation during the last years, which seems hard to explain when purely looking at the fundamentals.\nThe stock performance of almost 2,000% over the last 5 years is an illustration of the increased momentum of the hydrogen market.\nPlug Power shows some important parallels with Tesla, on which I will elaborate in this article.\nIf the sentiment can remain positive while growth continues, short-term fundamentals might not matter much.\n\nhttp://www.fotogestoeber.de/iStock via Getty Images\nHow can a company in a niche sector which has continuously burned cash over the years have a market capitalization of over $17B? Plug Power (PLUG) is a pure-play hydrogen company that has yet to run a profit. Still, the stock has returned a total of almost 2,000% over the last 5 years.\nIn this article, I will investigate the promises and expectations behind Plug Power and compare the stock to another stock with large promises: Tesla (TSLA).\nGreat stock performance, but a lofty valuation\nPlug Power has behaved somewhat like a battleground stock during the last couple of years. Ever since the 2014 hydrogen rally, Plug Power has remained a stock that lured investors who believe in the technology, but also attracted quite some short-sellers, judged by its current short interest of almost 10 percent.\nMore recently, the stock has experienced a huge liftoff, most likely fueled by the announcement of the Build Back Better Plan of president Biden. Since then, Plug Power's stock more or less came back to earth again, even though it is still trading at a very high price to sales ratio.\nPlease review the following charts for illustration of these metrics:\nData by YCharts\nPlug Power development of share price, short interest, and price to sales ratio during the last 10 years. (source: YCharts)\nA true story stock\n\n A story stock refers to a company's shares whose value reflects expected outperformance, the culmination of some new innovation, or favorable press coverage, rather than its market value being solely based on fundamentals like assets and income (Source:Investopedia)\n\nA story can be a powerful backbone of stock performance. Though the hydrogen market is still somewhat of a niche, the story of Plug is one of great expectations.\nHydrogen is indeed a promising market. Let us explore the potential benefits and promises of hydrogen:\n\nGreen hydrogen can help to decarbonize multiple sectors in which it is difficult to reduce emissions, like long-haul transport, chemical industry, and iron and steel production.\nGreen hydrogen can contribute to improvements in air quality and energy security.\nHydrogen can be produced using a multitude of sources, such as renewables, nuclear energy, natural gas, oil, and even coal. Transportation can be done using pipelines or in liquefied form. It can be transformed into electricity very easily.\nHydrogen can play an important role in coping with the variable outputs of renewable energy sources. Wind and solar energy output are not always in sync with electricity demand, and hydrogen can be used as a store or energy in times when renewable energy production outpaces demand. These storages can be used in times when renewable energy output is lower than demand, and can be saved for days, weeks, or even months, and can even be transported over long distances if needed.\nClean hydrogen is currently used in an expanding number of projects worldwide, and it seems to be a matter of time before the technology is scaled up and costs are brought down.\nCurrently, hydrogen is mostly used in oil refining processes and for the production of fertilizers. Sectors in which it is still hardly used, like transport, buildings, and power generation seem large untapped markets.\n\nAs such, hydrogen could play an important supporting role in the renewable energy transition, supplying markets that are difficult or impractical to reach for batteries.\nPlug Power has a focused strategy, is already an established business in the hydrogen market, and has a large growing number of commercial relationships. This might mean that the company has the potential to become one of the first pure-play hydrogen companies which could transition from a story stock to a large positive cash flow company.\nThe commercial relationships and collaborations which Plug is undertaking are among the most important future drivers of growth for the company, among which are collaborations with Airbus(OTCPK:EADSF),Phillips66(PSX),Acciona(OTCPK:ACXIF),BAE Systems(OTCPK:BAESF),Baker Hughes(BKR), and Brookfield Renewable(BEP).\nParallels with early-stage Tesla\nI think it is very interesting to compare Plug Power with Tesla. This seems to make sense since they were both one of the largest first movers in big markets: EV for Tesla and hydrogen for Plug. Tesla also was (and might still be) a good example of a story stock, with their large promises of electrifying the automotive sector.\nLet us look at the share price development, short percentage, and PS ratio of Tesla during the period from 2010 to the end of 2019:\nData by YCharts\nTesla's development of share price, short interest, and price to sales ratio between 2010 and the end of 2019. (source: YCharts)\nThere are some noticeable differences between the share price development of Plug Power and an earlier-stage Tesla. First of all, from 2012 to 2019, the percentage of Tesla's stock sold short has consistently oscillated around 20%. Plug Power is already under 10% and has moved around 15% for the largest part of the last couple of years. But the biggest difference between the two stocks is probably that the price to sales ratio of Tesla has trended down quickly between 2010 and the end of 2019. Since Plug Power's price to sales ratio is heavily influenced by its recent outlier, let us take a look at a graph comparing the two between 2010 and September of this year:\nData by YCharts\nTesla and Plug Power development price to sales ratio between 2010 and September 2021. (source: YCharts)\nThese two ratios look to have a lot more in common. But as we can already see, after the end of 2019, Tesla's price to sales ratio went sharply up again. The reason for this was, of course, the almost unprecedented skyrocketing of the Tesla stock starting from the end of 2019. This is illustrated in the following graph of what happened to Tesla shares from September 2019 until now:\nData by YCharts\nDevelopment of Tesla share price, short interest, and price to sales ratio between September 2019 and now. (source: YCharts)\nAs the stock price of Tesla skyrocketed, the short percentage went down sharply and the PS ratio went up.\nThe million-dollar question is of course, could this happen to Plug Power as well? Technically, if we look solely at the metrics of Plug compared with the metrics of Tesla just before the stock price exploded, the P/S ratio of Plug is still much too high to expect that the stock could go in the same direction in short order. I also believe that fundamentally, Plug would need to experience some serious growth for the stock to be able to regain its recent upward momentum.\nAnother similarity between Plug and Tesla is that negative earnings surprises have been many at Plug recently, this happened to Tesla as well in 2019. At the time, Tesla's stock price was not negatively impacted by those surprises. Currently, the market seems to shake off Plug Power's results as well, though the stock did drop by more than 50% since last year.\nCurrently, expectations still beat metrics\nLike Tesla, Plug's share price seems to be governed more by growth expectations than by current stock metrics. Thiscouldmean that Plug would be able to go in the same direction as Tesla if enough investors remain convinced that their business model is profitable for the future and if growth can be expected to continue. Also, as for Tesla, in the long term, fundamental metrics will need to correspond with their lofty valuations. This means that the companies will need to deliver on their expectations.\nThese are some very large ifs.\nOf course, the hydrogen market is different from the EV market. Since the energy density of hydrogen is very high, it will likely be able to compete in markets where batteries still have issues, like long-haul transport. On the other hand, on an energy efficiency level, batteries have some large benefits over hydrogen for smaller transport purposes. On aggregate, I am skeptical about hydrogen being able to be a strong competitor in the EV space, but it will likely play a large role in other modes of transport, as in energy storage.\nPlug Power has been trading like a stock for believers, which shows some strong parallels with Tesla. Theoretically, the stock could follow the same direction as Tesla did, but this is anyone's guess and I believe it would take more growth to continue its upward momentum.\nPlug Power is a promising business, but the company had some bad results recently. This did not impact the stock much during the last 2 years. In the short term, the stock price seems to be most impacted by sentiment and not by fundamentals. This makes it a wonderful stock for traders, but as a long-term investor, I am staying on the sidelines.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1122,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":698545633,"gmtCreate":1640480310602,"gmtModify":1640480414613,"author":{"id":"3585001294737518","authorId":"3585001294737518","name":"Universe宇宙","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3585001294737518","idStr":"3585001294737518"},"themes":[],"htmlText":"First post 😉","listText":"First post 😉","text":"First post 😉","images":[],"top":1,"highlighted":2,"essential":1,"paper":1,"likeSize":6,"commentSize":17,"repostSize":0,"link":"https://laohu8.com/post/698545633","repostId":"2194171798","repostType":4,"repost":{"id":"2194171798","pubTimestamp":1640480255,"share":"https://www.laohu8.com/m/news/2194171798?lang=&edition=full","pubTime":"2021-12-26 08:57","market":"us","language":"en","title":"1 Retail Stock That Can Go Head-to-Head With E-Commerce","url":"https://stock-news.laohu8.com/highlight/detail?id=2194171798","media":"Motley Fool","summary":"This company aced its pivot to omnichannel retail.","content":"<p>It wasn't too long ago that <b>Best Buy</b>'s (NYSE:BBY) viability was in doubt. E-commerce retailers like <b>Amazon</b> (NASDAQ:AMZN) were taking market share, and many of Best Buy's stores simply weren't set up well to compete. In this <i>Fool Live</i> video clip,&nbsp;<b>recorded on Dec. 13,&nbsp;</b>Fool.com contributors Jason Hall and Danny Vena discuss Best Buy's impressive transformation and what could be ahead.</p>\n<p><b>Jason Hall:</b> This company is an absolute survivor. You go back to the early 2000s when Best Buy was really just emerging as a national player. What a lot of people don't know is that the company almost got put out of business for bait-and-switch tactics because they had a high-pressure commission salesforce, and they were baiting and switching. And the company, they still deny that, but the reality is that's what they were doing.</p>\n<p>They came away from it, they dropped their entire sales staff to hourly, changed the model completely. Coincided with the birth of the internet and people not really needing to find a salesperson to explain the difference between two dryers anymore -- that's what the internet is for. They revolutionized their business and went on a 10-year raging growth path. Then the internet started to become the enemy of the business, as Matt was talking about. Then they were able to pivot with their omnichannel. That's worked really well.</p>\n<p>I think just right now, they're dealing with the fact that everything they sell has a semiconductor in it. There's not enough of those around anymore. If that's a problem in the near term. But I think it's an opportunity in the long term because everything they sell has a semiconductor in it, that means they are selling the things that people want. I think it fits right in the middle of this pack. It's a good, strong business. It's a survivor, probably not a market beater, market killer anyway, probably a run-at-market-perform business. But I think it's pretty well positioned.</p>\n<p><b>Danny Vena:</b> Yes, this is a company that I voted probably the high end of middle of the pack. I voted this No. 4 [out of 10 \"holiday shopping\" stocks]. For me, I think one of the more overlooked things about Best Buy, and I absolutely agree with everything that Jason said and the fact that the company has done remarkably well at doing the omnichannel business during the pandemic. They had folks order stuff online, pickup in store so they could get it right away. They were able to tap into that remote work from home, trends that happened.</p>\n<p>I think one of the most overlooked things about what Best Buy has done is they have introduced essentially a subscription program. They already had one where you could pay $199 a year and you could bring in your computer and have them diagnosis it. They could add software, they could do a lot of things. Now, they have changed that to where you get unlimited calls with Geek Squad. They will help you with essentially anything having to do with electronics. That I think is going to be a high-margin business. I think it's going to lift their margins. I think it gives them an opportunity to keep their brand front of mind with consumers.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>1 Retail Stock That Can Go Head-to-Head With E-Commerce</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n1 Retail Stock That Can Go Head-to-Head With E-Commerce\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-26 08:57 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/12/25/1-retail-stock-that-can-go-head-to-head-with-e-com/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>It wasn't too long ago that Best Buy's (NYSE:BBY) viability was in doubt. E-commerce retailers like Amazon (NASDAQ:AMZN) were taking market share, and many of Best Buy's stores simply weren't set up ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/12/25/1-retail-stock-that-can-go-head-to-head-with-e-com/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4532":"文艺复兴科技持仓","AMZN":"亚马逊","BK4554":"元宇宙及AR概念","BK4567":"ESG概念","BK4507":"流媒体概念","BK4534":"瑞士信贷持仓","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4566":"资本集团","BK4524":"宅经济概念","BK4535":"淡马锡持仓","BK4527":"明星科技股","BK4559":"巴菲特持仓","BK4538":"云计算","BK4550":"红杉资本持仓","BK4076":"电脑与电子产品零售","BK4503":"景林资产持仓","BK4122":"互联网与直销零售","BK4551":"寇图资本持仓","BK4561":"索罗斯持仓","BBY":"百思买","BK4548":"巴美列捷福持仓"},"source_url":"https://www.fool.com/investing/2021/12/25/1-retail-stock-that-can-go-head-to-head-with-e-com/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2194171798","content_text":"It wasn't too long ago that Best Buy's (NYSE:BBY) viability was in doubt. E-commerce retailers like Amazon (NASDAQ:AMZN) were taking market share, and many of Best Buy's stores simply weren't set up well to compete. In this Fool Live video clip, recorded on Dec. 13, Fool.com contributors Jason Hall and Danny Vena discuss Best Buy's impressive transformation and what could be ahead.\nJason Hall: This company is an absolute survivor. You go back to the early 2000s when Best Buy was really just emerging as a national player. What a lot of people don't know is that the company almost got put out of business for bait-and-switch tactics because they had a high-pressure commission salesforce, and they were baiting and switching. And the company, they still deny that, but the reality is that's what they were doing.\nThey came away from it, they dropped their entire sales staff to hourly, changed the model completely. Coincided with the birth of the internet and people not really needing to find a salesperson to explain the difference between two dryers anymore -- that's what the internet is for. They revolutionized their business and went on a 10-year raging growth path. Then the internet started to become the enemy of the business, as Matt was talking about. Then they were able to pivot with their omnichannel. That's worked really well.\nI think just right now, they're dealing with the fact that everything they sell has a semiconductor in it. There's not enough of those around anymore. If that's a problem in the near term. But I think it's an opportunity in the long term because everything they sell has a semiconductor in it, that means they are selling the things that people want. I think it fits right in the middle of this pack. It's a good, strong business. It's a survivor, probably not a market beater, market killer anyway, probably a run-at-market-perform business. But I think it's pretty well positioned.\nDanny Vena: Yes, this is a company that I voted probably the high end of middle of the pack. I voted this No. 4 [out of 10 \"holiday shopping\" stocks]. For me, I think one of the more overlooked things about Best Buy, and I absolutely agree with everything that Jason said and the fact that the company has done remarkably well at doing the omnichannel business during the pandemic. They had folks order stuff online, pickup in store so they could get it right away. They were able to tap into that remote work from home, trends that happened.\nI think one of the most overlooked things about what Best Buy has done is they have introduced essentially a subscription program. They already had one where you could pay $199 a year and you could bring in your computer and have them diagnosis it. They could add software, they could do a lot of things. Now, they have changed that to where you get unlimited calls with Geek Squad. They will help you with essentially anything having to do with electronics. That I think is going to be a high-margin business. I think it's going to lift their margins. I think it gives them an opportunity to keep their brand front of mind with consumers.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1363,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":698202424,"gmtCreate":1640397716691,"gmtModify":1640397832003,"author":{"id":"3585001294737518","authorId":"3585001294737518","name":"Universe宇宙","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3585001294737518","idStr":"3585001294737518"},"themes":[],"htmlText":"First post 😉","listText":"First post 😉","text":"First post 😉","images":[],"top":1,"highlighted":2,"essential":1,"paper":1,"likeSize":5,"commentSize":15,"repostSize":0,"link":"https://laohu8.com/post/698202424","repostId":"1159652805","repostType":4,"repost":{"id":"1159652805","pubTimestamp":1640397611,"share":"https://www.laohu8.com/m/news/1159652805?lang=&edition=full","pubTime":"2021-12-25 10:00","market":"us","language":"en","title":"Electric boat developer Forza X1 files for a $29 million IPO","url":"https://stock-news.laohu8.com/highlight/detail?id=1159652805","media":"Renaissance Capital","summary":"Forza X1, a fully electric boat developer being spun out of Twin Vee PowerCats, filed on Thursday wi","content":"<p>Forza X1, a fully electric boat developer being spun out of Twin Vee PowerCats, filed on Thursday with the SEC to raise up to $29 million in an initial public offering.</p>\n<p>The company states that it&nbsp;aims to be among the first to develop and manufacture fully electric, affordable boats with mass appeal. Forza X1 is focused on the creation and implementation of marine electric vehicle (\"EV\") technology to control and power its electric boats utilizing a proprietary outboard electric motor. It believes to be one the first companies to design a fully integrated electric boat including the hull, outboard motor and control system for mass production. To date, Forza has designed and manufactured only prototypes of its electric sport boat, has not yet commercialized its boats, and has not sold any boats.</p>\n<p>The Ft. Pierce, FL-based company was founded in 2009 and plans to list on the Nasdaq under the symbol&nbsp;FRZA. ThinkEquity is the sole bookrunner on the deal. No pricing terms were disclosed.</p>","source":"lsy1603787993745","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Electric boat developer Forza X1 files for a $29 million IPO</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nElectric boat developer Forza X1 files for a $29 million IPO\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-25 10:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.renaissancecapital.com/IPO-Center/News/89801/Electric-boat-developer-Forza-X1-files-for-a-$29-million-IPO><strong>Renaissance Capital</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Forza X1, a fully electric boat developer being spun out of Twin Vee PowerCats, filed on Thursday with the SEC to raise up to $29 million in an initial public offering.\nThe company states that it aims...</p>\n\n<a href=\"https://www.renaissancecapital.com/IPO-Center/News/89801/Electric-boat-developer-Forza-X1-files-for-a-$29-million-IPO\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.renaissancecapital.com/IPO-Center/News/89801/Electric-boat-developer-Forza-X1-files-for-a-$29-million-IPO","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1159652805","content_text":"Forza X1, a fully electric boat developer being spun out of Twin Vee PowerCats, filed on Thursday with the SEC to raise up to $29 million in an initial public offering.\nThe company states that it aims to be among the first to develop and manufacture fully electric, affordable boats with mass appeal. Forza X1 is focused on the creation and implementation of marine electric vehicle (\"EV\") technology to control and power its electric boats utilizing a proprietary outboard electric motor. It believes to be one the first companies to design a fully integrated electric boat including the hull, outboard motor and control system for mass production. To date, Forza has designed and manufactured only prototypes of its electric sport boat, has not yet commercialized its boats, and has not sold any boats.\nThe Ft. Pierce, FL-based company was founded in 2009 and plans to list on the Nasdaq under the symbol FRZA. ThinkEquity is the sole bookrunner on the deal. No pricing terms were disclosed.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1203,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":698101186,"gmtCreate":1640312559157,"gmtModify":1640313719476,"author":{"id":"3585001294737518","authorId":"3585001294737518","name":"Universe宇宙","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3585001294737518","idStr":"3585001294737518"},"themes":[],"htmlText":"Time to take your pills?&nbsp;[LOL]&nbsp;","listText":"Time to take your pills?&nbsp;[LOL]&nbsp;","text":"Time to take your pills? [LOL]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":7,"repostSize":0,"link":"https://laohu8.com/post/698101186","repostId":"1110395878","repostType":4,"repost":{"id":"1110395878","pubTimestamp":1640310818,"share":"https://www.laohu8.com/m/news/1110395878?lang=&edition=full","pubTime":"2021-12-24 09:53","market":"us","language":"en","title":"Pfizer’s Covid Pill Gets Green Light. Investors Are Starting to Pay Attention to the Stock.","url":"https://stock-news.laohu8.com/highlight/detail?id=1110395878","media":"Barrons","summary":"The Covid-19 pill is here, and it couldn’t have come at a better time.\nThe pandemic grew darker over","content":"<p>The Covid-19 pill is here, and it couldn’t have come at a better time.</p>\n<p>The pandemic grew darker over the past two weeks, as the Omicron variant swept into the U.S. With most of the widely used therapies rendered useless by the variant’s mutations, and case counts quickly climbing, doctors and public health officials have been increasingly worried.</p>\n<p>The Food and Drug Administration’s authorization of&nbsp;Pfizer’s&nbsp;(ticker: PFE) Covid-19 pill Paxlovid on Wednesday offered some hope. The pill is cleared only for high-risk individuals, and supplies will initially be limited, but it will save lives.</p>\n<p>The authorization represents an extraordinary coup for Pfizer, its second of the pandemic. Analysts expect Pfizer to sell $21.7 billion worth of the drug in 2022, according to FactSet, though the company now says that it will make 120 million courses of the drug next year, 40 million more than previously forecast, which will probably drive those estimates higher.</p>\n<p>As <i>Barron’s</i> argued in November, the success of Paxlovid is more evidence that the company’s decision in 2019 to rid itself of all but its innovative biopharma business was a smart one.</p>\n<p>Investors had been slow to buy into the revamped Pfizer, but late this year they caught up fast. In the 12 months before November of this year, Pfizer shares trailed the&nbsp;S&amp;P 500&nbsp;index, even as it rolled out its Covid-19 vaccine. Since the start of November, however, Pfizer shares have exploded. The stock is up 36.4% since then, while the S&amp;P 500 has climbed just 1.6%.</p>\n<p>And the stock remains relatively cheap, trading at just 9.8 times earnings expected over the next 12 months, according to FactSet, a discount to peers like&nbsp;Eli Lilly&nbsp;(LLY), which trades at 31.7 times earnings, and&nbsp;Johnson &amp; Johnson&nbsp;(JNJ), at 16.1 times earnings.</p>\n<p>The good news for Pfizer this week was matched by less-good news for&nbsp;Merck&nbsp;(MRK). Though early data on its Covid-19 pill molnupiravir sent vaccine stocks lower and Merck shares higher, the shine has since come off the drug, as updated data have suggested that it’s less efficacious than it initially appeared, and safety questions have lingered.</p>\n<p>The FDA issued an emergency-use authorization for molnupiravir on Thursday, a day after it issued Paxlovid’s, under far more restrictive terms. The authorization allows for molnupiravir to be used only when other Covid-19 treatments, like Paxlovid, are not accessible or not clinically appropriate. The agency also did not recommend the drug for use during pregnancy, and advised that men who take molnupiravir should use birth control for at least three months afterward.</p>\n<p>Earlier hopes that molnupiravir could be a long-term revenue driver are evaporating. The disappointment is a reminder of the challenge facing Merck before the end of this decade: the loss of patent protections on Keytruda, the cancer drug blockbuster that accounts for roughly a third of its revenue. Merck has been working toward filling that gap. It doesn’t appear that molnupiravir will be a big contributor to that effort.</p>","source":"lsy1601382232898","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pfizer’s Covid Pill Gets Green Light. Investors Are Starting to Pay Attention to the Stock.</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPfizer’s Covid Pill Gets Green Light. Investors Are Starting to Pay Attention to the Stock.\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-24 09:53 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.barrons.com/articles/pfizer-covid-pill-pfe-stock-51640266734?mod=hp_LATEST><strong>Barrons</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The Covid-19 pill is here, and it couldn’t have come at a better time.\nThe pandemic grew darker over the past two weeks, as the Omicron variant swept into the U.S. With most of the widely used ...</p>\n\n<a href=\"https://www.barrons.com/articles/pfizer-covid-pill-pfe-stock-51640266734?mod=hp_LATEST\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞"},"source_url":"https://www.barrons.com/articles/pfizer-covid-pill-pfe-stock-51640266734?mod=hp_LATEST","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1110395878","content_text":"The Covid-19 pill is here, and it couldn’t have come at a better time.\nThe pandemic grew darker over the past two weeks, as the Omicron variant swept into the U.S. With most of the widely used therapies rendered useless by the variant’s mutations, and case counts quickly climbing, doctors and public health officials have been increasingly worried.\nThe Food and Drug Administration’s authorization of Pfizer’s (ticker: PFE) Covid-19 pill Paxlovid on Wednesday offered some hope. The pill is cleared only for high-risk individuals, and supplies will initially be limited, but it will save lives.\nThe authorization represents an extraordinary coup for Pfizer, its second of the pandemic. Analysts expect Pfizer to sell $21.7 billion worth of the drug in 2022, according to FactSet, though the company now says that it will make 120 million courses of the drug next year, 40 million more than previously forecast, which will probably drive those estimates higher.\nAs Barron’s argued in November, the success of Paxlovid is more evidence that the company’s decision in 2019 to rid itself of all but its innovative biopharma business was a smart one.\nInvestors had been slow to buy into the revamped Pfizer, but late this year they caught up fast. In the 12 months before November of this year, Pfizer shares trailed the S&P 500 index, even as it rolled out its Covid-19 vaccine. Since the start of November, however, Pfizer shares have exploded. The stock is up 36.4% since then, while the S&P 500 has climbed just 1.6%.\nAnd the stock remains relatively cheap, trading at just 9.8 times earnings expected over the next 12 months, according to FactSet, a discount to peers like Eli Lilly (LLY), which trades at 31.7 times earnings, and Johnson & Johnson (JNJ), at 16.1 times earnings.\nThe good news for Pfizer this week was matched by less-good news for Merck (MRK). Though early data on its Covid-19 pill molnupiravir sent vaccine stocks lower and Merck shares higher, the shine has since come off the drug, as updated data have suggested that it’s less efficacious than it initially appeared, and safety questions have lingered.\nThe FDA issued an emergency-use authorization for molnupiravir on Thursday, a day after it issued Paxlovid’s, under far more restrictive terms. The authorization allows for molnupiravir to be used only when other Covid-19 treatments, like Paxlovid, are not accessible or not clinically appropriate. The agency also did not recommend the drug for use during pregnancy, and advised that men who take molnupiravir should use birth control for at least three months afterward.\nEarlier hopes that molnupiravir could be a long-term revenue driver are evaporating. The disappointment is a reminder of the challenge facing Merck before the end of this decade: the loss of patent protections on Keytruda, the cancer drug blockbuster that accounts for roughly a third of its revenue. Merck has been working toward filling that gap. It doesn’t appear that molnupiravir will be a big contributor to that effort.","news_type":1},"isVote":1,"tweetType":1,"viewCount":967,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":698103995,"gmtCreate":1640312409253,"gmtModify":1640313683685,"author":{"id":"3585001294737518","authorId":"3585001294737518","name":"Universe宇宙","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3585001294737518","idStr":"3585001294737518"},"themes":[],"htmlText":"[Spurting]&nbsp;[Facepalm]&nbsp;","listText":"[Spurting]&nbsp;[Facepalm]&nbsp;","text":"[Spurting] [Facepalm]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/698103995","repostId":"2193812513","repostType":4,"repost":{"id":"2193812513","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1640311240,"share":"https://www.laohu8.com/m/news/2193812513?lang=&edition=full","pubTime":"2021-12-24 10:00","market":"us","language":"en","title":"United, Delta cancel more than 200 U.S. Christmas Eve flights amid COVID surge","url":"https://stock-news.laohu8.com/highlight/detail?id=2193812513","media":"Reuters","summary":"Dec 23 (Reuters) - United Airlines and Delta Air Lines on Thursday said they had each canceled dozen","content":"<p>Dec 23 (Reuters) - United Airlines&nbsp;and Delta Air Lines&nbsp;on Thursday said they had each canceled dozens of Christmas Eve flights, as the spreading COVID-19 Omicron variant takes a toll on its flight crews and other workers.</p>\n<p>Chicago-based United canceled 120 flights for Friday, while Atlanta-based Delta said it has canceled about 90. Both said they were working to contact passengers so they would not be stranded at airports.</p>\n<p>\"The nationwide spike in Omicron cases this week has had a direct impact on our flight crews and the people who run our operation. As a result, we’ve unfortunately had to cancel some flights and are notifying impacted customers in advance of them coming to the airport,\" United said.</p>\n<p>Delta said it has \"exhausted all options and resources -- including rerouting and substitutions of aircraft and crews to cover scheduled flying -- before canceling around 90 flights for Friday.\"</p>\n<p>Delta cited potential inclement weather and the impact of the Omicron variant for the cancellations.</p>\n<p>On Tuesday, Delta Chief Executive Ed Bastian asked the head of the U.S. Centers for Disease Control and Prevention&nbsp;to shrink quarantine guidelines for fully vaccinated individuals who experience breakthrough COVID-19 infections, citing the impact on the carrier's workforce. Bastian asked that the isolation period be cut to five days from the current 10.</p>\n<p>That request was echoed both by Airlines for America, a trade group representing major cargo and passenger carriers, which wrote to the CDC on Thursday, and by JetBlue on Wednesday.</p>\n<p>The CDC released updated quarantine guidance for healthcare workers on Thursday, cutting the isolation time to seven days for workers who test positive for COVID-19 but are asymptomatic, providing they test negative.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>United, Delta cancel more than 200 U.S. Christmas Eve flights amid COVID surge</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUnited, Delta cancel more than 200 U.S. Christmas Eve flights amid COVID surge\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-12-24 10:00</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Dec 23 (Reuters) - United Airlines&nbsp;and Delta Air Lines&nbsp;on Thursday said they had each canceled dozens of Christmas Eve flights, as the spreading COVID-19 Omicron variant takes a toll on its flight crews and other workers.</p>\n<p>Chicago-based United canceled 120 flights for Friday, while Atlanta-based Delta said it has canceled about 90. Both said they were working to contact passengers so they would not be stranded at airports.</p>\n<p>\"The nationwide spike in Omicron cases this week has had a direct impact on our flight crews and the people who run our operation. As a result, we’ve unfortunately had to cancel some flights and are notifying impacted customers in advance of them coming to the airport,\" United said.</p>\n<p>Delta said it has \"exhausted all options and resources -- including rerouting and substitutions of aircraft and crews to cover scheduled flying -- before canceling around 90 flights for Friday.\"</p>\n<p>Delta cited potential inclement weather and the impact of the Omicron variant for the cancellations.</p>\n<p>On Tuesday, Delta Chief Executive Ed Bastian asked the head of the U.S. Centers for Disease Control and Prevention&nbsp;to shrink quarantine guidelines for fully vaccinated individuals who experience breakthrough COVID-19 infections, citing the impact on the carrier's workforce. Bastian asked that the isolation period be cut to five days from the current 10.</p>\n<p>That request was echoed both by Airlines for America, a trade group representing major cargo and passenger carriers, which wrote to the CDC on Thursday, and by JetBlue on Wednesday.</p>\n<p>The CDC released updated quarantine guidance for healthcare workers on Thursday, cutting the isolation time to seven days for workers who test positive for COVID-19 but are asymptomatic, providing they test negative.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2193812513","content_text":"Dec 23 (Reuters) - United Airlines and Delta Air Lines on Thursday said they had each canceled dozens of Christmas Eve flights, as the spreading COVID-19 Omicron variant takes a toll on its flight crews and other workers.\nChicago-based United canceled 120 flights for Friday, while Atlanta-based Delta said it has canceled about 90. Both said they were working to contact passengers so they would not be stranded at airports.\n\"The nationwide spike in Omicron cases this week has had a direct impact on our flight crews and the people who run our operation. As a result, we’ve unfortunately had to cancel some flights and are notifying impacted customers in advance of them coming to the airport,\" United said.\nDelta said it has \"exhausted all options and resources -- including rerouting and substitutions of aircraft and crews to cover scheduled flying -- before canceling around 90 flights for Friday.\"\nDelta cited potential inclement weather and the impact of the Omicron variant for the cancellations.\nOn Tuesday, Delta Chief Executive Ed Bastian asked the head of the U.S. Centers for Disease Control and Prevention to shrink quarantine guidelines for fully vaccinated individuals who experience breakthrough COVID-19 infections, citing the impact on the carrier's workforce. Bastian asked that the isolation period be cut to five days from the current 10.\nThat request was echoed both by Airlines for America, a trade group representing major cargo and passenger carriers, which wrote to the CDC on Thursday, and by JetBlue on Wednesday.\nThe CDC released updated quarantine guidance for healthcare workers on Thursday, cutting the isolation time to seven days for workers who test positive for COVID-19 but are asymptomatic, providing they test negative.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1234,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":698100213,"gmtCreate":1640312232853,"gmtModify":1640313628252,"author":{"id":"3585001294737518","authorId":"3585001294737518","name":"Universe宇宙","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3585001294737518","idStr":"3585001294737518"},"themes":[],"htmlText":"First post 😉","listText":"First post 😉","text":"First post 😉","images":[],"top":1,"highlighted":2,"essential":1,"paper":1,"likeSize":3,"commentSize":17,"repostSize":0,"link":"https://laohu8.com/post/698100213","repostId":"1130812556","repostType":4,"repost":{"id":"1130812556","pubTimestamp":1640311286,"share":"https://www.laohu8.com/m/news/1130812556?lang=&edition=full","pubTime":"2021-12-24 10:01","market":"hk","language":"en","title":"Hong Kong: Stocks rise in opening trade","url":"https://stock-news.laohu8.com/highlight/detail?id=1130812556","media":"AFP","summary":"Hong Kong stocks rose at the open of a shortened pre-holiday session Friday (Dec 24) following stron","content":"<p>Hong Kong stocks rose at the open of a shortened pre-holiday session Friday (Dec 24) following strong gains on Wall Street as fears over the Omicron coronavirus variant faded.</p>\n<p>The Hang Seng Index climbed 0.45 per cent or 105.08 points to 23,298.72.</p>\n<p>The Shanghai Composite Index added 0.08 per cent or 2.89 points to 3,646.23, while the Shenzhen Composite Index on China's second exchange eased 0.02 per cent or 0.62 point to 2,524.12.</p>\n<p></p>","source":"lsy1605843958005","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Hong Kong: Stocks rise in opening trade</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHong Kong: Stocks rise in opening trade\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-24 10:01 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.businesstimes.com.sg/stocks/hong-kong-stocks-rise-in-opening-trade-3><strong>AFP</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Hong Kong stocks rose at the open of a shortened pre-holiday session Friday (Dec 24) following strong gains on Wall Street as fears over the Omicron coronavirus variant faded.\nThe Hang Seng Index ...</p>\n\n<a href=\"https://www.businesstimes.com.sg/stocks/hong-kong-stocks-rise-in-opening-trade-3\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"HSTECH":"恒生科技指数","HSCEI":"国企指数","HSI":"恒生指数"},"source_url":"https://www.businesstimes.com.sg/stocks/hong-kong-stocks-rise-in-opening-trade-3","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1130812556","content_text":"Hong Kong stocks rose at the open of a shortened pre-holiday session Friday (Dec 24) following strong gains on Wall Street as fears over the Omicron coronavirus variant faded.\nThe Hang Seng Index climbed 0.45 per cent or 105.08 points to 23,298.72.\nThe Shanghai Composite Index added 0.08 per cent or 2.89 points to 3,646.23, while the Shenzhen Composite Index on China's second exchange eased 0.02 per cent or 0.62 point to 2,524.12.","news_type":1},"isVote":1,"tweetType":1,"viewCount":912,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":698911075,"gmtCreate":1640274037782,"gmtModify":1640274147296,"author":{"id":"3585001294737518","authorId":"3585001294737518","name":"Universe宇宙","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3585001294737518","idStr":"3585001294737518"},"themes":[],"htmlText":"😉","listText":"😉","text":"😉","images":[],"top":1,"highlighted":2,"essential":1,"paper":1,"likeSize":6,"commentSize":16,"repostSize":0,"link":"https://laohu8.com/post/698911075","repostId":"1192623075","repostType":4,"repost":{"id":"1192623075","pubTimestamp":1640269891,"share":"https://www.laohu8.com/m/news/1192623075?lang=&edition=full","pubTime":"2021-12-23 22:31","market":"us","language":"en","title":"U.S. adds Merck pill as 2nd easy-to-use drug against COVID-19","url":"https://stock-news.laohu8.com/highlight/detail?id=1192623075","media":"SeattleTimes","summary":"U.S. health regulators on Thursday authorized the second pill against COVID-19, providing another ea","content":"<p>U.S. health regulators on Thursday authorized the second pill against COVID-19, providing another easy-to-use medication to battle the rising tide of omicron infections.</p>\n<p>The Food and Drug Administration authorization of Merck’s molnupiravir comes one day after the agency cleared a competing drug from Pfizer. That pill, Paxlovid, is likely to become the first-choice treatment against the virus, thanks to its superior benefits and milder side effects.</p>\n<p>As a result, Merck’s pill is expected to have a smaller role against the pandemic than predicted just a few weeks ago. Its ability to head off severe COVID-19 is much smaller than initially announced and the drug label will warn of serious safety issues, including the potential for birth defects.</p>\n<p>The Food and Drug Administration authorized Merck’s drug for adults with early symptoms of COVID-19 who face the highest risks of hospitalization, including older people and those with conditions like obesity and heart disease. The U.K. first authorized the pill in early November.</p>\n<p>Known as molnupiravir, the Merck drug will carry a warning against use during pregnancy. Women of childbearing age should use birth control during treatment and for a few days after while men should use birth control for at least three months after their final dose, the FDA said.</p>\n<p>The restrictions were expected after an FDA advisory panel only narrowly endorsed the drug last month, warning that its use would have to be strictly tailored to patients who can benefit the most.</p>\n<p>The Pfizer pill works differently and doesn’t carry the same risks. Additionally, Pfizer’s drug was roughly three times more effective in testing, reducing hospitalization and death by nearly 90% among high-risk patients, compared with 30% for Merck’s.</p>\n<p>Some experts question whether there will be much of a role for the Merck drug in the U.S.</p>\n<p>“To the extent that there’s an ample supply of Pfizer’s pill, I think it won’t be used,” said Dr. Gregory Poland of the Mayo Clinic, referring to the Merck drug. “There would be no reason, given it has less efficacy and a higher risk of side effects.”</p>\n<p>For now, the FDA decision provides another potential option against the virus that has killed more than 800,000 Americans, even as health officials brace for record-setting cases, hospitalizations and deaths driven by the omicron variant. Antiviral pills, including Merck’s, are expected to be effective against omicron because they don’t target the spike protein where most of the variant’s worrisome mutations reside.</p>\n<p>The FDA based its decision on results showing nearly 7% of patients taking the drug ended up in the hospital and one died at the end of 30 days. That compared with 10% of patients hospitalized who were taking the placebo and nine deaths.</p>\n<p>Federal officials have agreed to purchase enough of the drug to treat 3.1 million people.</p>\n<p>The U.S. will pay about $700 for each course of Merck’s drug, which requires patients to take four pills twice a day for five days. A review by Harvard University and King’s College London estimated it costs about $18 to make each 40-pill course of treatment.</p>\n<p>Merck’s drug inserts tiny errors into the coronavirus’ genetic code to slow its reproduction. That genetic effect has raised concerns that the drug could cause mutations in human fetuses and even spur more virulent strains of the virus. But FDA scientists said the variant risk is largely theoretical because people take the drug for such a short period of time.</p>","source":"lsy1640271591192","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>U.S. adds Merck pill as 2nd easy-to-use drug against COVID-19</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nU.S. adds Merck pill as 2nd easy-to-use drug against COVID-19\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-23 22:31 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.seattletimes.com/business/us-adds-merck-pill-as-2nd-easy-to-use-drug-against-covid-19/><strong>SeattleTimes</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>U.S. health regulators on Thursday authorized the second pill against COVID-19, providing another easy-to-use medication to battle the rising tide of omicron infections.\nThe Food and Drug ...</p>\n\n<a href=\"https://www.seattletimes.com/business/us-adds-merck-pill-as-2nd-easy-to-use-drug-against-covid-19/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.seattletimes.com/business/us-adds-merck-pill-as-2nd-easy-to-use-drug-against-covid-19/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1192623075","content_text":"U.S. health regulators on Thursday authorized the second pill against COVID-19, providing another easy-to-use medication to battle the rising tide of omicron infections.\nThe Food and Drug Administration authorization of Merck’s molnupiravir comes one day after the agency cleared a competing drug from Pfizer. That pill, Paxlovid, is likely to become the first-choice treatment against the virus, thanks to its superior benefits and milder side effects.\nAs a result, Merck’s pill is expected to have a smaller role against the pandemic than predicted just a few weeks ago. Its ability to head off severe COVID-19 is much smaller than initially announced and the drug label will warn of serious safety issues, including the potential for birth defects.\nThe Food and Drug Administration authorized Merck’s drug for adults with early symptoms of COVID-19 who face the highest risks of hospitalization, including older people and those with conditions like obesity and heart disease. The U.K. first authorized the pill in early November.\nKnown as molnupiravir, the Merck drug will carry a warning against use during pregnancy. Women of childbearing age should use birth control during treatment and for a few days after while men should use birth control for at least three months after their final dose, the FDA said.\nThe restrictions were expected after an FDA advisory panel only narrowly endorsed the drug last month, warning that its use would have to be strictly tailored to patients who can benefit the most.\nThe Pfizer pill works differently and doesn’t carry the same risks. Additionally, Pfizer’s drug was roughly three times more effective in testing, reducing hospitalization and death by nearly 90% among high-risk patients, compared with 30% for Merck’s.\nSome experts question whether there will be much of a role for the Merck drug in the U.S.\n“To the extent that there’s an ample supply of Pfizer’s pill, I think it won’t be used,” said Dr. Gregory Poland of the Mayo Clinic, referring to the Merck drug. “There would be no reason, given it has less efficacy and a higher risk of side effects.”\nFor now, the FDA decision provides another potential option against the virus that has killed more than 800,000 Americans, even as health officials brace for record-setting cases, hospitalizations and deaths driven by the omicron variant. Antiviral pills, including Merck’s, are expected to be effective against omicron because they don’t target the spike protein where most of the variant’s worrisome mutations reside.\nThe FDA based its decision on results showing nearly 7% of patients taking the drug ended up in the hospital and one died at the end of 30 days. That compared with 10% of patients hospitalized who were taking the placebo and nine deaths.\nFederal officials have agreed to purchase enough of the drug to treat 3.1 million people.\nThe U.S. will pay about $700 for each course of Merck’s drug, which requires patients to take four pills twice a day for five days. A review by Harvard University and King’s College London estimated it costs about $18 to make each 40-pill course of treatment.\nMerck’s drug inserts tiny errors into the coronavirus’ genetic code to slow its reproduction. That genetic effect has raised concerns that the drug could cause mutations in human fetuses and even spur more virulent strains of the virus. But FDA scientists said the variant risk is largely theoretical because people take the drug for such a short period of time.","news_type":1},"isVote":1,"tweetType":1,"viewCount":340,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":698910635,"gmtCreate":1640273837209,"gmtModify":1640273966430,"author":{"id":"3585001294737518","authorId":"3585001294737518","name":"Universe宇宙","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3585001294737518","idStr":"3585001294737518"},"themes":[],"htmlText":"First post 😉","listText":"First post 😉","text":"First post 😉","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/698910635","repostId":"1109764882","repostType":4,"repost":{"id":"1109764882","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1640273505,"share":"https://www.laohu8.com/m/news/1109764882?lang=&edition=full","pubTime":"2021-12-23 23:31","market":"us","language":"en","title":"Tesla shares rose nearly 2% in early trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1109764882","media":"Tiger Newspress","summary":"Tesla shares rose nearly 2% in early trading.A day after saying he had “sold enough” to meet his goa","content":"<p>Tesla&nbsp;shares&nbsp;rose&nbsp;nearly&nbsp;2%&nbsp;in&nbsp;early&nbsp;trading.<img src=\"https://static.tigerbbs.com/2503c828d8b377eafa4087febd8581d6\" tg-width=\"709\" tg-height=\"601\" width=\"100%\" height=\"auto\">A day after saying he had “sold enough” to meet his goal of selling 10% of his Tesla Inc. stake, Chief Executive Elon Musk on Wednesday tweeted that he’s “almost done,” and disclosed in filings with the Securities and Exchange Commission that he has exercised more stock options and sold another 934,000 shares, worth about $928.6 million.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tesla shares rose nearly 2% in early trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTesla shares rose nearly 2% in early trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-12-23 23:31</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Tesla&nbsp;shares&nbsp;rose&nbsp;nearly&nbsp;2%&nbsp;in&nbsp;early&nbsp;trading.<img src=\"https://static.tigerbbs.com/2503c828d8b377eafa4087febd8581d6\" tg-width=\"709\" tg-height=\"601\" width=\"100%\" height=\"auto\">A day after saying he had “sold enough” to meet his goal of selling 10% of his Tesla Inc. stake, Chief Executive Elon Musk on Wednesday tweeted that he’s “almost done,” and disclosed in filings with the Securities and Exchange Commission that he has exercised more stock options and sold another 934,000 shares, worth about $928.6 million.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TSLA":"特斯拉"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1109764882","content_text":"Tesla shares rose nearly 2% in early trading.A day after saying he had “sold enough” to meet his goal of selling 10% of his Tesla Inc. stake, Chief Executive Elon Musk on Wednesday tweeted that he’s “almost done,” and disclosed in filings with the Securities and Exchange Commission that he has exercised more stock options and sold another 934,000 shares, worth about $928.6 million.","news_type":1},"isVote":1,"tweetType":1,"viewCount":381,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":691182995,"gmtCreate":1640149746490,"gmtModify":1640152357210,"author":{"id":"3585001294737518","authorId":"3585001294737518","name":"Universe宇宙","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3585001294737518","idStr":"3585001294737518"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/C6L.SI\">$SINGAPORE AIRLINES LTD(C6L.SI)$</a>going to drop to $2.50?&nbsp;[Surprised]&nbsp;[Doubt]&nbsp;Even vaccinated still restrict their travel plan? Lmao.&nbsp;[Spurting]&nbsp;[Facepalm]&nbsp;Democracy&nbsp;has died?&nbsp;[Onlooker]&nbsp;","listText":"<a href=\"https://laohu8.com/S/C6L.SI\">$SINGAPORE AIRLINES LTD(C6L.SI)$</a>going to drop to $2.50?&nbsp;[Surprised]&nbsp;[Doubt]&nbsp;Even vaccinated still restrict their travel plan? Lmao.&nbsp;[Spurting]&nbsp;[Facepalm]&nbsp;Democracy&nbsp;has died?&nbsp;[Onlooker]&nbsp;","text":"$SINGAPORE AIRLINES LTD(C6L.SI)$going to drop to $2.50? [Surprised] [Doubt] Even vaccinated still restrict their travel plan? Lmao. [Spurting] [Facepalm] Democracy has died? [Onlooker]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/691182995","repostId":"2193316202","repostType":2,"repost":{"id":"2193316202","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1640144528,"share":"https://www.laohu8.com/m/news/2193316202?lang=&edition=full","pubTime":"2021-12-22 11:42","market":"sg","language":"en","title":"Singapore to freeze new ticket sales for quarantine-free travel","url":"https://stock-news.laohu8.com/highlight/detail?id=2193316202","media":"Reuters","summary":"SINGAPORE, Dec 22 (Reuters) - Singapore will freeze all new ticket sales for flights and buses under","content":"<p>SINGAPORE, Dec 22 (Reuters) - Singapore will freeze all new ticket sales for flights and buses under its programme for quarantine-free travel into the city-state from Dec. 23 to Jan. 20, the government said on Wednesday, citing risk from the fast-spreading Omicron COVID-19 variant.</p>\n<p>Under the vaccinated travel lane (VTL) programme, Singapore allows quarantine-free entry from some countries to fully vaccinated travellers on designated flights or buses. The travellers have to undergo regular testing.</p>\n<p>Singapore has set up these lanes for about two dozen countries, including Australia, India, the United Kingdom and the United States.</p>\n<p>The government said it will also temporarily reduce the VTL quotas and ticket sales for travel after Jan. 20, 2022. For flights, the total ticket sales will be capped at 50% of the allocated quota.</p>\n<p>\"Our border measures will help to buy us time to study and understand the Omicron variant, and to strengthen our defences, including enhancing our healthcare capacity, and getting more people vaccinated and boosted,\" the health ministry said in a statement.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Singapore to freeze new ticket sales for quarantine-free travel</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSingapore to freeze new ticket sales for quarantine-free travel\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-12-22 11:42</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>SINGAPORE, Dec 22 (Reuters) - Singapore will freeze all new ticket sales for flights and buses under its programme for quarantine-free travel into the city-state from Dec. 23 to Jan. 20, the government said on Wednesday, citing risk from the fast-spreading Omicron COVID-19 variant.</p>\n<p>Under the vaccinated travel lane (VTL) programme, Singapore allows quarantine-free entry from some countries to fully vaccinated travellers on designated flights or buses. The travellers have to undergo regular testing.</p>\n<p>Singapore has set up these lanes for about two dozen countries, including Australia, India, the United Kingdom and the United States.</p>\n<p>The government said it will also temporarily reduce the VTL quotas and ticket sales for travel after Jan. 20, 2022. For flights, the total ticket sales will be capped at 50% of the allocated quota.</p>\n<p>\"Our border measures will help to buy us time to study and understand the Omicron variant, and to strengthen our defences, including enhancing our healthcare capacity, and getting more people vaccinated and boosted,\" the health ministry said in a statement.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"C6L.SI":"新加坡航空公司"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2193316202","content_text":"SINGAPORE, Dec 22 (Reuters) - Singapore will freeze all new ticket sales for flights and buses under its programme for quarantine-free travel into the city-state from Dec. 23 to Jan. 20, the government said on Wednesday, citing risk from the fast-spreading Omicron COVID-19 variant.\nUnder the vaccinated travel lane (VTL) programme, Singapore allows quarantine-free entry from some countries to fully vaccinated travellers on designated flights or buses. The travellers have to undergo regular testing.\nSingapore has set up these lanes for about two dozen countries, including Australia, India, the United Kingdom and the United States.\nThe government said it will also temporarily reduce the VTL quotas and ticket sales for travel after Jan. 20, 2022. For flights, the total ticket sales will be capped at 50% of the allocated quota.\n\"Our border measures will help to buy us time to study and understand the Omicron variant, and to strengthen our defences, including enhancing our healthcare capacity, and getting more people vaccinated and boosted,\" the health ministry said in a statement.","news_type":1},"isVote":1,"tweetType":1,"viewCount":913,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":691314184,"gmtCreate":1640136482157,"gmtModify":1640136576182,"author":{"id":"3585001294737518","authorId":"3585001294737518","name":"Universe宇宙","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3585001294737518","idStr":"3585001294737518"},"themes":[],"htmlText":"First post 😉","listText":"First post 😉","text":"First post 😉","images":[],"top":1,"highlighted":2,"essential":1,"paper":1,"likeSize":1,"commentSize":20,"repostSize":0,"link":"https://laohu8.com/post/691314184","repostId":"2193695165","repostType":4,"repost":{"id":"2193695165","pubTimestamp":1640136264,"share":"https://www.laohu8.com/m/news/2193695165?lang=&edition=full","pubTime":"2021-12-22 09:24","market":"us","language":"en","title":"The IPOs to expect in 2022: Reddit, Instacart and others could hit Wall Street","url":"https://stock-news.laohu8.com/highlight/detail?id=2193695165","media":"MarketWatch","summary":"Stripe is the biggest name in a crowded field of potential financial-technology startups looking to go public after a wave of Wall Street entries in 2021. As the IPO market slowed down at the end of 2021, companies that had been expected to jump on the hot market were left out in the cold, but many of them are still expected to test the waters in 2022.Technology companies dominated the market for initial public offerings in 2021, representing nine of the 10 largest deals, according to David Ethr","content":"<p>Stripe is the biggest name in a crowded field of potential financial-technology startups looking to go public after a wave of Wall Street entries in 2021</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/799116978a720c57ebcad12f97a1ab87\" tg-width=\"700\" tg-height=\"487\" width=\"100%\" height=\"auto\"><span>MarketWatch photo illustration/iStockphoto</span></p>\n<p>As the IPO market slowed down at the end of 2021, companies that had been expected to jump on the hot market were left out in the cold, but many of them are still expected to test the waters in 2022.</p>\n<p>Technology companies dominated the market for initial public offerings in 2021, representing nine of the 10 largest deals, according to David Ethridge, the U.S. IPO services leader at PwC. And with companies staying private longer, there remains a deep backlog of mature technology companies that could finally make their debuts in the year ahead.</p>\n<p>Among the most highly anticipated candidates within the tech sphere are social-networking platform Reddit, grocery-delivery service Instacart, and data-analytics company Databricks. And following what Rainmaker Securities managing director Greg Martin called a \"banner year for fintech\" deals, more attention will be focused on Stripe, which notched a $95 billion private-market valuation this year but has thus far resisted the public markets.</p>\n<p>Here's what to watch for among tech and fintech IPOs, and beyond, in the year ahead.</p>\n<p><b>Late to the gig IPO party?</b></p>\n<p>Instacart had its moment at the height of the pandemic, as lockdowns drove more people to try out grocery delivery. But unlike fellow gig-economy player DoorDash Inc, which went public in December 2020, Instacart has held off on an IPO, instead going through some management changes and working on new growth initiatives.</p>\n<p>Chief Executive Fidji Simo, a Facebook (FB) veteran, has been at the helm since the summer, and Instacart could be inching closer to a debut, potentially in the second half of 2021. New CEOs typically need nine months to a year leading their companies before they can launch into an IPO, according to MKM Partners analyst Rohit Kulkarni, and Instacart in particular may also need a few more quarters \"to go through all these reopening headwinds.\"</p>\n<p>The company was last valued at $39 billion in a March 2021 private funding round. One key question is whether the company can live up to that valuation in an IPO that takes place during something more closely resembling post-pandemic times.</p>\n<p>\"It's hard to replicate what they did in 2020,\" said Martin, whose platform Rainmaker Securities allows for the trading of pre-IPO shares in private companies. \"The valuation may have gotten a bit ahead.\"</p>\n<p>An Instacart spokesperson declined to comment about the company's IPO ambitions.</p>\n<p><b>The ultimate WallStreetBet</b></p>\n<p>Reddit has helped launch meme stocks, and now the company looks closer to having a stock of its own. The message-board company announced in December that it has filed confidential paperwork with the Securities and Exchange Commission for a potential IPO after being valued at about $10 billion in an August funding round.</p>\n<p>Reddit is perhaps best known in the investment community for its WallStreetBets \"subreddit,\" a forum on which users discuss stock picks and other topics around trading. The company makes money through advertising and a paid membership tier through which users can browse the app without ads and access other perks.</p>\n<p>As a private company, Reddit has avoided some of the scrutiny that fellow social-media companies <a href=\"https://laohu8.com/S/TWTR\">Twitter</a> Inc. (TWTR) and Facebook-parent <a href=\"https://laohu8.com/S/FB\">Meta Platforms</a> Inc. have faced over their roles in the spread of misinformation online. By going public, Reddit could find more of a spotlight on its practices and policies.</p>\n<p>The company reportedly is on track to generate $350 million in revenue this year, according to The Information, at least double its 2020 total.</p>\n<p>Reddit may not be the only social platform to test the public markets in 2022, with Martin noting that he's seen strong secondary-market demand for Discord on his platform, suggesting that the company is <a href=\"https://laohu8.com/S/AONE.U\">one</a> to \"keep an eye on\" in the year to come.</p>\n<p>\"We don't have anything to say at this time,\" a Discord spokesperson said in response to MarketWatch's inquiry about potential IPO plans.</p>\n<p><b>The year of Stripe?</b></p>\n<p>Likened to Amazon.com Inc.'s&nbsp;AWS cloud-computing business except for payments infrastructure, Stripe helps power many hot tech companies, including Lyft Inc., Peloton Interactive Inc.&nbsp;and <a href=\"https://laohu8.com/S/SHOP\">Shopify Inc</a>.&nbsp;Similar to Square-parent Block Inc., the company provides payment-processing technology, invoicing tools, and business financing, among other features.</p>\n<p>But with a private-market valuation of nearly $100 billion, Stripe continues to test the boundaries of how long a hot technology company can avoid the public markets. Will 2022 finally be the year that the fintech giant takes the plunge?</p>\n<p>IPO watchers are split on whether Stripe will make its debut. Given the company's secrecy about potential IPO ambitions, it seems that Stripe executives are content operating the business as a private company, Kulkarni said. He would be \"surprised\" to see Stripe turn public in the year ahead.</p>\n<p>Martin, a shareholder of Stripe, is more upbeat about the chances. \"The company is so tightly controlled by the founders, and there's some sense that they never need to go public,\" he said, given that Stripe has been able to offer liquidity for investors and raise new capital easily. Still, he expects the company will hit the IPO market in 2022.</p>\n<p><b>A fintech parade</b></p>\n<p>Stripe isn't the only hot fintech among rumored IPO candidates. The year ahead could bring \"five or six massive 'decacorn'\" IPOs in the fintech space, said Martin, acknowledging that Stripe's would actually be a \"centicorn\" deal given that the company is hovering around a $100 billion valuation.</p>\n<p>Swedish fintech company Klarna is one highly anticipated name, especially since its buy-now, pay-later rival Affirm Holdings Inc. <a href=\"https://laohu8.com/S/AFRM\">$(AFRM)$</a>was one of the biggest IPO market successes of 2021. Like Affirm, Klarna lets consumers split purchases into installments. The company was valued at $46 billion through a June funding round.</p>\n<p>Though based in Europe, Klarna could make more of a splash if it chose to debut on a U.S. exchange, said Avery Spear, a data analyst at Renaissance Capital. Doing so would unlock \"a bigger pool of capital,\" she continued.</p>\n<p>A Klarna spokesperson said that the company doesn't comment on IPO plans and that \"this is a matter only our CEO can speak to.\"</p>\n<p>Other possibilities include Revolut and Chime, neobanks privately valued at $33 billion and $25 billion, respectively. They would follow Nu Holdings Inc., a Brazilian company that runs Nubank, which came public in early December.</p>\n<p>Chime declined to comment on its IPO ambitions.</p>\n<p>Martin is also watching Plaid, which nabbed a $13.4 billion private-market valuation in April after its deal with <a href=\"https://laohu8.com/S/V\">Visa</a> Inc. (V)was called off. The company makes it easier for people to link their bank accounts to services like <a href=\"https://laohu8.com/S/PYPL\">PayPal</a> Holdings Inc.'s Venmo. And Brex, which provides credit cards and other financial products to businesses, also cracks his watch list. The company secured an October funding round that valued it at $12.3 billion, according to TechCrunch.</p>\n<p>Plaid declined to comment on its IPO plans. A Brex spokesperson said the company didn't have comment on its plans.</p>\n<p>\"The fintech companies will definitely dominate 2022,\" Martin said.</p>\n<p><b>The next <a href=\"https://laohu8.com/S/SNOW\">Snowflake</a></b></p>\n<p>Snowflake Inc.'s (SNOW) reception on Wall Street has been anything but chilly, and another trendy cloud company may be looking to achieve a similar fate.</p>\n<p>Databricks, which helps companies process and analyze data, \"has been a long anticipated IPO,\" said Kulkarni, and it may finally make a jump to the public markets in 2022. The company has nabbed a $38 billion private-market valuation.</p>\n<p>A Databricks spokesperson said the company didn't have further comment beyond what it has already said publicly. Chief Executive Ali Ghodsi said that he expects the company to eventually come public in the \"not-too-distant future\" when speaking to CNBC in December.</p>\n<p>Other software names on Kulkarni's watch list include Tanium and Canva. Tanium \"operates in an extremely attractive end market\" by providing cybersecurity services, he said. Canva, based in Australia, makes design software that challenges offerings from Adobe Inc.</p>\n<p>Elsewhere on the horizon, social-media management company Hootsuite might be aiming for an IPO, per Santosh Rao, the head of research at <a href=\"https://laohu8.com/S/MHC.AU\">Manhattan</a> Venture Partners. The Canadian company was founded in 2008 but it doesn't appear to be profitable yet, which could be problematic given current market attitudes, in his view.</p>\n<p>\"Even the big guys are getting punished for not showing any profits after so long,\" Rao said. The company reportedly was aiming for an IPO in Canada \"before Christmas,\" according to Betakit, a publication that covers Canadian startups. That offering never materialized.</p>\n<p><b>Winning fans</b></p>\n<p>Fanatics recently scored a deal to replace Topps as the maker of Major League Baseball trading cards, and the sporting company could soon be heading for the big leagues itself. The MLB deal shook up the industry enough that Topps and Panini, two big card makers, both shelved their own IPO plans after Topps won the baseball business.</p>\n<p>Last valued at $18 billion in August, the company recently scooped up former <a href=\"https://laohu8.com/S/IACI\">IAC/InterActiveCorp</a>. <a href=\"https://laohu8.com/S/IAC\">$(IAC)$</a> chief financial officer Glenn Schiffman to serve in the same role at Fanatics, which could be a sign that the company has IPO ambitions.</p>\n<p>Schiffman worked with various online brands at IAC, and his Fanatics corporate bio mentions that he will \"drive the financial direction of the company as it expands beyond commerce into new verticals across the sports ecosystem to become a leading global digital sports platform.\"</p>\n<p>\"While an IPO is clearly an available option to us, there is no update on any timeline,\" a Fanatics spokesperson told MarketWatch. \"Any public offering is just a moment in time as our focus remains on expanding the business and building the leading digital sports platform over the next decade and beyond.\"</p>\n<p><b>Nothing's impossible</b></p>\n<p>Impossible Foods once seemed like a likely IPO candidate for the beginning of 2022, according to Martin, but he's seen secondary-market demand cool off for the maker of plant-based meat. Publicly held rival Beyond Meat Inc.&nbsp;has seen its stock price roughly cut in half during 2021, which could be impacting sentiment toward Impossible as well.</p>\n<p>The company, which raised roughly $500 million in a November funding round, still remains a name to monitor, especially if Beyond Meat shares fall back into favor on Wall Street or if the company's financials look better than Beyond's. Impossible hired a former fintech exec as its permanent chief financial officer in August, which could signal an effort to get the books ready for Wall Street.</p>\n<p><b>Private equity coming public</b></p>\n<p>One of the more likely IPO bets for 2022 is TPG Partners LLC, a private-equity firm that has already filed its prospectus with the SEC. The company's sizable roster of 23 underwriting banks suggests that TPG could be headed for a large offering, perhaps raking in upward of $1 billion.</p>","source":"lsy1603348471595","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>The IPOs to expect in 2022: Reddit, Instacart and others could hit Wall Street</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThe IPOs to expect in 2022: Reddit, Instacart and others could hit Wall Street\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-22 09:24 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.marketwatch.com/story/the-ipos-to-expect-in-2022-reddit-instacart-and-others-could-hit-wall-street-11640116396?mod=home-page><strong>MarketWatch</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Stripe is the biggest name in a crowded field of potential financial-technology startups looking to go public after a wave of Wall Street entries in 2021\nMarketWatch photo illustration/iStockphoto\nAs ...</p>\n\n<a href=\"https://www.marketwatch.com/story/the-ipos-to-expect-in-2022-reddit-instacart-and-others-could-hit-wall-street-11640116396?mod=home-page\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.marketwatch.com/story/the-ipos-to-expect-in-2022-reddit-instacart-and-others-could-hit-wall-street-11640116396?mod=home-page","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2193695165","content_text":"Stripe is the biggest name in a crowded field of potential financial-technology startups looking to go public after a wave of Wall Street entries in 2021\nMarketWatch photo illustration/iStockphoto\nAs the IPO market slowed down at the end of 2021, companies that had been expected to jump on the hot market were left out in the cold, but many of them are still expected to test the waters in 2022.\nTechnology companies dominated the market for initial public offerings in 2021, representing nine of the 10 largest deals, according to David Ethridge, the U.S. IPO services leader at PwC. And with companies staying private longer, there remains a deep backlog of mature technology companies that could finally make their debuts in the year ahead.\nAmong the most highly anticipated candidates within the tech sphere are social-networking platform Reddit, grocery-delivery service Instacart, and data-analytics company Databricks. And following what Rainmaker Securities managing director Greg Martin called a \"banner year for fintech\" deals, more attention will be focused on Stripe, which notched a $95 billion private-market valuation this year but has thus far resisted the public markets.\nHere's what to watch for among tech and fintech IPOs, and beyond, in the year ahead.\nLate to the gig IPO party?\nInstacart had its moment at the height of the pandemic, as lockdowns drove more people to try out grocery delivery. But unlike fellow gig-economy player DoorDash Inc, which went public in December 2020, Instacart has held off on an IPO, instead going through some management changes and working on new growth initiatives.\nChief Executive Fidji Simo, a Facebook (FB) veteran, has been at the helm since the summer, and Instacart could be inching closer to a debut, potentially in the second half of 2021. New CEOs typically need nine months to a year leading their companies before they can launch into an IPO, according to MKM Partners analyst Rohit Kulkarni, and Instacart in particular may also need a few more quarters \"to go through all these reopening headwinds.\"\nThe company was last valued at $39 billion in a March 2021 private funding round. One key question is whether the company can live up to that valuation in an IPO that takes place during something more closely resembling post-pandemic times.\n\"It's hard to replicate what they did in 2020,\" said Martin, whose platform Rainmaker Securities allows for the trading of pre-IPO shares in private companies. \"The valuation may have gotten a bit ahead.\"\nAn Instacart spokesperson declined to comment about the company's IPO ambitions.\nThe ultimate WallStreetBet\nReddit has helped launch meme stocks, and now the company looks closer to having a stock of its own. The message-board company announced in December that it has filed confidential paperwork with the Securities and Exchange Commission for a potential IPO after being valued at about $10 billion in an August funding round.\nReddit is perhaps best known in the investment community for its WallStreetBets \"subreddit,\" a forum on which users discuss stock picks and other topics around trading. The company makes money through advertising and a paid membership tier through which users can browse the app without ads and access other perks.\nAs a private company, Reddit has avoided some of the scrutiny that fellow social-media companies Twitter Inc. (TWTR) and Facebook-parent Meta Platforms Inc. have faced over their roles in the spread of misinformation online. By going public, Reddit could find more of a spotlight on its practices and policies.\nThe company reportedly is on track to generate $350 million in revenue this year, according to The Information, at least double its 2020 total.\nReddit may not be the only social platform to test the public markets in 2022, with Martin noting that he's seen strong secondary-market demand for Discord on his platform, suggesting that the company is one to \"keep an eye on\" in the year to come.\n\"We don't have anything to say at this time,\" a Discord spokesperson said in response to MarketWatch's inquiry about potential IPO plans.\nThe year of Stripe?\nLikened to Amazon.com Inc.'s AWS cloud-computing business except for payments infrastructure, Stripe helps power many hot tech companies, including Lyft Inc., Peloton Interactive Inc. and Shopify Inc. Similar to Square-parent Block Inc., the company provides payment-processing technology, invoicing tools, and business financing, among other features.\nBut with a private-market valuation of nearly $100 billion, Stripe continues to test the boundaries of how long a hot technology company can avoid the public markets. Will 2022 finally be the year that the fintech giant takes the plunge?\nIPO watchers are split on whether Stripe will make its debut. Given the company's secrecy about potential IPO ambitions, it seems that Stripe executives are content operating the business as a private company, Kulkarni said. He would be \"surprised\" to see Stripe turn public in the year ahead.\nMartin, a shareholder of Stripe, is more upbeat about the chances. \"The company is so tightly controlled by the founders, and there's some sense that they never need to go public,\" he said, given that Stripe has been able to offer liquidity for investors and raise new capital easily. Still, he expects the company will hit the IPO market in 2022.\nA fintech parade\nStripe isn't the only hot fintech among rumored IPO candidates. The year ahead could bring \"five or six massive 'decacorn'\" IPOs in the fintech space, said Martin, acknowledging that Stripe's would actually be a \"centicorn\" deal given that the company is hovering around a $100 billion valuation.\nSwedish fintech company Klarna is one highly anticipated name, especially since its buy-now, pay-later rival Affirm Holdings Inc. $(AFRM)$was one of the biggest IPO market successes of 2021. Like Affirm, Klarna lets consumers split purchases into installments. The company was valued at $46 billion through a June funding round.\nThough based in Europe, Klarna could make more of a splash if it chose to debut on a U.S. exchange, said Avery Spear, a data analyst at Renaissance Capital. Doing so would unlock \"a bigger pool of capital,\" she continued.\nA Klarna spokesperson said that the company doesn't comment on IPO plans and that \"this is a matter only our CEO can speak to.\"\nOther possibilities include Revolut and Chime, neobanks privately valued at $33 billion and $25 billion, respectively. They would follow Nu Holdings Inc., a Brazilian company that runs Nubank, which came public in early December.\nChime declined to comment on its IPO ambitions.\nMartin is also watching Plaid, which nabbed a $13.4 billion private-market valuation in April after its deal with Visa Inc. (V)was called off. The company makes it easier for people to link their bank accounts to services like PayPal Holdings Inc.'s Venmo. And Brex, which provides credit cards and other financial products to businesses, also cracks his watch list. The company secured an October funding round that valued it at $12.3 billion, according to TechCrunch.\nPlaid declined to comment on its IPO plans. A Brex spokesperson said the company didn't have comment on its plans.\n\"The fintech companies will definitely dominate 2022,\" Martin said.\nThe next Snowflake\nSnowflake Inc.'s (SNOW) reception on Wall Street has been anything but chilly, and another trendy cloud company may be looking to achieve a similar fate.\nDatabricks, which helps companies process and analyze data, \"has been a long anticipated IPO,\" said Kulkarni, and it may finally make a jump to the public markets in 2022. The company has nabbed a $38 billion private-market valuation.\nA Databricks spokesperson said the company didn't have further comment beyond what it has already said publicly. Chief Executive Ali Ghodsi said that he expects the company to eventually come public in the \"not-too-distant future\" when speaking to CNBC in December.\nOther software names on Kulkarni's watch list include Tanium and Canva. Tanium \"operates in an extremely attractive end market\" by providing cybersecurity services, he said. Canva, based in Australia, makes design software that challenges offerings from Adobe Inc.\nElsewhere on the horizon, social-media management company Hootsuite might be aiming for an IPO, per Santosh Rao, the head of research at Manhattan Venture Partners. The Canadian company was founded in 2008 but it doesn't appear to be profitable yet, which could be problematic given current market attitudes, in his view.\n\"Even the big guys are getting punished for not showing any profits after so long,\" Rao said. The company reportedly was aiming for an IPO in Canada \"before Christmas,\" according to Betakit, a publication that covers Canadian startups. That offering never materialized.\nWinning fans\nFanatics recently scored a deal to replace Topps as the maker of Major League Baseball trading cards, and the sporting company could soon be heading for the big leagues itself. The MLB deal shook up the industry enough that Topps and Panini, two big card makers, both shelved their own IPO plans after Topps won the baseball business.\nLast valued at $18 billion in August, the company recently scooped up former IAC/InterActiveCorp. $(IAC)$ chief financial officer Glenn Schiffman to serve in the same role at Fanatics, which could be a sign that the company has IPO ambitions.\nSchiffman worked with various online brands at IAC, and his Fanatics corporate bio mentions that he will \"drive the financial direction of the company as it expands beyond commerce into new verticals across the sports ecosystem to become a leading global digital sports platform.\"\n\"While an IPO is clearly an available option to us, there is no update on any timeline,\" a Fanatics spokesperson told MarketWatch. \"Any public offering is just a moment in time as our focus remains on expanding the business and building the leading digital sports platform over the next decade and beyond.\"\nNothing's impossible\nImpossible Foods once seemed like a likely IPO candidate for the beginning of 2022, according to Martin, but he's seen secondary-market demand cool off for the maker of plant-based meat. Publicly held rival Beyond Meat Inc. has seen its stock price roughly cut in half during 2021, which could be impacting sentiment toward Impossible as well.\nThe company, which raised roughly $500 million in a November funding round, still remains a name to monitor, especially if Beyond Meat shares fall back into favor on Wall Street or if the company's financials look better than Beyond's. Impossible hired a former fintech exec as its permanent chief financial officer in August, which could signal an effort to get the books ready for Wall Street.\nPrivate equity coming public\nOne of the more likely IPO bets for 2022 is TPG Partners LLC, a private-equity firm that has already filed its prospectus with the SEC. The company's sizable roster of 23 underwriting banks suggests that TPG could be headed for a large offering, perhaps raking in upward of $1 billion.","news_type":1},"isVote":1,"tweetType":1,"viewCount":596,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":693723112,"gmtCreate":1640084108977,"gmtModify":1640084110154,"author":{"id":"3585001294737518","authorId":"3585001294737518","name":"Universe宇宙","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3585001294737518","idStr":"3585001294737518"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/C6L.SI\">$SINGAPORE AIRLINES LTD(C6L.SI)$</a>is over valued?&nbsp;[Doubt]&nbsp;Omicron covid virus roaming around us, and some policy makers wanted to lock down again, cancel public events, etc.The high inflation and high oil prices means higher cost to SIA. Did you also notice the high electricity bill&nbsp;too?No covid vaccine can help as they are NOT&nbsp;the silver bullet, and they cannot remove&nbsp;covid virus from this planet, and also cannot prevent covid mutation, and thus other countries will cancel travel oversea, since the covid virus will continue to roam with us and mutate.Please enlighten me and&nbsp;feel free to comment below.","listText":"<a href=\"https://laohu8.com/S/C6L.SI\">$SINGAPORE AIRLINES LTD(C6L.SI)$</a>is over valued?&nbsp;[Doubt]&nbsp;Omicron covid virus roaming around us, and some policy makers wanted to lock down again, cancel public events, etc.The high inflation and high oil prices means higher cost to SIA. Did you also notice the high electricity bill&nbsp;too?No covid vaccine can help as they are NOT&nbsp;the silver bullet, and they cannot remove&nbsp;covid virus from this planet, and also cannot prevent covid mutation, and thus other countries will cancel travel oversea, since the covid virus will continue to roam with us and mutate.Please enlighten me and&nbsp;feel free to comment below.","text":"$SINGAPORE AIRLINES LTD(C6L.SI)$is over valued? [Doubt] Omicron covid virus roaming around us, and some policy makers wanted to lock down again, cancel public events, etc.The high inflation and high oil prices means higher cost to SIA. Did you also notice the high electricity bill too?No covid vaccine can help as they are NOT the silver bullet, and they cannot remove covid virus from this planet, and also cannot prevent covid mutation, and thus other countries will cancel travel oversea, since the covid virus will continue to roam with us and mutate.Please enlighten me and feel free to comment below.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/693723112","isVote":1,"tweetType":1,"viewCount":656,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":693492191,"gmtCreate":1640057561236,"gmtModify":1640058748060,"author":{"id":"3585001294737518","authorId":"3585001294737518","name":"Universe宇宙","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3585001294737518","idStr":"3585001294737518"},"themes":[],"htmlText":"First post 😉","listText":"First post 😉","text":"First post 😉","images":[],"top":1,"highlighted":2,"essential":1,"paper":1,"likeSize":4,"commentSize":16,"repostSize":0,"link":"https://laohu8.com/post/693492191","repostId":"1180317442","repostType":4,"repost":{"id":"1180317442","pubTimestamp":1640057402,"share":"https://www.laohu8.com/m/news/1180317442?lang=&edition=full","pubTime":"2021-12-21 11:30","market":"us","language":"en","title":"Let the Roblox Share Price Decline to $70, Then Start a Position","url":"https://stock-news.laohu8.com/highlight/detail?id=1180317442","media":"InvestorPlace","summary":"After a meteoric rise, hot metaverse bet RBLX stock just needs to cool down","content":"<p>California-based online entertainment platform&nbsp;<b>Roblox</b>&nbsp;(NYSE:<b><u>RBLX</u></b>) empowers people to play video games and socialize in a vast, 3D, virtual world. Since the company was an early-stage entrant in the red-hot metaverse space, RBLX stock has generated major buzz on Wall Street.</p>\n<p>Indeed, as the term “metaverse” gained traction in the financial news headlines, Roblox share price soared. However, as the old saying goes, trees don’t grow straight to the heavens.</p>\n<p>In other words, even white-hot RBLX stock couldn’t just keep going up forever. All it took was a worse-than-expected user-growth update, and Roblox was suddenly out of favor with investors.</p>\n<p>It’s funny how the tide of sentiment can turn so quickly. Contrarians who still believe in the future of metaverse-anchored gaming can take advantage of the market’s overreaction as Roblox’s news has not been all bad.</p>\n<p><b>A Closer Look at RBLX Stock</b></p>\n<p>Just to recap, RBLX stock&nbsp;debuted on March 10&nbsp;of this year. Interestingly enough, the shares became publicly traded through the&nbsp;very first direct listing of 2021.</p>\n<p>The stock actually began trading at $64.50 and finished its first day of trading at $69.50. Then its upward momentum accelerated as its price ramped up to a 52-week high of $141.60 in November.</p>\n<p>Unfortunately, this moon shot wasn’t sustainable. RBLX stock fell quickly in November’s back half and continued declining in December, falling as low as $95 and change.</p>\n<p>Experts often recommend avoiding buying sharply falling stocks in order to refrain from “catching a falling knife.”</p>\n<p>Roblox has fairly solid support at $70, so it’s not a terrible idea to be patient and let its share price hit that critical price point before taking a position in the name.</p>\n<p><b>A Subtle Bug</b></p>\n<p>Some may assume that RBLX stock simply fell victim to gravity after flying too far, too fast.</p>\n<p>Yet this wasn’t just an instance of Icarus flying too close to the sun. Rather, there were specific incidents that popped the shares’ bubble.</p>\n<p>The first of these incidents took place in late October and early November, when Roblox reportedly experienced a three-day&nbsp;outage during the Halloween weekend.</p>\n<p>This was a period in which the company would typically take in at least $15 million in revenue. So&nbsp; that three-day outage was a big deal for Roblox. Just as painfully, RBLX stock lost more than $1.5 billion worth of its market capitalization as a result of this incident.</p>\n<p>Of course, Roblox CEO David Baszucki had some ” ‘splaining” to do. He claimed that the outage had been “especially difficult” as it involved a “combination of several factors.”</p>\n<p>“A core system in our infrastructure became overwhelmed, prompted by a subtle bug in our backend service communications while under heavy load… This was not due to any peak in external traffic or any particular experience,” Baszucki explained.</p>\n<p><b>A Possible Overreaction</b></p>\n<p>Evidently, Roblox’s investors weren’t too impressed with the CEO’s account or at least Baszucki’s explanation didn’t prevent many investors from unloading all of their RBLX stock.</p>\n<p>Fast-forward to mid-December, and Roblox released its&nbsp;usage statistics&nbsp;for the month of November. Investors reacted very negatively to the data, and they may have overreacted.</p>\n<p>Roblox counted 49.4 million average daily active users in November, up 35% year-over-year. That sounds pretty good, if you ask me.</p>\n<p>On the other hand, that figure was less than the 50.5 million average daily active users Roblox reported for the first 27 days of October.</p>\n<p>That’s not a huge decline. And in November, Roblox generated estimated bookings of between $208 million and $211 million, up 22% to 24% YOY.</p>\n<p>On top of all that, Roblox reported 3.6 billion hours engaged in November, representing a 32% YOY gain.</p>\n<p><b>The Bottom Line</b></p>\n<p>It’s not always easy to tread the line between optimism and caution.</p>\n<p>Yet that’s the right approach to RBLX stock, given the investing community’s negative sentiment towards Roblox at the moment. Thus, it’s wise to let the share price continue on its likely path to $70 and then re-evaluate and take a long position in the name if you’re ready to do so.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Let the Roblox Share Price Decline to $70, Then Start a Position</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nLet the Roblox Share Price Decline to $70, Then Start a Position\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-21 11:30 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/12/let-the-roblox-share-price-decline-to-70-then-start-a-position/><strong>InvestorPlace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>California-based online entertainment platform Roblox (NYSE:RBLX) empowers people to play video games and socialize in a vast, 3D, virtual world. Since the company was an early-stage entrant in the ...</p>\n\n<a href=\"https://investorplace.com/2021/12/let-the-roblox-share-price-decline-to-70-then-start-a-position/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://investorplace.com/2021/12/let-the-roblox-share-price-decline-to-70-then-start-a-position/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1180317442","content_text":"California-based online entertainment platform Roblox (NYSE:RBLX) empowers people to play video games and socialize in a vast, 3D, virtual world. Since the company was an early-stage entrant in the red-hot metaverse space, RBLX stock has generated major buzz on Wall Street.\nIndeed, as the term “metaverse” gained traction in the financial news headlines, Roblox share price soared. However, as the old saying goes, trees don’t grow straight to the heavens.\nIn other words, even white-hot RBLX stock couldn’t just keep going up forever. All it took was a worse-than-expected user-growth update, and Roblox was suddenly out of favor with investors.\nIt’s funny how the tide of sentiment can turn so quickly. Contrarians who still believe in the future of metaverse-anchored gaming can take advantage of the market’s overreaction as Roblox’s news has not been all bad.\nA Closer Look at RBLX Stock\nJust to recap, RBLX stock debuted on March 10 of this year. Interestingly enough, the shares became publicly traded through the very first direct listing of 2021.\nThe stock actually began trading at $64.50 and finished its first day of trading at $69.50. Then its upward momentum accelerated as its price ramped up to a 52-week high of $141.60 in November.\nUnfortunately, this moon shot wasn’t sustainable. RBLX stock fell quickly in November’s back half and continued declining in December, falling as low as $95 and change.\nExperts often recommend avoiding buying sharply falling stocks in order to refrain from “catching a falling knife.”\nRoblox has fairly solid support at $70, so it’s not a terrible idea to be patient and let its share price hit that critical price point before taking a position in the name.\nA Subtle Bug\nSome may assume that RBLX stock simply fell victim to gravity after flying too far, too fast.\nYet this wasn’t just an instance of Icarus flying too close to the sun. Rather, there were specific incidents that popped the shares’ bubble.\nThe first of these incidents took place in late October and early November, when Roblox reportedly experienced a three-day outage during the Halloween weekend.\nThis was a period in which the company would typically take in at least $15 million in revenue. So  that three-day outage was a big deal for Roblox. Just as painfully, RBLX stock lost more than $1.5 billion worth of its market capitalization as a result of this incident.\nOf course, Roblox CEO David Baszucki had some ” ‘splaining” to do. He claimed that the outage had been “especially difficult” as it involved a “combination of several factors.”\n“A core system in our infrastructure became overwhelmed, prompted by a subtle bug in our backend service communications while under heavy load… This was not due to any peak in external traffic or any particular experience,” Baszucki explained.\nA Possible Overreaction\nEvidently, Roblox’s investors weren’t too impressed with the CEO’s account or at least Baszucki’s explanation didn’t prevent many investors from unloading all of their RBLX stock.\nFast-forward to mid-December, and Roblox released its usage statistics for the month of November. Investors reacted very negatively to the data, and they may have overreacted.\nRoblox counted 49.4 million average daily active users in November, up 35% year-over-year. That sounds pretty good, if you ask me.\nOn the other hand, that figure was less than the 50.5 million average daily active users Roblox reported for the first 27 days of October.\nThat’s not a huge decline. And in November, Roblox generated estimated bookings of between $208 million and $211 million, up 22% to 24% YOY.\nOn top of all that, Roblox reported 3.6 billion hours engaged in November, representing a 32% YOY gain.\nThe Bottom Line\nIt’s not always easy to tread the line between optimism and caution.\nYet that’s the right approach to RBLX stock, given the investing community’s negative sentiment towards Roblox at the moment. Thus, it’s wise to let the share price continue on its likely path to $70 and then re-evaluate and take a long position in the name if you’re ready to do so.","news_type":1},"isVote":1,"tweetType":1,"viewCount":473,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":693874129,"gmtCreate":1640009255761,"gmtModify":1640009256997,"author":{"id":"3585001294737518","authorId":"3585001294737518","name":"Universe宇宙","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3585001294737518","idStr":"3585001294737518"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/U/36984908995200\">@小虎活动</a><a href=\"https://laohu8.com/U/3527667667103859\">@TigerEvents</a>, please come out with lots of events that have lots of rewards for us. Merry Christmas 2021. [YoYo] [YoYo]","listText":"<a href=\"https://laohu8.com/U/36984908995200\">@小虎活动</a><a href=\"https://laohu8.com/U/3527667667103859\">@TigerEvents</a>, please come out with lots of events that have lots of rewards for us. Merry Christmas 2021. [YoYo] [YoYo]","text":"@小虎活动@TigerEvents, please come out with lots of events that have lots of rewards for us. Merry Christmas 2021. [YoYo] [YoYo]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/693874129","repostId":"690720270","repostType":1,"repost":{"id":690720270,"gmtCreate":1639710618789,"gmtModify":1639740219765,"author":{"id":"36984908995200","authorId":"36984908995200","name":"小虎活动","avatar":"https://static.tigerbbs.com/9e396d03155923b283948d2dec9191f8","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"36984908995200","idStr":"36984908995200"},"themes":[],"title":"小虎活动账号搬迁通知，快来关注TigerEvents","htmlText":"Hello,大家好，感谢大家过去一年的支持，小虎君提前祝大家圣诞快乐！ 由于合规的原因，小虎活动在海外的老虎社区注册了一个新的账号@TigerEvent ，这个账号与之前的小虎活动一样，也是跟大家一起玩玩游戏，聊聊投资。 欢迎大家关注我的海外账号@TigerEvent ，另外也欢迎各位虎友把这个消息告诉给身边的朋友。 凡是看到这个帖子，关注@TigerEvent&nbsp;的虎友，可以在下贴留言，我会给每一位朋友派发66虎币。 再次感谢大家的支持，祝大家节日快乐 HUAT HUAT HUAT","listText":"Hello,大家好，感谢大家过去一年的支持，小虎君提前祝大家圣诞快乐！ 由于合规的原因，小虎活动在海外的老虎社区注册了一个新的账号@TigerEvent ，这个账号与之前的小虎活动一样，也是跟大家一起玩玩游戏，聊聊投资。 欢迎大家关注我的海外账号@TigerEvent ，另外也欢迎各位虎友把这个消息告诉给身边的朋友。 凡是看到这个帖子，关注@TigerEvent&nbsp;的虎友，可以在下贴留言，我会给每一位朋友派发66虎币。 再次感谢大家的支持，祝大家节日快乐 HUAT HUAT HUAT","text":"Hello,大家好，感谢大家过去一年的支持，小虎君提前祝大家圣诞快乐！ 由于合规的原因，小虎活动在海外的老虎社区注册了一个新的账号@TigerEvent ，这个账号与之前的小虎活动一样，也是跟大家一起玩玩游戏，聊聊投资。 欢迎大家关注我的海外账号@TigerEvent ，另外也欢迎各位虎友把这个消息告诉给身边的朋友。 凡是看到这个帖子，关注@TigerEvent 的虎友，可以在下贴留言，我会给每一位朋友派发66虎币。 再次感谢大家的支持，祝大家节日快乐 HUAT HUAT HUAT","images":[{"img":"https://static.tigerbbs.com/30a204e229cb683b504eb4c24a6a9439","width":"1170","height":"815"}],"top":1,"highlighted":2,"essential":1,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/690720270","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":446,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":693871074,"gmtCreate":1640008398750,"gmtModify":1640008479714,"author":{"id":"3585001294737518","authorId":"3585001294737518","name":"Universe宇宙","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3585001294737518","idStr":"3585001294737518"},"themes":[],"htmlText":"First post 😉","listText":"First post 😉","text":"First post 😉","images":[],"top":1,"highlighted":2,"essential":1,"paper":1,"likeSize":7,"commentSize":19,"repostSize":0,"link":"https://laohu8.com/post/693871074","repostId":"1138448212","repostType":4,"repost":{"id":"1138448212","weMediaInfo":{"introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"media_name":"Dow Jones","id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"pubTimestamp":1640008237,"share":"https://www.laohu8.com/m/news/1138448212?lang=&edition=full","pubTime":"2021-12-20 21:50","market":"us","language":"en","title":"Summit Therapeutics Shares Fall nearly 30% After Failing to Meet Endpoint in Phase 3 Ri-CoDIFy Study","url":"https://stock-news.laohu8.com/highlight/detail?id=1138448212","media":"Dow Jones","summary":"Summit Therapeutics Inc. shares fell nearly 30% to $3.5 after the company said its Phase 3 Ri-CoDIFy","content":"<p>Summit Therapeutics Inc. shares fell&nbsp;nearly 30% to $3.5 after the company said its Phase 3 Ri-CoDIFy study didn't meet its primary endpoint for superiority for the treatment of C. difficle infection.</p>\n<p><img src=\"https://static.tigerbbs.com/5780de0c9ef3f0248ec3fa67eaa2037e\" tg-width=\"703\" tg-height=\"593\" referrerpolicy=\"no-referrer\"></p>\n<p>The investigational drug, ridinilazole, resulted in a higher observed sustained clinicial response than the antibiotic vancomycin but not superiority, Summit said. Sustained clinical response is defined as clinical response of the treated episode of CDI and no recurrence of the infection through 30 days after the end of treatment, the company said.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Summit Therapeutics Shares Fall nearly 30% After Failing to Meet Endpoint in Phase 3 Ri-CoDIFy Study </title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSummit Therapeutics Shares Fall nearly 30% After Failing to Meet Endpoint in Phase 3 Ri-CoDIFy Study \n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2021-12-20 21:50</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p>Summit Therapeutics Inc. shares fell&nbsp;nearly 30% to $3.5 after the company said its Phase 3 Ri-CoDIFy study didn't meet its primary endpoint for superiority for the treatment of C. difficle infection.</p>\n<p><img src=\"https://static.tigerbbs.com/5780de0c9ef3f0248ec3fa67eaa2037e\" tg-width=\"703\" tg-height=\"593\" referrerpolicy=\"no-referrer\"></p>\n<p>The investigational drug, ridinilazole, resulted in a higher observed sustained clinicial response than the antibiotic vancomycin but not superiority, Summit said. Sustained clinical response is defined as clinical response of the treated episode of CDI and no recurrence of the infection through 30 days after the end of treatment, the company said.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SMMT":"Summit Therapeutics PLC"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1138448212","content_text":"Summit Therapeutics Inc. shares fell nearly 30% to $3.5 after the company said its Phase 3 Ri-CoDIFy study didn't meet its primary endpoint for superiority for the treatment of C. difficle infection.\n\nThe investigational drug, ridinilazole, resulted in a higher observed sustained clinicial response than the antibiotic vancomycin but not superiority, Summit said. Sustained clinical response is defined as clinical response of the treated episode of CDI and no recurrence of the infection through 30 days after the end of treatment, the company said.","news_type":1},"isVote":1,"tweetType":1,"viewCount":327,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":699489138,"gmtCreate":1639876444722,"gmtModify":1639876535602,"author":{"id":"3585001294737518","authorId":"3585001294737518","name":"Universe宇宙","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3585001294737518","idStr":"3585001294737518"},"themes":[],"htmlText":"😉","listText":"😉","text":"😉","images":[],"top":1,"highlighted":2,"essential":1,"paper":1,"likeSize":5,"commentSize":14,"repostSize":0,"link":"https://laohu8.com/post/699489138","repostId":"1164517103","repostType":4,"repost":{"id":"1164517103","pubTimestamp":1639874793,"share":"https://www.laohu8.com/m/news/1164517103?lang=&edition=full","pubTime":"2021-12-19 08:46","market":"us","language":"en","title":"US IPO Week Ahead: The IPO market decks the halls with 1 IPO in the short holiday week","url":"https://stock-news.laohu8.com/highlight/detail?id=1164517103","media":"renaissancecap...","summary":"Just one IPO is scheduled to go public in the shortened holiday week.\nOTC-listed Cerberus Cyber Sent","content":"<p>Just one IPO is scheduled to go public in the shortened holiday week.</p>\n<p>OTC-listed&nbsp;<a href=\"https://laohu8.com/S/CISO\"><b>Cerberus Cyber Sentinel</b></a> plans to raise $10 million at a $631 million market cap. The company provides a range of cybersecurity consulting and related services, including Secured Managed Services and Compliance Services, among others. Cerberus Cyber Sentinel has delivered explosive growth, but it is unprofitable with negative cash flow.</p>\n<p><img src=\"https://static.tigerbbs.com/8dfff81a3d62b2a5b41793d751f8e793\" tg-width=\"696\" tg-height=\"121\" width=\"100%\" height=\"auto\">IPO Market Snapshot</p>\n<p>The Renaissance IPO Indices are market cap weighted baskets of newly public companies. As of 12/16/21, the Renaissance IPO Index was down 14% year-to-date, while the S&amp;P 500 was up 24%. Renaissance Capital's IPO ETF (NYSE: IPO) tracks the index, and top ETF holdings include Snowflake (SNOW) and Moderna (MRNA). The Renaissance International IPO Index was down 29% year-to-date, while the ACWX was up 6%. Renaissance Capital’s International IPO ETF (NYSE: IPOS) tracks the index, and top ETF holdings include Meituan-Dianping and SoftBank.</p>","source":"lsy1619493174116","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>US IPO Week Ahead: The IPO market decks the halls with 1 IPO in the short holiday week</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUS IPO Week Ahead: The IPO market decks the halls with 1 IPO in the short holiday week\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-19 08:46 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.renaissancecapital.com/IPO-Center/News/89650/US-IPO-Week-Ahead-The-IPO-market-decks-the-halls-with-1-IPO-in-the-short-ho><strong>renaissancecap...</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Just one IPO is scheduled to go public in the shortened holiday week.\nOTC-listed Cerberus Cyber Sentinel plans to raise $10 million at a $631 million market cap. The company provides a range of ...</p>\n\n<a href=\"https://www.renaissancecapital.com/IPO-Center/News/89650/US-IPO-Week-Ahead-The-IPO-market-decks-the-halls-with-1-IPO-in-the-short-ho\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"CISO":"CISO Global"},"source_url":"https://www.renaissancecapital.com/IPO-Center/News/89650/US-IPO-Week-Ahead-The-IPO-market-decks-the-halls-with-1-IPO-in-the-short-ho","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1164517103","content_text":"Just one IPO is scheduled to go public in the shortened holiday week.\nOTC-listed Cerberus Cyber Sentinel plans to raise $10 million at a $631 million market cap. The company provides a range of cybersecurity consulting and related services, including Secured Managed Services and Compliance Services, among others. Cerberus Cyber Sentinel has delivered explosive growth, but it is unprofitable with negative cash flow.\nIPO Market Snapshot\nThe Renaissance IPO Indices are market cap weighted baskets of newly public companies. As of 12/16/21, the Renaissance IPO Index was down 14% year-to-date, while the S&P 500 was up 24%. Renaissance Capital's IPO ETF (NYSE: IPO) tracks the index, and top ETF holdings include Snowflake (SNOW) and Moderna (MRNA). The Renaissance International IPO Index was down 29% year-to-date, while the ACWX was up 6%. Renaissance Capital’s International IPO ETF (NYSE: IPOS) tracks the index, and top ETF holdings include Meituan-Dianping and SoftBank.","news_type":1},"isVote":1,"tweetType":1,"viewCount":507,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":699195773,"gmtCreate":1639754156313,"gmtModify":1639754157556,"author":{"id":"3585001294737518","authorId":"3585001294737518","name":"Universe宇宙","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3585001294737518","idStr":"3585001294737518"},"themes":[],"htmlText":"U.S. stocks sink at Friday's open,Nasdaq Composite Index declines 0.9%","listText":"U.S. stocks sink at Friday's open,Nasdaq Composite Index declines 0.9%","text":"U.S. stocks sink at Friday's open,Nasdaq Composite Index declines 0.9%","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/699195773","repostId":"1114105828","repostType":4,"repost":{"id":"1114105828","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1639751560,"share":"https://www.laohu8.com/m/news/1114105828?lang=&edition=full","pubTime":"2021-12-17 22:32","market":"us","language":"en","title":"U.S. stocks sink at Friday's open,Nasdaq Composite Index declines 0.9%","url":"https://stock-news.laohu8.com/highlight/detail?id=1114105828","media":"Tiger Newspress","summary":"U.S. stocks sink at Friday's open as 10-year Treasury yield falls below 1.4% to cap Fed week,Nasdaq ","content":"<p>U.S. stocks sink at Friday's open as 10-year Treasury yield falls below 1.4% to cap Fed week,Nasdaq Composite Index declines 0.9%,Dow trades 0.5% lower; S&amp;P 500 down 0.6%.</p>\n<p>Shares of FedEx (FDX) jumped after the shipping giant raised its full-year earnings forecast, delivered better-than-expected fiscal second-quarter results and authorized a new $5 billion stock buyback program. Rivian (RIVN), meanwhile, saw shares sink following its first quarterly report since its IPO last month. The electric-vehicle makersaid in its shareholder letterit expected to be \"a few hundred vehicles short\" of its prior target of producing 1,200 units by the end of this year.</p>\n<p>Investors' main focus this week has remained fixed on the Federal Reserve's updated outlook on monetary policy for next year, with the central bank's projections delivered mid-week suggesting the Fedcould hike interest rates three times next year.</p>\n<p>The specter of higher rates — and a lower-liquidity environment as the central bank also speeds up the tapering process of its asset purchases — has continued to weigh heavily on longer-duration technology and growth stocks valued heavily on future earnings potential. The Nasdaq Composite has fallen by 5% over the past month through Thursday's close. And shares of some notable technology stocks extended declines on Friday, with Apple (AAPL) shares dropping by more than 1% in early trading after a nearly 4% decrease on Thursday.</p>\n<p>On the other hand, cyclical stocks in the energy and financials sectors outperformed on Thursday, with the prospects of higher interest rates and stronger growth seen as benefitting these sectors.</p>\n<p>\"The thing investors have to understand is, we're going through a major transition in monetary policy,\" Troy Gayeski, FS Investments chief market strategist,told Yahoo Finance Live on Thursday.\"The Fed has been running emergency policies arguably far longer than they should have been, and as that money supply growth slows down as they ease off the balance sheet expansion and ultimately hike next year, one would at least expect more volatility in markets. And that's really what we've been seeing the last month.\"</p>\n<p>\"The biggest difference between now and six months ago, or even more than a year ago, is you could pretty much go long anything and you were confident it was going to go up. The economy was booming, we had a lot of fiscal stimulus, we still had unprecedented monetary policy stimulus,\" he added. \"And it's a very different environment in 2022 where you're going to have to pick and choose much more carefully.\"</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>U.S. stocks sink at Friday's open,Nasdaq Composite Index declines 0.9%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nU.S. stocks sink at Friday's open,Nasdaq Composite Index declines 0.9%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-12-17 22:32</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>U.S. stocks sink at Friday's open as 10-year Treasury yield falls below 1.4% to cap Fed week,Nasdaq Composite Index declines 0.9%,Dow trades 0.5% lower; S&amp;P 500 down 0.6%.</p>\n<p>Shares of FedEx (FDX) jumped after the shipping giant raised its full-year earnings forecast, delivered better-than-expected fiscal second-quarter results and authorized a new $5 billion stock buyback program. Rivian (RIVN), meanwhile, saw shares sink following its first quarterly report since its IPO last month. The electric-vehicle makersaid in its shareholder letterit expected to be \"a few hundred vehicles short\" of its prior target of producing 1,200 units by the end of this year.</p>\n<p>Investors' main focus this week has remained fixed on the Federal Reserve's updated outlook on monetary policy for next year, with the central bank's projections delivered mid-week suggesting the Fedcould hike interest rates three times next year.</p>\n<p>The specter of higher rates — and a lower-liquidity environment as the central bank also speeds up the tapering process of its asset purchases — has continued to weigh heavily on longer-duration technology and growth stocks valued heavily on future earnings potential. The Nasdaq Composite has fallen by 5% over the past month through Thursday's close. And shares of some notable technology stocks extended declines on Friday, with Apple (AAPL) shares dropping by more than 1% in early trading after a nearly 4% decrease on Thursday.</p>\n<p>On the other hand, cyclical stocks in the energy and financials sectors outperformed on Thursday, with the prospects of higher interest rates and stronger growth seen as benefitting these sectors.</p>\n<p>\"The thing investors have to understand is, we're going through a major transition in monetary policy,\" Troy Gayeski, FS Investments chief market strategist,told Yahoo Finance Live on Thursday.\"The Fed has been running emergency policies arguably far longer than they should have been, and as that money supply growth slows down as they ease off the balance sheet expansion and ultimately hike next year, one would at least expect more volatility in markets. And that's really what we've been seeing the last month.\"</p>\n<p>\"The biggest difference between now and six months ago, or even more than a year ago, is you could pretty much go long anything and you were confident it was going to go up. The economy was booming, we had a lot of fiscal stimulus, we still had unprecedented monetary policy stimulus,\" he added. \"And it's a very different environment in 2022 where you're going to have to pick and choose much more carefully.\"</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1114105828","content_text":"U.S. stocks sink at Friday's open as 10-year Treasury yield falls below 1.4% to cap Fed week,Nasdaq Composite Index declines 0.9%,Dow trades 0.5% lower; S&P 500 down 0.6%.\nShares of FedEx (FDX) jumped after the shipping giant raised its full-year earnings forecast, delivered better-than-expected fiscal second-quarter results and authorized a new $5 billion stock buyback program. Rivian (RIVN), meanwhile, saw shares sink following its first quarterly report since its IPO last month. The electric-vehicle makersaid in its shareholder letterit expected to be \"a few hundred vehicles short\" of its prior target of producing 1,200 units by the end of this year.\nInvestors' main focus this week has remained fixed on the Federal Reserve's updated outlook on monetary policy for next year, with the central bank's projections delivered mid-week suggesting the Fedcould hike interest rates three times next year.\nThe specter of higher rates — and a lower-liquidity environment as the central bank also speeds up the tapering process of its asset purchases — has continued to weigh heavily on longer-duration technology and growth stocks valued heavily on future earnings potential. The Nasdaq Composite has fallen by 5% over the past month through Thursday's close. And shares of some notable technology stocks extended declines on Friday, with Apple (AAPL) shares dropping by more than 1% in early trading after a nearly 4% decrease on Thursday.\nOn the other hand, cyclical stocks in the energy and financials sectors outperformed on Thursday, with the prospects of higher interest rates and stronger growth seen as benefitting these sectors.\n\"The thing investors have to understand is, we're going through a major transition in monetary policy,\" Troy Gayeski, FS Investments chief market strategist,told Yahoo Finance Live on Thursday.\"The Fed has been running emergency policies arguably far longer than they should have been, and as that money supply growth slows down as they ease off the balance sheet expansion and ultimately hike next year, one would at least expect more volatility in markets. And that's really what we've been seeing the last month.\"\n\"The biggest difference between now and six months ago, or even more than a year ago, is you could pretty much go long anything and you were confident it was going to go up. The economy was booming, we had a lot of fiscal stimulus, we still had unprecedented monetary policy stimulus,\" he added. \"And it's a very different environment in 2022 where you're going to have to pick and choose much more carefully.\"","news_type":1},"isVote":1,"tweetType":1,"viewCount":473,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3585001294737518","authorId":"3585001294737518","name":"Universe宇宙","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":6,"crmLevelSwitch":0,"authorIdStr":"3585001294737518","idStr":"3585001294737518"},"content":"buy cryptocurrencies now? [Doubt]","text":"buy cryptocurrencies now? [Doubt]","html":"buy cryptocurrencies now? [Doubt]"}],"imageCount":0,"langContent":"CN","totalScore":0}],"hots":[{"id":873978367,"gmtCreate":1636852328392,"gmtModify":1636852522095,"author":{"id":"3585001294737518","authorId":"3585001294737518","name":"Universe宇宙","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3585001294737518","authorIdStr":"3585001294737518"},"themes":[],"htmlText":"Consider first inflation's&nbsp;impact on earnings: Because companies often are able to charge higher prices when inflation heats up — they have \"pricing power,\"&nbsp;in other words — their earnings do not suffer as much as you might think.&nbsp;","listText":"Consider first inflation's&nbsp;impact on earnings: Because companies often are able to charge higher prices when inflation heats up — they have \"pricing power,\"&nbsp;in other words — their earnings do not suffer as much as you might think.&nbsp;","text":"Consider first inflation's impact on earnings: Because companies often are able to charge higher prices when inflation heats up — they have \"pricing power,\" in other words — their earnings do not suffer as much as you might think.","images":[],"top":1,"highlighted":2,"essential":1,"paper":1,"likeSize":7,"commentSize":32,"repostSize":0,"link":"https://laohu8.com/post/873978367","repostId":"2183043548","repostType":4,"repost":{"id":"2183043548","pubTimestamp":1636852012,"share":"https://www.laohu8.com/m/news/2183043548?lang=&edition=full","pubTime":"2021-11-14 09:06","market":"us","language":"en","title":"If inflation is more than transitory, consumer prices and stocks could both keep climbing","url":"https://stock-news.laohu8.com/highlight/detail?id=2183043548","media":"MarketWatch","summary":"The stock market is a good inflation hedge\nAgence France-Presse/Getty Images\n\nConventional wisdom sa","content":"<p>The stock market is a good inflation hedge</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/cd7f220695081ff57f1ed561e56d2713\" tg-width=\"700\" tg-height=\"390\" width=\"100%\" height=\"auto\"><span>Agence France-Presse/Getty Images</span></p>\n<p></p>\n<p>Conventional wisdom says that inflation is bad for the stock market. Yet the U.S. stock market this year has remained strong in the face of unexpectedly high inflation.</p>\n<p>Since mid-May, when it was first reported that the CPI’s 12-month rate of change had spiked, the S&amp;P 500&nbsp;has gained more than 15% and the tech-heavy Nasdaq 100 index&nbsp;is up almost 23%.</p>\n<p>Does that mean the stock market is living on borrowed time, and will soon succumb to the gravitational pull exerted by higher inflation? Or is the conventional wisdom on this subject just wrong?</p>\n<p>Now is a good time to investigate these questions, since the U.S. government reported this week that the CPI over the latest 12 months has risen at its fastest rate in over 30 years.</p>\n<p>My analysis of the historical record reveals that the relationship between equities and inflation is far more complex than it initially appears. That’s because there are both plusses and minuses to inflation’s impact, and it’s difficult to predict the net impact of inflation’s various consequences.</p>\n<p>Consider first inflation’s impact on earnings: Because companies often are able to charge higher prices when inflation heats up — they have “pricing power,” in other words — their earnings do not suffer as much as you might think. In fact, according to data back to 1871 provided by Yale University’s Robert Shiller, the S&amp;P 500’s nominal earnings per share have grown faster, on average, when inflation has been higher.</p>\n<p>This tendency is why the stock market is a good inflation hedge. Yet investors all too often overlook this valuable tendency, since they focus on nominal earnings growth rates rather than real growth rates. They extrapolate the slower nominal earnings growth rate of a low-inflation period even when inflation heats up. Economists often refer to this mistake as “money illusion” or “inflation illusion.”</p>\n<p>Corporate earnings’ ability to hedge inflation is the good news. The bad news is that inflation causes P/E ratios to decline, since inflation reduces the discounted value of future years’ earnings.</p>\n<p>These two distinct impacts are summarized in the chart below. To construct the chart, I segregated the period since 1871 into two subsets according to the CPI’s trailing 2-year rate of change. Notice that the EPS growth rate has tended to be higher when inflation is higher, but the P/E ratio has tended to be lower.</p>\n<p><img src=\"https://static.tigerbbs.com/370baeb3b581e82486aa533711b4363e\" tg-width=\"700\" tg-height=\"482\" width=\"100%\" height=\"auto\"></p>\n<p><b>What to watch for — and watch out for</b></p>\n<p></p>\n<p>How do these countervailing factors interact in practice? The answer depends on whether you focus on the near-term or the long-term. Over the near-term — up to a year, or so — inflation historically has been a net negative for stocks. That’s because inflation’s negative impact on the P/E ratio is immediate, while its positive impact on earnings doesn’t kick in for a couple of years. Once your time horizon extends two or three years, these effects on average cancel each other out.</p>\n<p>The investment implication: If inflation proves to be more than transitory and the stock market declines significantly, you might want to treat the selloff as a buying opportunity.</p>\n<p></p>\n<p></p>","source":"lsy1603348471595","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>If inflation is more than transitory, consumer prices and stocks could both keep climbing</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIf inflation is more than transitory, consumer prices and stocks could both keep climbing\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-14 09:06 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.marketwatch.com/story/inflation-is-boosting-prices-and-stocks-heres-why-that-isnt-a-surprise-11636672378?mod=home-page><strong>MarketWatch</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The stock market is a good inflation hedge\nAgence France-Presse/Getty Images\n\nConventional wisdom says that inflation is bad for the stock market. Yet the U.S. stock market this year has remained ...</p>\n\n<a href=\"https://www.marketwatch.com/story/inflation-is-boosting-prices-and-stocks-heres-why-that-isnt-a-surprise-11636672378?mod=home-page\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.marketwatch.com/story/inflation-is-boosting-prices-and-stocks-heres-why-that-isnt-a-surprise-11636672378?mod=home-page","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2183043548","content_text":"The stock market is a good inflation hedge\nAgence France-Presse/Getty Images\n\nConventional wisdom says that inflation is bad for the stock market. Yet the U.S. stock market this year has remained strong in the face of unexpectedly high inflation.\nSince mid-May, when it was first reported that the CPI’s 12-month rate of change had spiked, the S&P 500 has gained more than 15% and the tech-heavy Nasdaq 100 index is up almost 23%.\nDoes that mean the stock market is living on borrowed time, and will soon succumb to the gravitational pull exerted by higher inflation? Or is the conventional wisdom on this subject just wrong?\nNow is a good time to investigate these questions, since the U.S. government reported this week that the CPI over the latest 12 months has risen at its fastest rate in over 30 years.\nMy analysis of the historical record reveals that the relationship between equities and inflation is far more complex than it initially appears. That’s because there are both plusses and minuses to inflation’s impact, and it’s difficult to predict the net impact of inflation’s various consequences.\nConsider first inflation’s impact on earnings: Because companies often are able to charge higher prices when inflation heats up — they have “pricing power,” in other words — their earnings do not suffer as much as you might think. In fact, according to data back to 1871 provided by Yale University’s Robert Shiller, the S&P 500’s nominal earnings per share have grown faster, on average, when inflation has been higher.\nThis tendency is why the stock market is a good inflation hedge. Yet investors all too often overlook this valuable tendency, since they focus on nominal earnings growth rates rather than real growth rates. They extrapolate the slower nominal earnings growth rate of a low-inflation period even when inflation heats up. Economists often refer to this mistake as “money illusion” or “inflation illusion.”\nCorporate earnings’ ability to hedge inflation is the good news. The bad news is that inflation causes P/E ratios to decline, since inflation reduces the discounted value of future years’ earnings.\nThese two distinct impacts are summarized in the chart below. To construct the chart, I segregated the period since 1871 into two subsets according to the CPI’s trailing 2-year rate of change. Notice that the EPS growth rate has tended to be higher when inflation is higher, but the P/E ratio has tended to be lower.\n\nWhat to watch for — and watch out for\n\nHow do these countervailing factors interact in practice? The answer depends on whether you focus on the near-term or the long-term. Over the near-term — up to a year, or so — inflation historically has been a net negative for stocks. That’s because inflation’s negative impact on the P/E ratio is immediate, while its positive impact on earnings doesn’t kick in for a couple of years. Once your time horizon extends two or three years, these effects on average cancel each other out.\nThe investment implication: If inflation proves to be more than transitory and the stock market declines significantly, you might want to treat the selloff as a buying opportunity.","news_type":1},"isVote":1,"tweetType":1,"viewCount":180,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":820426453,"gmtCreate":1633420550227,"gmtModify":1633521867358,"author":{"id":"3585001294737518","authorId":"3585001294737518","name":"Universe宇宙","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3585001294737518","authorIdStr":"3585001294737518"},"themes":[],"htmlText":"Opinion: Stock market's volatile October history means it's time to steady yourself for a 'black swan' event.(https://www.marketwatch.com/story/stock-markets-volatile-october-history-means-its-time-to-steady-yourself-for-a-black-swan-event-11633366226)<a href=\"https://laohu8.com/S/.DJI\">$DJIA(.DJI)$</a><a href=\"https://laohu8.com/S/.SPX\">$S&amp;P 500(.SPX)$</a><a href=\"https://laohu8.com/U/3559581955535845\">@koolgal</a>","listText":"Opinion: Stock market's volatile October history means it's time to steady yourself for a 'black swan' event.(https://www.marketwatch.com/story/stock-markets-volatile-october-history-means-its-time-to-steady-yourself-for-a-black-swan-event-11633366226)<a href=\"https://laohu8.com/S/.DJI\">$DJIA(.DJI)$</a><a href=\"https://laohu8.com/S/.SPX\">$S&amp;P 500(.SPX)$</a><a href=\"https://laohu8.com/U/3559581955535845\">@koolgal</a>","text":"Opinion: Stock market's volatile October history means it's time to steady yourself for a 'black swan' event.(https://www.marketwatch.com/story/stock-markets-volatile-october-history-means-its-time-to-steady-yourself-for-a-black-swan-event-11633366226)$DJIA(.DJI)$$S&P 500(.SPX)$@koolgal","images":[],"top":1,"highlighted":2,"essential":1,"paper":1,"likeSize":2,"commentSize":28,"repostSize":0,"link":"https://laohu8.com/post/820426453","isVote":1,"tweetType":1,"viewCount":635,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3559581955535845","authorId":"3559581955535845","name":"koolgal","avatar":"https://static.tigerbbs.com/c05274d88ffc0434623e57350c52c70a","crmLevel":6,"crmLevelSwitch":0,"idStr":"3559581955535845","authorIdStr":"3559581955535845"},"content":"I am scared of Black Swan events. 🤔","text":"I am scared of Black Swan events. 🤔","html":"I am scared of Black Swan events. 🤔"}],"imageCount":0,"langContent":"CN","totalScore":0},{"id":820485817,"gmtCreate":1633416907339,"gmtModify":1633521901441,"author":{"id":"3585001294737518","authorId":"3585001294737518","name":"Universe宇宙","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3585001294737518","authorIdStr":"3585001294737518"},"themes":[],"htmlText":"Inflation is REAL. Ask yourself how much the price of your purchases have increase! Interest rate will go up, right?//<a href=\"https://laohu8.com/U/3559581955535845\">@koolgal</a>:Inflation is the underlying cause of worry for businesses but in raising prices the concern is whether they can lose out to their competitors. 👍😊","listText":"Inflation is REAL. Ask yourself how much the price of your purchases have increase! Interest rate will go up, right?//<a href=\"https://laohu8.com/U/3559581955535845\">@koolgal</a>:Inflation is the underlying cause of worry for businesses but in raising prices the concern is whether they can lose out to their competitors. 👍😊","text":"Inflation is REAL. Ask yourself how much the price of your purchases have increase! Interest rate will go up, right?//@koolgal:Inflation is the underlying cause of worry for businesses but in raising prices the concern is whether they can lose out to their competitors. 👍😊","images":[],"top":1,"highlighted":2,"essential":1,"paper":1,"likeSize":2,"commentSize":28,"repostSize":0,"link":"https://laohu8.com/post/820485817","repostId":"1185304471","repostType":4,"repost":{"id":"1185304471","pubTimestamp":1633360698,"share":"https://www.laohu8.com/m/news/1185304471?lang=&edition=full","pubTime":"2021-10-04 23:18","market":"us","language":"en","title":"Fed's Bullard: U.S. businesses having no problems raising prices","url":"https://stock-news.laohu8.com/highlight/detail?id=1185304471","media":"finance.yahoo","summary":"(Reuters) - U.S. businesses are having few problems raising prices on customers for the first time i","content":"<p>(Reuters) - U.S. businesses are having few problems raising prices on customers for the first time in years, St. Louis Federal Reserve Bank President James Bullard said on Monday, as he warned that inflation could remain elevated for some time to come amid fears higher expectations become entrenched.</p>\n<p>Bullard's business contacts in his Fed district and around the country \"typically say 'don't worry my company's going to be profitable because I am going to raise prices and we've had no difficulty raising prices in this environment,'\" Bullard said during an event held by the International Economic Forum of the Americas.</p>\n<p>Bullard is among the strongest advocates at the U.S. central bank for aggressive moves to combat higher-than-expected inflation and he sees two interest rate hikes needed in 2022. Interest rates remain near zero currently, where they have been since the onset of the COVID-19 pandemic in early 2020.</p>\n<p>\"I am concerned about the changing mentality, I would say, around prices in the economy and the relative freedom that businesses feel that they can just pass on increased costs easily to their customers. For years, that's not been the case,\" Bullard added.</p>","source":"lsy1612507957220","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Fed's Bullard: U.S. businesses having no problems raising prices</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nFed's Bullard: U.S. businesses having no problems raising prices\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-04 23:18 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/feds-bullard-u-businesses-having-151026032.html><strong>finance.yahoo</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>(Reuters) - U.S. businesses are having few problems raising prices on customers for the first time in years, St. Louis Federal Reserve Bank President James Bullard said on Monday, as he warned that ...</p>\n\n<a href=\"https://finance.yahoo.com/news/feds-bullard-u-businesses-having-151026032.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".DJI":"道琼斯"},"source_url":"https://finance.yahoo.com/news/feds-bullard-u-businesses-having-151026032.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1185304471","content_text":"(Reuters) - U.S. businesses are having few problems raising prices on customers for the first time in years, St. Louis Federal Reserve Bank President James Bullard said on Monday, as he warned that inflation could remain elevated for some time to come amid fears higher expectations become entrenched.\nBullard's business contacts in his Fed district and around the country \"typically say 'don't worry my company's going to be profitable because I am going to raise prices and we've had no difficulty raising prices in this environment,'\" Bullard said during an event held by the International Economic Forum of the Americas.\nBullard is among the strongest advocates at the U.S. central bank for aggressive moves to combat higher-than-expected inflation and he sees two interest rate hikes needed in 2022. Interest rates remain near zero currently, where they have been since the onset of the COVID-19 pandemic in early 2020.\n\"I am concerned about the changing mentality, I would say, around prices in the economy and the relative freedom that businesses feel that they can just pass on increased costs easily to their customers. For years, that's not been the case,\" Bullard added.","news_type":1},"isVote":1,"tweetType":1,"viewCount":185,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3559581955535845","authorId":"3559581955535845","name":"koolgal","avatar":"https://static.tigerbbs.com/c05274d88ffc0434623e57350c52c70a","crmLevel":6,"crmLevelSwitch":0,"idStr":"3559581955535845","authorIdStr":"3559581955535845"},"content":"I agree. Our money becomes smaller and smaller over time. 👍😊","text":"I agree. Our money becomes smaller and smaller over time. 👍😊","html":"I agree. Our money becomes smaller and smaller over time. 👍😊"}],"imageCount":0,"langContent":"CN","totalScore":0},{"id":853110063,"gmtCreate":1634779002409,"gmtModify":1634779014300,"author":{"id":"3585001294737518","authorId":"3585001294737518","name":"Universe宇宙","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3585001294737518","authorIdStr":"3585001294737518"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/C6L.SI\">$SINGAPORE AIRLINES LTD(C6L.SI)$</a>Going down to less than $4 due to news on CDC level 4, renew of&nbsp;high number of COVID cases, rising&nbsp;oil prices and the possible of new COVID mutation?Please enlighten below.","listText":"<a href=\"https://laohu8.com/S/C6L.SI\">$SINGAPORE AIRLINES LTD(C6L.SI)$</a>Going down to less than $4 due to news on CDC level 4, renew of&nbsp;high number of COVID cases, rising&nbsp;oil prices and the possible of new COVID mutation?Please enlighten below.","text":"$SINGAPORE AIRLINES LTD(C6L.SI)$Going down to less than $4 due to news on CDC level 4, renew of high number of COVID cases, rising oil prices and the possible of new COVID mutation?Please enlighten below.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":17,"commentSize":16,"repostSize":4,"link":"https://laohu8.com/post/853110063","isVote":1,"tweetType":1,"viewCount":12216,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3576136587240958","authorId":"3576136587240958","name":"HiddenDragon","avatar":"https://static.tigerbbs.com/041eb19e38ad8e9d74b41569dcdfd51d","crmLevel":6,"crmLevelSwitch":0,"idStr":"3576136587240958","authorIdStr":"3576136587240958"},"content":"oil price go up never mind, can adjust airfare. Problem is oil price not stable, bad pricing will affect profit.","text":"oil price go up never mind, can adjust airfare. Problem is oil price not stable, bad pricing will affect profit.","html":"oil price go up never mind, can adjust airfare. Problem is oil price not stable, bad pricing will affect profit."}],"imageCount":0,"langContent":"CN","totalScore":0},{"id":875012933,"gmtCreate":1637587348565,"gmtModify":1637592284634,"author":{"id":"3585001294737518","authorId":"3585001294737518","name":"Universe宇宙","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3585001294737518","authorIdStr":"3585001294737518"},"themes":[],"htmlText":"Pfizer Inc. $(PFE)$ and BioNTech SE (BNTX) said Monday that topline results from a longer-term analysis of the safety and efficacy of their COVID-19 vaccine in people 12 through 15 show that a two-dose series of the Pfizer-BioNTech COVID-19 Vaccine (30-ug per dose) was 100% effective against COVID-19.","listText":"Pfizer Inc. $(PFE)$ and BioNTech SE (BNTX) said Monday that topline results from a longer-term analysis of the safety and efficacy of their COVID-19 vaccine in people 12 through 15 show that a two-dose series of the Pfizer-BioNTech COVID-19 Vaccine (30-ug per dose) was 100% effective against COVID-19.","text":"Pfizer Inc. $(PFE)$ and BioNTech SE (BNTX) said Monday that topline results from a longer-term analysis of the safety and efficacy of their COVID-19 vaccine in people 12 through 15 show that a two-dose series of the Pfizer-BioNTech COVID-19 Vaccine (30-ug per dose) was 100% effective against COVID-19.","images":[],"top":1,"highlighted":2,"essential":1,"paper":1,"likeSize":8,"commentSize":18,"repostSize":0,"link":"https://laohu8.com/post/875012933","repostId":"2185787906","repostType":4,"repost":{"id":"2185787906","weMediaInfo":{"introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"media_name":"Dow Jones","id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"pubTimestamp":1637583120,"share":"https://www.laohu8.com/m/news/2185787906?lang=&edition=full","pubTime":"2021-11-22 20:12","market":"us","language":"en","title":"Pfizer and BioNTech say follow-on Phase III study shows vaccine safe for 12- to 15-year-olds","url":"https://stock-news.laohu8.com/highlight/detail?id=2185787906","media":"Dow Jones","summary":"Pfizer Inc. $(PFE)$ and BioNTech SE (BNTX) said Monday that topline results from a longer-term analy","content":"<p>Pfizer Inc. <a href=\"https://laohu8.com/S/PFE\">$(PFE)$</a> and <a href=\"https://laohu8.com/S/BNTX\">BioNTech SE</a> (BNTX) said Monday that topline results from a longer-term analysis of the safety and efficacy of their COVID-19 vaccine in people 12 through 15 show that a two-dose series of the Pfizer-BioNTech COVID-19 Vaccine (30-ug per dose) was 100% effective against COVID-19.</p>\n<p>The follow-up test measured seven days through four-plus months after the second dose. The companies said the adverse event profile \"was generally consistent with other clinical safety data for the vaccine, with no serious safety concerns observed in individuals with at least six months of safety follow-up after the second dose.\"</p>\n<p>BioNTech shares rose 2% and Pfizer added 1% in pre-market trades.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pfizer and BioNTech say follow-on Phase III study shows vaccine safe for 12- to 15-year-olds</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPfizer and BioNTech say follow-on Phase III study shows vaccine safe for 12- to 15-year-olds\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2021-11-22 20:12</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p>Pfizer Inc. <a href=\"https://laohu8.com/S/PFE\">$(PFE)$</a> and <a href=\"https://laohu8.com/S/BNTX\">BioNTech SE</a> (BNTX) said Monday that topline results from a longer-term analysis of the safety and efficacy of their COVID-19 vaccine in people 12 through 15 show that a two-dose series of the Pfizer-BioNTech COVID-19 Vaccine (30-ug per dose) was 100% effective against COVID-19.</p>\n<p>The follow-up test measured seven days through four-plus months after the second dose. The companies said the adverse event profile \"was generally consistent with other clinical safety data for the vaccine, with no serious safety concerns observed in individuals with at least six months of safety follow-up after the second dose.\"</p>\n<p>BioNTech shares rose 2% and Pfizer added 1% in pre-market trades.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2185787906","content_text":"Pfizer Inc. $(PFE)$ and BioNTech SE (BNTX) said Monday that topline results from a longer-term analysis of the safety and efficacy of their COVID-19 vaccine in people 12 through 15 show that a two-dose series of the Pfizer-BioNTech COVID-19 Vaccine (30-ug per dose) was 100% effective against COVID-19.\nThe follow-up test measured seven days through four-plus months after the second dose. The companies said the adverse event profile \"was generally consistent with other clinical safety data for the vaccine, with no serious safety concerns observed in individuals with at least six months of safety follow-up after the second dose.\"\nBioNTech shares rose 2% and Pfizer added 1% in pre-market trades.","news_type":1},"isVote":1,"tweetType":1,"viewCount":498,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"9000000000000180","authorId":"9000000000000180","name":"PhilipJones","avatar":"https://static.tigerbbs.com/e573674bfcfd4e7c46cab3576d3fff51","crmLevel":1,"crmLevelSwitch":0,"idStr":"9000000000000180","authorIdStr":"9000000000000180"},"content":"60.00 all day long!! Best Buy for this over priced market any way you look at it! PFE AT 51.50 is a STEAL!!🏆💰😎","text":"60.00 all day long!! Best Buy for this over priced market any way you look at it! PFE AT 51.50 is a STEAL!!🏆💰😎","html":"60.00 all day long!! Best Buy for this over priced market any way you look at it! PFE AT 51.50 is a STEAL!!🏆💰😎"}],"imageCount":0,"langContent":"CN","totalScore":0},{"id":820482349,"gmtCreate":1633416713981,"gmtModify":1633521917350,"author":{"id":"3585001294737518","authorId":"3585001294737518","name":"Universe宇宙","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3585001294737518","authorIdStr":"3585001294737518"},"themes":[],"htmlText":"Go Merck! <a href=\"https://laohu8.com/S/MRK\">$Merck(MRK)$</a>🚀🚀🚀🌜🌕🌛//<a href=\"https://laohu8.com/U/3559581955535845\">@koolgal</a>:Merck is the new wonder pill to be subject to regulatory approval.&nbsp; As such, it will continue its exponential growth!&nbsp; Go Merck! 🚀🚀🚀🌛🌛🌛","listText":"Go Merck! <a href=\"https://laohu8.com/S/MRK\">$Merck(MRK)$</a>🚀🚀🚀🌜🌕🌛//<a href=\"https://laohu8.com/U/3559581955535845\">@koolgal</a>:Merck is the new wonder pill to be subject to regulatory approval.&nbsp; As such, it will continue its exponential growth!&nbsp; Go Merck! 🚀🚀🚀🌛🌛🌛","text":"Go Merck! $Merck(MRK)$🚀🚀🚀🌜🌕🌛//@koolgal:Merck is the new wonder pill to be subject to regulatory approval. As such, it will continue its exponential growth! Go Merck! 🚀🚀🚀🌛🌛🌛","images":[],"top":1,"highlighted":2,"essential":1,"paper":1,"likeSize":4,"commentSize":23,"repostSize":0,"link":"https://laohu8.com/post/820482349","repostId":"1140558350","repostType":4,"repost":{"id":"1140558350","pubTimestamp":1633355202,"share":"https://www.laohu8.com/m/news/1140558350?lang=&edition=full","pubTime":"2021-10-04 21:46","market":"us","language":"en","title":"Merck extends gains after data for COVID-19 pill as vaccine makers retreat","url":"https://stock-news.laohu8.com/highlight/detail?id=1140558350","media":"seekingalpha","summary":"After reaching a 52-week high on Friday, Merck(NYSE:MRK)continues its winning streak in the pre-mark","content":"<ul>\n <li>After reaching a 52-week high on Friday, Merck(NYSE:MRK)continues its winning streak in the pre-market trading&nbsp;~4.0% higher,&nbsp;with ~1.8 million shares changing hands.</li>\n <li>Meantime, the established vaccine makers, notably, BioNTech(NASDAQ:BNTX), the partner of Pfizer(NYSE:PFE)for the first COVID-19 vaccine approved in the U.S., and Moderna(NASDAQ:MRNA), have extended their losses.</li>\n <li>In an interim analysis of a late-stage trial involving patients with mild-to-moderate COVID-19, Merck’s drug molnupiravir developed in partnership with Ridgeback Biotherapeutics, was found to have cutthe risk of hospitalization or death by 50%.</li>\n <li>Moderna (MRNA) and BioNTech (BNTX) are notable decliners, trading&nbsp;~5.1% and ~6.0% lower,&nbsp;while the COVID-19 vaccine developer Novavax(NASDAQ:NVAX)has&nbsp;lost ~6.3%&nbsp;after sliding ~26.8% last week to rank among the&nbsp;worst performers in healthcare.</li>\n <li>However, Pfizer (PFE) and Johnson &amp; Johnson(NYSE:JNJ)are trading flat, with&nbsp;losses standing at ~0.8% and ~0.1%&nbsp;in the pre-market.</li>\n <li>Pfizer’s (PFE) own experimental oral COVID-19 therapy PF-07321332 is undergoing a Phase 2/3 study in combination with a low dose of ritonavirfor the prevention of COVID-19.</li>\n <li>Meanwhile,<i>TheNew York Times</i>&nbsp;reported today that Johnson &amp; Johnson (JNJ) is planning to seek regulatory authorization for its COVID-19booster shot early this week.</li>\n</ul>","source":"seekingalpha","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Merck extends gains after data for COVID-19 pill as vaccine makers retreat</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMerck extends gains after data for COVID-19 pill as vaccine makers retreat\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-04 21:46 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3748031-merck-extends-gains-after-data-for-covid-19-pill-as-vaccine-makers-retreat><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After reaching a 52-week high on Friday, Merck(NYSE:MRK)continues its winning streak in the pre-market trading ~4.0% higher, with ~1.8 million shares changing hands.\nMeantime, the established vaccine ...</p>\n\n<a href=\"https://seekingalpha.com/news/3748031-merck-extends-gains-after-data-for-covid-19-pill-as-vaccine-makers-retreat\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc.","MRK":"默沙东","PFE":"辉瑞","NVAX":"诺瓦瓦克斯医药","BNTX":"BioNTech SE"},"source_url":"https://seekingalpha.com/news/3748031-merck-extends-gains-after-data-for-covid-19-pill-as-vaccine-makers-retreat","is_english":true,"share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","article_id":"1140558350","content_text":"After reaching a 52-week high on Friday, Merck(NYSE:MRK)continues its winning streak in the pre-market trading ~4.0% higher, with ~1.8 million shares changing hands.\nMeantime, the established vaccine makers, notably, BioNTech(NASDAQ:BNTX), the partner of Pfizer(NYSE:PFE)for the first COVID-19 vaccine approved in the U.S., and Moderna(NASDAQ:MRNA), have extended their losses.\nIn an interim analysis of a late-stage trial involving patients with mild-to-moderate COVID-19, Merck’s drug molnupiravir developed in partnership with Ridgeback Biotherapeutics, was found to have cutthe risk of hospitalization or death by 50%.\nModerna (MRNA) and BioNTech (BNTX) are notable decliners, trading ~5.1% and ~6.0% lower, while the COVID-19 vaccine developer Novavax(NASDAQ:NVAX)has lost ~6.3% after sliding ~26.8% last week to rank among the worst performers in healthcare.\nHowever, Pfizer (PFE) and Johnson & Johnson(NYSE:JNJ)are trading flat, with losses standing at ~0.8% and ~0.1% in the pre-market.\nPfizer’s (PFE) own experimental oral COVID-19 therapy PF-07321332 is undergoing a Phase 2/3 study in combination with a low dose of ritonavirfor the prevention of COVID-19.\nMeanwhile,TheNew York Times reported today that Johnson & Johnson (JNJ) is planning to seek regulatory authorization for its COVID-19booster shot early this week.","news_type":1},"isVote":1,"tweetType":1,"viewCount":455,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3559581955535845","authorId":"3559581955535845","name":"koolgal","avatar":"https://static.tigerbbs.com/c05274d88ffc0434623e57350c52c70a","crmLevel":6,"crmLevelSwitch":0,"idStr":"3559581955535845","authorIdStr":"3559581955535845"},"content":"Higher and Higher 👍😊🚀🚀🚀","text":"Higher and Higher 👍😊🚀🚀🚀","html":"Higher and Higher 👍😊🚀🚀🚀"}],"imageCount":0,"langContent":"CN","totalScore":0},{"id":606293734,"gmtCreate":1638881468465,"gmtModify":1638882058546,"author":{"id":"3585001294737518","authorId":"3585001294737518","name":"Universe宇宙","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3585001294737518","authorIdStr":"3585001294737518"},"themes":[],"htmlText":"At The Wall Street Journal's Annual CEO Council Monday, Tesla CEO Elon Musk said he was not keen on the Biden administration's infrastructure bill and called the federal budget deficit 'insane.'","listText":"At The Wall Street Journal's Annual CEO Council Monday, Tesla CEO Elon Musk said he was not keen on the Biden administration's infrastructure bill and called the federal budget deficit 'insane.'","text":"At The Wall Street Journal's Annual CEO Council Monday, Tesla CEO Elon Musk said he was not keen on the Biden administration's infrastructure bill and called the federal budget deficit 'insane.'","images":[],"top":1,"highlighted":2,"essential":1,"paper":1,"likeSize":7,"commentSize":20,"repostSize":0,"link":"https://laohu8.com/post/606293734","repostId":"1106389268","repostType":4,"isVote":1,"tweetType":1,"viewCount":634,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":876779208,"gmtCreate":1637370125895,"gmtModify":1637370671262,"author":{"id":"3585001294737518","authorId":"3585001294737518","name":"Universe宇宙","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3585001294737518","authorIdStr":"3585001294737518"},"themes":[],"htmlText":"The booster dose, the FDA said, can come six months after the completion of the two-shot series of both the Pfizer and Moderna vaccines following a review of Emergency Use Authorization approvals for both drugmakers. The FDA approved Pfizer's COVID vaccine, known as 'Comiranty', for booster shots inolder and at risk Americans in late September, one month after asimilar nod for Moderna's in immunocompromised individuals.","listText":"The booster dose, the FDA said, can come six months after the completion of the two-shot series of both the Pfizer and Moderna vaccines following a review of Emergency Use Authorization approvals for both drugmakers. The FDA approved Pfizer's COVID vaccine, known as 'Comiranty', for booster shots inolder and at risk Americans in late September, one month after asimilar nod for Moderna's in immunocompromised individuals.","text":"The booster dose, the FDA said, can come six months after the completion of the two-shot series of both the Pfizer and Moderna vaccines following a review of Emergency Use Authorization approvals for both drugmakers. The FDA approved Pfizer's COVID vaccine, known as 'Comiranty', for booster shots inolder and at risk Americans in late September, one month after asimilar nod for Moderna's in immunocompromised individuals.","images":[],"top":1,"highlighted":2,"essential":1,"paper":1,"likeSize":5,"commentSize":23,"repostSize":0,"link":"https://laohu8.com/post/876779208","repostId":"1147615281","repostType":4,"repost":{"id":"1147615281","pubTimestamp":1637364985,"share":"https://www.laohu8.com/m/news/1147615281?lang=&edition=full","pubTime":"2021-11-20 07:36","market":"us","language":"en","title":"Pfizer Stock Leaps, Moderna Surges As FDA Approves Adult COVID Booster Shots","url":"https://stock-news.laohu8.com/highlight/detail?id=1147615281","media":"The Street","summary":"The Food & Drug Administration approved booster shots of both the Pfizer and Moderna Covid vaccines ","content":"<p>The Food &amp; Drug Administration approved booster shots of both the Pfizer and Moderna Covid vaccines for all American adults Friday.</p>\n<p>$Pfizer Inc&nbsp;(<b>PFE</b>)$ shares jumped higher Friday, while $Moderna&nbsp;(<b>MRNA</b>)$&nbsp;surged alongside it, after the U.S. Food &amp; Drug Administration approved the use of their Covid booster shots in all American adults.</p>\n<p>The booster dose, the FDA said, can come six months after the completion of the two-shot series of both the Pfizer and Moderna vaccines following a review of&nbsp;Emergency Use Authorization approvals for both drugmakers.&nbsp;The FDA approved Pfizer's COVID vaccine, known as 'Comiranty', for booster shots inolder and at risk Americans in late September, one month after asimilar nod for Moderna's in&nbsp;immunocompromised individuals.</p>\n<p>A panel advising the Centers for Disease Control and Prevention will meet later Friday to assess the booster shot application as President Joe Biden continues to push for broader take-up of the vaccines heading into the winter months.</p>\n<p>That move followed a dire warning from outgoing German Chancellor Angela Merkel, who called the Covid situation \"dramatic\" as infections surge and fatalities rise.</p>\n<p>The lockdown, as well as fresh restrictions on movement and businesses in Germany, pushed the euro to a mid-July low of 1.1289 against the U.S. dollar and clipped bets on near-term energy demand in the world's biggest economic bloc.</p>\n<p>“As we near the two-year mark in our fight against COVID-19, we have reached another critical milestone with the expanded authorization of a booster dose of our COVID-19 vaccine in individuals 18 years and older,” said Pfizer CEO Albert Bourla. “With boosters, more adults will now have the opportunity to help preserve a high-level of protection against this disease. We are grateful to the FDA for their rigorous review, and the action taken today that we hope will help accelerate our path out of this pandemic.”</p>\n<p>Earlier this week, Pfizer agreed to sell 10 million doses of its developing Covid antiviral pill Paxlovid,&nbsp;which is currently being reviewed for Emergency Use Approval by the FDA, to the United States Department of Health and Human Services for around $5.3 billion.</p>\n<p>At $530 per tablet, the cost is around 25% cheaper than the $700 price agreed with Merck &amp; Co.&nbsp;(<b>MRK</b>)&nbsp;last month to buy1.7 million doses its 'molnupiravir' treatmentof \"mild-to-moderate Covid in adults who are at risk for progressing to severe forms of disease, or hospitalization.</p>","source":"lsy1610613172068","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pfizer Stock Leaps, Moderna Surges As FDA Approves Adult COVID Booster Shots</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPfizer Stock Leaps, Moderna Surges As FDA Approves Adult COVID Booster Shots\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-20 07:36 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.thestreet.com/markets/pfizer-stock-leaps-moderna-surges-as-fda-approves-covid-boosters><strong>The Street</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The Food & Drug Administration approved booster shots of both the Pfizer and Moderna Covid vaccines for all American adults Friday.\n$Pfizer Inc (PFE)$ shares jumped higher Friday, while $Moderna (MRNA...</p>\n\n<a href=\"https://www.thestreet.com/markets/pfizer-stock-leaps-moderna-surges-as-fda-approves-covid-boosters\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.thestreet.com/markets/pfizer-stock-leaps-moderna-surges-as-fda-approves-covid-boosters","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1147615281","content_text":"The Food & Drug Administration approved booster shots of both the Pfizer and Moderna Covid vaccines for all American adults Friday.\n$Pfizer Inc (PFE)$ shares jumped higher Friday, while $Moderna (MRNA)$ surged alongside it, after the U.S. Food & Drug Administration approved the use of their Covid booster shots in all American adults.\nThe booster dose, the FDA said, can come six months after the completion of the two-shot series of both the Pfizer and Moderna vaccines following a review of Emergency Use Authorization approvals for both drugmakers. The FDA approved Pfizer's COVID vaccine, known as 'Comiranty', for booster shots inolder and at risk Americans in late September, one month after asimilar nod for Moderna's in immunocompromised individuals.\nA panel advising the Centers for Disease Control and Prevention will meet later Friday to assess the booster shot application as President Joe Biden continues to push for broader take-up of the vaccines heading into the winter months.\nThat move followed a dire warning from outgoing German Chancellor Angela Merkel, who called the Covid situation \"dramatic\" as infections surge and fatalities rise.\nThe lockdown, as well as fresh restrictions on movement and businesses in Germany, pushed the euro to a mid-July low of 1.1289 against the U.S. dollar and clipped bets on near-term energy demand in the world's biggest economic bloc.\n“As we near the two-year mark in our fight against COVID-19, we have reached another critical milestone with the expanded authorization of a booster dose of our COVID-19 vaccine in individuals 18 years and older,” said Pfizer CEO Albert Bourla. “With boosters, more adults will now have the opportunity to help preserve a high-level of protection against this disease. We are grateful to the FDA for their rigorous review, and the action taken today that we hope will help accelerate our path out of this pandemic.”\nEarlier this week, Pfizer agreed to sell 10 million doses of its developing Covid antiviral pill Paxlovid, which is currently being reviewed for Emergency Use Approval by the FDA, to the United States Department of Health and Human Services for around $5.3 billion.\nAt $530 per tablet, the cost is around 25% cheaper than the $700 price agreed with Merck & Co. (MRK) last month to buy1.7 million doses its 'molnupiravir' treatmentof \"mild-to-moderate Covid in adults who are at risk for progressing to severe forms of disease, or hospitalization.","news_type":1},"isVote":1,"tweetType":1,"viewCount":209,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":820424374,"gmtCreate":1633421008324,"gmtModify":1633571934955,"author":{"id":"3585001294737518","authorId":"3585001294737518","name":"Universe宇宙","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3585001294737518","authorIdStr":"3585001294737518"},"themes":[],"htmlText":"4 big risks that could trip up the stock market soon: Goldman(https://finance.yahoo.com/news/4-big-risks-that-could-trip-up-the-stock-market-soon-goldman-160805923.html)The investment bank's chief U.S. equity strategist David Kostin warned on Monday of four risks to investors from upcoming corporate earnings reports: (1) supply chain bottlenecks; (2) climbing oil prices; (3) inflationary labor costs; and (4) slowing China economic growth.&nbsp;Add one more - (5) new covid virus breakthrough and mutations?&nbsp;[疑问]&nbsp;<a href=\"https://laohu8.com/S/BBBY\">$Bed Bath &amp; Beyond(BBBY)$</a><a href=\"https://laohu8.com/S/QQQ\">$NASDAQ-100 Index ETF(QQQ)$</a><a href=\"https://laohu8.com/U/3559581955535845\">@koolgal</a>","listText":"4 big risks that could trip up the stock market soon: Goldman(https://finance.yahoo.com/news/4-big-risks-that-could-trip-up-the-stock-market-soon-goldman-160805923.html)The investment bank's chief U.S. equity strategist David Kostin warned on Monday of four risks to investors from upcoming corporate earnings reports: (1) supply chain bottlenecks; (2) climbing oil prices; (3) inflationary labor costs; and (4) slowing China economic growth.&nbsp;Add one more - (5) new covid virus breakthrough and mutations?&nbsp;[疑问]&nbsp;<a href=\"https://laohu8.com/S/BBBY\">$Bed Bath &amp; Beyond(BBBY)$</a><a href=\"https://laohu8.com/S/QQQ\">$NASDAQ-100 Index ETF(QQQ)$</a><a href=\"https://laohu8.com/U/3559581955535845\">@koolgal</a>","text":"4 big risks that could trip up the stock market soon: Goldman(https://finance.yahoo.com/news/4-big-risks-that-could-trip-up-the-stock-market-soon-goldman-160805923.html)The investment bank's chief U.S. equity strategist David Kostin warned on Monday of four risks to investors from upcoming corporate earnings reports: (1) supply chain bottlenecks; (2) climbing oil prices; (3) inflationary labor costs; and (4) slowing China economic growth. Add one more - (5) new covid virus breakthrough and mutations? [疑问] $Bed Bath & Beyond(BBBY)$$NASDAQ-100 Index ETF(QQQ)$@koolgal","images":[],"top":1,"highlighted":2,"essential":1,"paper":1,"likeSize":3,"commentSize":24,"repostSize":0,"link":"https://laohu8.com/post/820424374","isVote":1,"tweetType":1,"viewCount":488,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3559581955535845","authorId":"3559581955535845","name":"koolgal","avatar":"https://static.tigerbbs.com/c05274d88ffc0434623e57350c52c70a","crmLevel":6,"crmLevelSwitch":0,"idStr":"3559581955535845","authorIdStr":"3559581955535845"},"content":"Thanks for sharing 👍😊","text":"Thanks for sharing 👍😊","html":"Thanks for sharing 👍😊"}],"imageCount":0,"langContent":"CN","totalScore":0},{"id":600392165,"gmtCreate":1638064383805,"gmtModify":1638064709825,"author":{"id":"3585001294737518","authorId":"3585001294737518","name":"Universe宇宙","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3585001294737518","authorIdStr":"3585001294737518"},"themes":[],"htmlText":"There is no cure to covid?","listText":"There is no cure to covid?","text":"There is no cure to covid?","images":[],"top":1,"highlighted":2,"essential":1,"paper":1,"likeSize":4,"commentSize":23,"repostSize":0,"link":"https://laohu8.com/post/600392165","repostId":"2186286603","repostType":4,"isVote":1,"tweetType":1,"viewCount":52,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":606701446,"gmtCreate":1638924922608,"gmtModify":1638925133402,"author":{"id":"3585001294737518","authorId":"3585001294737518","name":"Universe宇宙","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3585001294737518","authorIdStr":"3585001294737518"},"themes":[],"htmlText":"Wall Street closes higher with Nasdaq boosted by tech rally","listText":"Wall Street closes higher with Nasdaq boosted by tech rally","text":"Wall Street closes higher with Nasdaq boosted by tech rally","images":[],"top":1,"highlighted":2,"essential":1,"paper":1,"likeSize":4,"commentSize":22,"repostSize":0,"link":"https://laohu8.com/post/606701446","repostId":"2189719656","repostType":4,"repost":{"id":"2189719656","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1638914193,"share":"https://www.laohu8.com/m/news/2189719656?lang=&edition=full","pubTime":"2021-12-08 05:56","market":"us","language":"en","title":"Wall Street closes higher with Nasdaq boosted by tech rally","url":"https://stock-news.laohu8.com/highlight/detail?id=2189719656","media":"Reuters","summary":"Wall Street's main indexes finished Tuesday's session with strong gains as investors shook off some ","content":"<p>Wall Street's main indexes finished Tuesday's session with strong gains as investors shook off some anxiety about the latest coronavirus variant and investors boosted Nasdaq by piling into technology stocks.</p>\n<p>Intel's announcement of plans to take its self-driving car unit <a href=\"https://laohu8.com/S/MBLY\">Mobileye</a> public in the United States next year pushed his shares to a 3% gain and cheered chip investors across the board.</p>\n<p>The Philadelphia SE Semiconductor index closed up 4.97% after hitting a near <a href=\"https://laohu8.com/S/AONE.U\">one</a>-month low on Tuesday.</p>\n<p>Investors were also reassured by positive news about the Omicron variant of COVID-19, which had helped send them fleeing from risky bets last week.</p>\n<p>Before market open, British drugmaker GSK said an antibody-based COVID-19 therapy it is developing with Vir Biotechnology was effective against all mutations of the Omicron variant.</p>\n<p>That news added to the relief rally along with infectious disease official Anthony Fauci's comment on Tuesday that preliminary evidence indicates while Omicron likely has a higher degree of transmissibility, it appears to be less severe. Fauci had made similar comments on Sunday.</p>\n<p>\"A week ago we saw a big scare because of Omicron and over the following week it appeared to be very contagious but less severe than people were worried about,\" said Peter Tuz, president of Chase Investment Counsel in Charlottesville, Virginia.</p>\n<p>Michael James, managing director of equity trading at Wedbush Securities in Los Angeles, said the Glaxosmithkline headline was already \"instrumental to people's sentiment.\"</p>\n<p>He also cited the Intel news and investor bets that the market would see its traditional December boost, known as the Santa Claus rally.</p>\n<p>\"There's certainly fears of missing out on the Santa Claus rally,\" said James. \"It's a bigger picture risk-on mentality that's taking hold today.\"</p>\n<p>The Dow Jones Industrial Average rose 492.4 points, or 1.4%, to 35,719.43, the S&amp;P 500 gained 95.08 points, or 2.07%, to 4,686.75 and the Nasdaq Composite added 461.76 points, or 3.03%, to 15,686.92.</p>\n<p>The CBOE volatility index , often referred to the Wall Street fear gauge, eased from a more than 10-month high last week. It ended the day down 19.5 points at 21.89, its lowest close since Oct. 6.</p>\n<p>All of the 11 major S&amp;P sectors advanced, with information technology sector closing up 3.5% for its biggest one-day percentage gain since March 9, with consumer discretionary following suit with a 2.4% gain.</p>\n<p>The S&amp;P 1500 Hotels, Restaurant and Leisure closed up 1.4%. After rallying for much of the day, the S&amp;P 1500 Airlines closed down 0.6%. The airline index had gained 5% on Monday.</p>\n<p>In the semiconductor industry, other big gainers besides Intel were Nvidia , which added 7.96%, while NXP Semiconductor and Applied Materials both advanced 6.5%.</p>\n<p>Vir Biotechnology closed up 11.9%.</p>\n<p>Merck &amp; Co fell 1.6% as Guggenheim downgraded the stock to \"neutral\" from \"buy\" after the drugmaker paused enrollment in two late-stage clinical trials testing its experimental drug for treatment and prevention of HIV-1.</p>\n<p>Advancing issues outnumbered declining ones on the NYSE by a 4.10-to-1 ratio; on Nasdaq, a 3.37-to-1 ratio favored advancers.</p>\n<p>The S&amp;P 500 posted 37 new 52-week highs and no new lows; the Nasdaq Composite recorded 52 new highs and 48 new lows.</p>\n<p>On U.S. exchanges, 11.38 billion shares changed hands compared with the 11.55 billion average for the last 20 sessions.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Wall Street closes higher with Nasdaq boosted by tech rally</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWall Street closes higher with Nasdaq boosted by tech rally\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-12-08 05:56</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Wall Street's main indexes finished Tuesday's session with strong gains as investors shook off some anxiety about the latest coronavirus variant and investors boosted Nasdaq by piling into technology stocks.</p>\n<p>Intel's announcement of plans to take its self-driving car unit <a href=\"https://laohu8.com/S/MBLY\">Mobileye</a> public in the United States next year pushed his shares to a 3% gain and cheered chip investors across the board.</p>\n<p>The Philadelphia SE Semiconductor index closed up 4.97% after hitting a near <a href=\"https://laohu8.com/S/AONE.U\">one</a>-month low on Tuesday.</p>\n<p>Investors were also reassured by positive news about the Omicron variant of COVID-19, which had helped send them fleeing from risky bets last week.</p>\n<p>Before market open, British drugmaker GSK said an antibody-based COVID-19 therapy it is developing with Vir Biotechnology was effective against all mutations of the Omicron variant.</p>\n<p>That news added to the relief rally along with infectious disease official Anthony Fauci's comment on Tuesday that preliminary evidence indicates while Omicron likely has a higher degree of transmissibility, it appears to be less severe. Fauci had made similar comments on Sunday.</p>\n<p>\"A week ago we saw a big scare because of Omicron and over the following week it appeared to be very contagious but less severe than people were worried about,\" said Peter Tuz, president of Chase Investment Counsel in Charlottesville, Virginia.</p>\n<p>Michael James, managing director of equity trading at Wedbush Securities in Los Angeles, said the Glaxosmithkline headline was already \"instrumental to people's sentiment.\"</p>\n<p>He also cited the Intel news and investor bets that the market would see its traditional December boost, known as the Santa Claus rally.</p>\n<p>\"There's certainly fears of missing out on the Santa Claus rally,\" said James. \"It's a bigger picture risk-on mentality that's taking hold today.\"</p>\n<p>The Dow Jones Industrial Average rose 492.4 points, or 1.4%, to 35,719.43, the S&amp;P 500 gained 95.08 points, or 2.07%, to 4,686.75 and the Nasdaq Composite added 461.76 points, or 3.03%, to 15,686.92.</p>\n<p>The CBOE volatility index , often referred to the Wall Street fear gauge, eased from a more than 10-month high last week. It ended the day down 19.5 points at 21.89, its lowest close since Oct. 6.</p>\n<p>All of the 11 major S&amp;P sectors advanced, with information technology sector closing up 3.5% for its biggest one-day percentage gain since March 9, with consumer discretionary following suit with a 2.4% gain.</p>\n<p>The S&amp;P 1500 Hotels, Restaurant and Leisure closed up 1.4%. After rallying for much of the day, the S&amp;P 1500 Airlines closed down 0.6%. The airline index had gained 5% on Monday.</p>\n<p>In the semiconductor industry, other big gainers besides Intel were Nvidia , which added 7.96%, while NXP Semiconductor and Applied Materials both advanced 6.5%.</p>\n<p>Vir Biotechnology closed up 11.9%.</p>\n<p>Merck &amp; Co fell 1.6% as Guggenheim downgraded the stock to \"neutral\" from \"buy\" after the drugmaker paused enrollment in two late-stage clinical trials testing its experimental drug for treatment and prevention of HIV-1.</p>\n<p>Advancing issues outnumbered declining ones on the NYSE by a 4.10-to-1 ratio; on Nasdaq, a 3.37-to-1 ratio favored advancers.</p>\n<p>The S&amp;P 500 posted 37 new 52-week highs and no new lows; the Nasdaq Composite recorded 52 new highs and 48 new lows.</p>\n<p>On U.S. exchanges, 11.38 billion shares changed hands compared with the 11.55 billion average for the last 20 sessions.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".DJI":"道琼斯",".SPX":"S&P 500 Index",".IXIC":"NASDAQ Composite"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2189719656","content_text":"Wall Street's main indexes finished Tuesday's session with strong gains as investors shook off some anxiety about the latest coronavirus variant and investors boosted Nasdaq by piling into technology stocks.\nIntel's announcement of plans to take its self-driving car unit Mobileye public in the United States next year pushed his shares to a 3% gain and cheered chip investors across the board.\nThe Philadelphia SE Semiconductor index closed up 4.97% after hitting a near one-month low on Tuesday.\nInvestors were also reassured by positive news about the Omicron variant of COVID-19, which had helped send them fleeing from risky bets last week.\nBefore market open, British drugmaker GSK said an antibody-based COVID-19 therapy it is developing with Vir Biotechnology was effective against all mutations of the Omicron variant.\nThat news added to the relief rally along with infectious disease official Anthony Fauci's comment on Tuesday that preliminary evidence indicates while Omicron likely has a higher degree of transmissibility, it appears to be less severe. Fauci had made similar comments on Sunday.\n\"A week ago we saw a big scare because of Omicron and over the following week it appeared to be very contagious but less severe than people were worried about,\" said Peter Tuz, president of Chase Investment Counsel in Charlottesville, Virginia.\nMichael James, managing director of equity trading at Wedbush Securities in Los Angeles, said the Glaxosmithkline headline was already \"instrumental to people's sentiment.\"\nHe also cited the Intel news and investor bets that the market would see its traditional December boost, known as the Santa Claus rally.\n\"There's certainly fears of missing out on the Santa Claus rally,\" said James. \"It's a bigger picture risk-on mentality that's taking hold today.\"\nThe Dow Jones Industrial Average rose 492.4 points, or 1.4%, to 35,719.43, the S&P 500 gained 95.08 points, or 2.07%, to 4,686.75 and the Nasdaq Composite added 461.76 points, or 3.03%, to 15,686.92.\nThe CBOE volatility index , often referred to the Wall Street fear gauge, eased from a more than 10-month high last week. It ended the day down 19.5 points at 21.89, its lowest close since Oct. 6.\nAll of the 11 major S&P sectors advanced, with information technology sector closing up 3.5% for its biggest one-day percentage gain since March 9, with consumer discretionary following suit with a 2.4% gain.\nThe S&P 1500 Hotels, Restaurant and Leisure closed up 1.4%. After rallying for much of the day, the S&P 1500 Airlines closed down 0.6%. The airline index had gained 5% on Monday.\nIn the semiconductor industry, other big gainers besides Intel were Nvidia , which added 7.96%, while NXP Semiconductor and Applied Materials both advanced 6.5%.\nVir Biotechnology closed up 11.9%.\nMerck & Co fell 1.6% as Guggenheim downgraded the stock to \"neutral\" from \"buy\" after the drugmaker paused enrollment in two late-stage clinical trials testing its experimental drug for treatment and prevention of HIV-1.\nAdvancing issues outnumbered declining ones on the NYSE by a 4.10-to-1 ratio; on Nasdaq, a 3.37-to-1 ratio favored advancers.\nThe S&P 500 posted 37 new 52-week highs and no new lows; the Nasdaq Composite recorded 52 new highs and 48 new lows.\nOn U.S. exchanges, 11.38 billion shares changed hands compared with the 11.55 billion average for the last 20 sessions.","news_type":1},"isVote":1,"tweetType":1,"viewCount":141,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":879465163,"gmtCreate":1636764905369,"gmtModify":1636765011701,"author":{"id":"3585001294737518","authorId":"3585001294737518","name":"Universe宇宙","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3585001294737518","authorIdStr":"3585001294737518"},"themes":[],"htmlText":"Wall Street stocks closed higher on Friday, with market-leading growth shares kick-starting indexes' climb as investors looked past disappointing U.S. economic data.","listText":"Wall Street stocks closed higher on Friday, with market-leading growth shares kick-starting indexes' climb as investors looked past disappointing U.S. economic data.","text":"Wall Street stocks closed higher on Friday, with market-leading growth shares kick-starting indexes' climb as investors looked past disappointing U.S. economic data.","images":[],"top":1,"highlighted":2,"essential":1,"paper":1,"likeSize":8,"commentSize":20,"repostSize":0,"link":"https://laohu8.com/post/879465163","repostId":"2183501235","repostType":4,"repost":{"id":"2183501235","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1636757850,"share":"https://www.laohu8.com/m/news/2183501235?lang=&edition=full","pubTime":"2021-11-13 06:57","market":"us","language":"en","title":"Wall Street ends higher with boost from big tech","url":"https://stock-news.laohu8.com/highlight/detail?id=2183501235","media":"Reuters","summary":"* Johnson & Johnson announces to split into two companies\n* Consumer sentiment hits 10-year low\n* Te","content":"<p>* Johnson &amp; Johnson announces to split into two companies</p>\n<p>* Consumer sentiment hits 10-year low</p>\n<p>* Tesla slides as Musk sells more shares</p>\n<p>* Indexes up: Dow 0.50%, S&amp;P 0.72%, Nasdaq 1.00%</p>\n<p>NEW YORK, Nov 12 (Reuters) - Wall Street stocks closed higher on Friday, with market-leading growth shares kick-starting indexes' climb as investors looked past disappointing U.S. economic data.</p>\n<p>Despite their advances, all three major U.S. stock indexes ended the session below last Friday's close, ending a five-week streak of weekly gains.</p>\n<p>Investors favored growth over value, with megacap tech stocks, led by Apple Inc and Microsoft Corp, doing the heavy lifting.</p>\n<p>The University of Michigan's preliminary consumer sentiment data for November unexpectedly dropped to a 10-year low, and a Labor Department report showed job openings barely budged from record highs even as workers are quitting in record numbers.</p>\n<p>\"Markets drifted higher today despite a very weak consumer sentiment report, as inflation seems to be hurting consumers more than corporate profits,\" said David Carter, chief investment officer at Lenox Wealth Advisors in New York.</p>\n<p>The souring mood of the consumer could be worrisome to retailers as the holiday shopping season draws near, and is likely to draw intensified scrutiny to upcoming retail earnings reports.</p>\n<p>Walmart Inc, Target Corp, Home Depot Inc&nbsp;and Macy's Inc are among the high profile retailers expected to report next week.</p>\n<p>\"Investors will be focused on guidance from retailers to determine if inflation will crimp profit margins or if costs can be passed through,\" Carter added.</p>\n<p>Retail results will herald the last days of what was a largely upbeat third-quarter earnings season. As of Friday, 459 of the companies in the S&amp;P 500 have reported. Of those, 80% delivered consensus-beating earnings, according to Refinitiv.</p>\n<p>The Dow Jones Industrial Average rose 179.08 points, or 0.5%, to 36,100.31. The S&amp;P 500 gained 33.58 points, or 0.72%, at 4,682.85 and the Nasdaq Composite added 156.68 points, or 1%, at 15,860.96.</p>\n<p>Ten of the 11 major sectors of the S&amp;P 500 ended higher, with communications services' 1.7% advance leading gainers. Energy's 0.3% dip represented the largest percentage loss.</p>\n<p>Shares of Johnson &amp; Johnson gained 1.2% after the healthcare giant announced splitting into two companies, dividing its consumer health care segments from its pharmaceuticals/medical devices business.</p>\n<p>Tesla Inc dropped 2.8% on news that Chief Executive Elon Musk has sold an additional $700 million in stock in the next chapter of a saga that began with Musk's infamous <a href=\"https://laohu8.com/S/TWTR\">Twitter</a> poll on whether he should offload shares in the company he founded.</p>\n<p>Rival electric automaker Rivian Automotive Inc advanced 5.7%, notching its third consecutive gain in as many days as a publicly traded company.</p>\n<p>U.S.-listed shares of Alibaba Group Holding slipped 0.6% following the e-commerce giant's report showing its slowest-ever Singles Day sales.</p>\n<p>Advancing issues outnumbered decliners on the NYSE by a 1.29-to-1 ratio; on Nasdaq, a 1.19-to-1 ratio favored advancers.</p>\n<p>The S&amp;P 500 posted 34 new 52-week highs and one new low; the Nasdaq Composite recorded 130 new highs and 96 new lows.</p>\n<p>Volume on U.S. exchanges was 10.32 billion shares, compared with the 10.94 billion average over the last 20 trading days.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Wall Street ends higher with boost from big tech</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWall Street ends higher with boost from big tech\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-11-13 06:57</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>* Johnson &amp; Johnson announces to split into two companies</p>\n<p>* Consumer sentiment hits 10-year low</p>\n<p>* Tesla slides as Musk sells more shares</p>\n<p>* Indexes up: Dow 0.50%, S&amp;P 0.72%, Nasdaq 1.00%</p>\n<p>NEW YORK, Nov 12 (Reuters) - Wall Street stocks closed higher on Friday, with market-leading growth shares kick-starting indexes' climb as investors looked past disappointing U.S. economic data.</p>\n<p>Despite their advances, all three major U.S. stock indexes ended the session below last Friday's close, ending a five-week streak of weekly gains.</p>\n<p>Investors favored growth over value, with megacap tech stocks, led by Apple Inc and Microsoft Corp, doing the heavy lifting.</p>\n<p>The University of Michigan's preliminary consumer sentiment data for November unexpectedly dropped to a 10-year low, and a Labor Department report showed job openings barely budged from record highs even as workers are quitting in record numbers.</p>\n<p>\"Markets drifted higher today despite a very weak consumer sentiment report, as inflation seems to be hurting consumers more than corporate profits,\" said David Carter, chief investment officer at Lenox Wealth Advisors in New York.</p>\n<p>The souring mood of the consumer could be worrisome to retailers as the holiday shopping season draws near, and is likely to draw intensified scrutiny to upcoming retail earnings reports.</p>\n<p>Walmart Inc, Target Corp, Home Depot Inc&nbsp;and Macy's Inc are among the high profile retailers expected to report next week.</p>\n<p>\"Investors will be focused on guidance from retailers to determine if inflation will crimp profit margins or if costs can be passed through,\" Carter added.</p>\n<p>Retail results will herald the last days of what was a largely upbeat third-quarter earnings season. As of Friday, 459 of the companies in the S&amp;P 500 have reported. Of those, 80% delivered consensus-beating earnings, according to Refinitiv.</p>\n<p>The Dow Jones Industrial Average rose 179.08 points, or 0.5%, to 36,100.31. The S&amp;P 500 gained 33.58 points, or 0.72%, at 4,682.85 and the Nasdaq Composite added 156.68 points, or 1%, at 15,860.96.</p>\n<p>Ten of the 11 major sectors of the S&amp;P 500 ended higher, with communications services' 1.7% advance leading gainers. Energy's 0.3% dip represented the largest percentage loss.</p>\n<p>Shares of Johnson &amp; Johnson gained 1.2% after the healthcare giant announced splitting into two companies, dividing its consumer health care segments from its pharmaceuticals/medical devices business.</p>\n<p>Tesla Inc dropped 2.8% on news that Chief Executive Elon Musk has sold an additional $700 million in stock in the next chapter of a saga that began with Musk's infamous <a href=\"https://laohu8.com/S/TWTR\">Twitter</a> poll on whether he should offload shares in the company he founded.</p>\n<p>Rival electric automaker Rivian Automotive Inc advanced 5.7%, notching its third consecutive gain in as many days as a publicly traded company.</p>\n<p>U.S.-listed shares of Alibaba Group Holding slipped 0.6% following the e-commerce giant's report showing its slowest-ever Singles Day sales.</p>\n<p>Advancing issues outnumbered decliners on the NYSE by a 1.29-to-1 ratio; on Nasdaq, a 1.19-to-1 ratio favored advancers.</p>\n<p>The S&amp;P 500 posted 34 new 52-week highs and one new low; the Nasdaq Composite recorded 130 new highs and 96 new lows.</p>\n<p>Volume on U.S. exchanges was 10.32 billion shares, compared with the 10.94 billion average over the last 20 trading days.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"161125":"标普500","513500":"标普500ETF","QID":"纳指两倍做空ETF","SSO":"两倍做多标普500ETF","09988":"阿里巴巴-W","SPXU":"三倍做空标普500ETF","SQQQ":"纳指三倍做空ETF","LHDX":"Lucira Health, Inc.","APR":"Apria, Inc.","UDOW":"道指三倍做多ETF-ProShares","SDS":"两倍做空标普500ETF","QLD":"纳指两倍做多ETF","OEF":"标普100指数ETF-iShares","DXD":"道指两倍做空ETF",".DJI":"道琼斯","SDOW":"道指三倍做空ETF-ProShares","SANA":"Sana Biotechnology, Inc.",".IXIC":"NASDAQ Composite","TQQQ":"纳指三倍做多ETF","IVV":"标普500指数ETF","PSQ":"纳指反向ETF",".SPX":"S&P 500 Index","OEX":"标普100","DDM":"道指两倍做多ETF","QNETCN":"纳斯达克中美互联网老虎指数","QQQ":"纳指100ETF","UPRO":"三倍做多标普500ETF","LABP":"Landos Biopharma, Inc.","SH":"标普500反向ETF","DOG":"道指反向ETF","DJX":"1/100道琼斯","CGEM":"Cullinan Therapeutics"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2183501235","content_text":"* Johnson & Johnson announces to split into two companies\n* Consumer sentiment hits 10-year low\n* Tesla slides as Musk sells more shares\n* Indexes up: Dow 0.50%, S&P 0.72%, Nasdaq 1.00%\nNEW YORK, Nov 12 (Reuters) - Wall Street stocks closed higher on Friday, with market-leading growth shares kick-starting indexes' climb as investors looked past disappointing U.S. economic data.\nDespite their advances, all three major U.S. stock indexes ended the session below last Friday's close, ending a five-week streak of weekly gains.\nInvestors favored growth over value, with megacap tech stocks, led by Apple Inc and Microsoft Corp, doing the heavy lifting.\nThe University of Michigan's preliminary consumer sentiment data for November unexpectedly dropped to a 10-year low, and a Labor Department report showed job openings barely budged from record highs even as workers are quitting in record numbers.\n\"Markets drifted higher today despite a very weak consumer sentiment report, as inflation seems to be hurting consumers more than corporate profits,\" said David Carter, chief investment officer at Lenox Wealth Advisors in New York.\nThe souring mood of the consumer could be worrisome to retailers as the holiday shopping season draws near, and is likely to draw intensified scrutiny to upcoming retail earnings reports.\nWalmart Inc, Target Corp, Home Depot Inc and Macy's Inc are among the high profile retailers expected to report next week.\n\"Investors will be focused on guidance from retailers to determine if inflation will crimp profit margins or if costs can be passed through,\" Carter added.\nRetail results will herald the last days of what was a largely upbeat third-quarter earnings season. As of Friday, 459 of the companies in the S&P 500 have reported. Of those, 80% delivered consensus-beating earnings, according to Refinitiv.\nThe Dow Jones Industrial Average rose 179.08 points, or 0.5%, to 36,100.31. The S&P 500 gained 33.58 points, or 0.72%, at 4,682.85 and the Nasdaq Composite added 156.68 points, or 1%, at 15,860.96.\nTen of the 11 major sectors of the S&P 500 ended higher, with communications services' 1.7% advance leading gainers. Energy's 0.3% dip represented the largest percentage loss.\nShares of Johnson & Johnson gained 1.2% after the healthcare giant announced splitting into two companies, dividing its consumer health care segments from its pharmaceuticals/medical devices business.\nTesla Inc dropped 2.8% on news that Chief Executive Elon Musk has sold an additional $700 million in stock in the next chapter of a saga that began with Musk's infamous Twitter poll on whether he should offload shares in the company he founded.\nRival electric automaker Rivian Automotive Inc advanced 5.7%, notching its third consecutive gain in as many days as a publicly traded company.\nU.S.-listed shares of Alibaba Group Holding slipped 0.6% following the e-commerce giant's report showing its slowest-ever Singles Day sales.\nAdvancing issues outnumbered decliners on the NYSE by a 1.29-to-1 ratio; on Nasdaq, a 1.19-to-1 ratio favored advancers.\nThe S&P 500 posted 34 new 52-week highs and one new low; the Nasdaq Composite recorded 130 new highs and 96 new lows.\nVolume on U.S. exchanges was 10.32 billion shares, compared with the 10.94 billion average over the last 20 trading days.","news_type":1},"isVote":1,"tweetType":1,"viewCount":226,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":693871074,"gmtCreate":1640008398750,"gmtModify":1640008479714,"author":{"id":"3585001294737518","authorId":"3585001294737518","name":"Universe宇宙","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3585001294737518","authorIdStr":"3585001294737518"},"themes":[],"htmlText":"First post 😉","listText":"First post 😉","text":"First post 😉","images":[],"top":1,"highlighted":2,"essential":1,"paper":1,"likeSize":7,"commentSize":19,"repostSize":0,"link":"https://laohu8.com/post/693871074","repostId":"1138448212","repostType":4,"repost":{"id":"1138448212","weMediaInfo":{"introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"media_name":"Dow Jones","id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"pubTimestamp":1640008237,"share":"https://www.laohu8.com/m/news/1138448212?lang=&edition=full","pubTime":"2021-12-20 21:50","market":"us","language":"en","title":"Summit Therapeutics Shares Fall nearly 30% After Failing to Meet Endpoint in Phase 3 Ri-CoDIFy Study","url":"https://stock-news.laohu8.com/highlight/detail?id=1138448212","media":"Dow Jones","summary":"Summit Therapeutics Inc. shares fell nearly 30% to $3.5 after the company said its Phase 3 Ri-CoDIFy","content":"<p>Summit Therapeutics Inc. shares fell&nbsp;nearly 30% to $3.5 after the company said its Phase 3 Ri-CoDIFy study didn't meet its primary endpoint for superiority for the treatment of C. difficle infection.</p>\n<p><img src=\"https://static.tigerbbs.com/5780de0c9ef3f0248ec3fa67eaa2037e\" tg-width=\"703\" tg-height=\"593\" referrerpolicy=\"no-referrer\"></p>\n<p>The investigational drug, ridinilazole, resulted in a higher observed sustained clinicial response than the antibiotic vancomycin but not superiority, Summit said. Sustained clinical response is defined as clinical response of the treated episode of CDI and no recurrence of the infection through 30 days after the end of treatment, the company said.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Summit Therapeutics Shares Fall nearly 30% After Failing to Meet Endpoint in Phase 3 Ri-CoDIFy Study </title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSummit Therapeutics Shares Fall nearly 30% After Failing to Meet Endpoint in Phase 3 Ri-CoDIFy Study \n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2021-12-20 21:50</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p>Summit Therapeutics Inc. shares fell&nbsp;nearly 30% to $3.5 after the company said its Phase 3 Ri-CoDIFy study didn't meet its primary endpoint for superiority for the treatment of C. difficle infection.</p>\n<p><img src=\"https://static.tigerbbs.com/5780de0c9ef3f0248ec3fa67eaa2037e\" tg-width=\"703\" tg-height=\"593\" referrerpolicy=\"no-referrer\"></p>\n<p>The investigational drug, ridinilazole, resulted in a higher observed sustained clinicial response than the antibiotic vancomycin but not superiority, Summit said. Sustained clinical response is defined as clinical response of the treated episode of CDI and no recurrence of the infection through 30 days after the end of treatment, the company said.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SMMT":"Summit Therapeutics PLC"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1138448212","content_text":"Summit Therapeutics Inc. shares fell nearly 30% to $3.5 after the company said its Phase 3 Ri-CoDIFy study didn't meet its primary endpoint for superiority for the treatment of C. difficle infection.\n\nThe investigational drug, ridinilazole, resulted in a higher observed sustained clinicial response than the antibiotic vancomycin but not superiority, Summit said. Sustained clinical response is defined as clinical response of the treated episode of CDI and no recurrence of the infection through 30 days after the end of treatment, the company said.","news_type":1},"isVote":1,"tweetType":1,"viewCount":327,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":605339657,"gmtCreate":1639110569605,"gmtModify":1639111145967,"author":{"id":"3585001294737518","authorId":"3585001294737518","name":"Universe宇宙","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3585001294737518","authorIdStr":"3585001294737518"},"themes":[],"htmlText":"Elon Musk, Other Leaders Sell Stock at Historic Levels as Market Soars, Tax Changes Loom","listText":"Elon Musk, Other Leaders Sell Stock at Historic Levels as Market Soars, Tax Changes Loom","text":"Elon Musk, Other Leaders Sell Stock at Historic Levels as Market Soars, Tax Changes Loom","images":[],"top":1,"highlighted":2,"essential":1,"paper":1,"likeSize":4,"commentSize":20,"repostSize":0,"link":"https://laohu8.com/post/605339657","repostId":"1113743057","repostType":4,"repost":{"id":"1113743057","pubTimestamp":1639094301,"share":"https://www.laohu8.com/m/news/1113743057?lang=&edition=full","pubTime":"2021-12-10 07:58","market":"us","language":"en","title":"Elon Musk, Other Leaders Sell Stock at Historic Levels as Market Soars, Tax Changes Loom","url":"https://stock-news.laohu8.com/highlight/detail?id=1113743057","media":"The Wall Street Journal","summary":"Company founders and leaders are unloading their stock at historic levels, with some selling shares ","content":"<p>Company founders and leaders are unloading their stock at historic levels, with some selling shares in their businesses for the first time in years, amid soaring market valuations and ahead of possible changes in U.S. and some state tax laws.</p>\n<p>So far this year, 48 top executives have collected more than $200 million each from stock sales, nearly four times the average number of insiders from 2016 through 2020, according to a Wall Street Journal analysis of data from the research firm InsiderScore.</p>\n<p>The wave has included super sellers such as cosmetics billionaire Ronald Lauder and Google co-founders Larry Page and Sergey Brin, who have sold shares for the first time in four years or more as the economic recovery fueled strong growth in sales and profit. Other high-profile insiders—including the Walton family, heirs to the Walmart Inc. WMT 1.39% fortune, and Mark Zuckerberg, chief executive of Facebook parent Meta Platforms Inc. FB -0.22% —have accelerated sales and are on track to break recent records for the number of shares they have sold.</p>\n<p>Across the S&amp;P 500, insiders have sold a record $63.5 billion in shares through November, a 50% increase from all of 2020, driven both by stock-market gains and an increase in sales by some big holders. The technology sector has led with $41 billion in sales across the entire market, up by more than a third, with a smaller amount but an even bigger increase in financial services.</p>\n<p>“What you’re seeing is unprecedented” in recent years, said Daniel Taylor, an accounting professor at the University of Pennsylvania’s Wharton School who studies trading by executives and directors. He said 2021 marks the most sales he can recall by insiders in a decade, resembling waves of sales during the twilight of the early 2000s dot-com boom.</p>\n<p>Insiders have a long history of selling at peaks and buying in troughs, Mr. Taylor said.</p>\n<p>Investors sometimes worry that large sales by insiders mean they don’t expect significant further share-price increases, and big, unexpected sales can weigh on share prices. Companies often require top executives to hold stakes equivalent to several times their annual salary, but many high-profile executives easily exceed those thresholds even after selling.</p>\n<p>Executives aren’t required to say why they sold, and few do. The heaviest selling came as lawmakers in Washington hashed out potential tax increases as part of the Democrats’ Build Back Better legislative package, at times considering raising the long-term capital-gains tax rate. In November, insiders unloaded a collective $15.59 billion.</p>\n<p>The legislation, pending in the Senate, imposes a 5% tax on adjusted gross income above $10 million beginning in 2022, and another 3% on income over $25 million, including capital gains from stock sales. Congressional revenue estimates assume taxpayers will accelerate capital gains in 2021. Wealthy taxpayers could save up to $8 million in taxes on every $100 million of shares sold ahead of the effective date, Mr. Taylor said. Such potential tax savings have been “a powerful incentive to sell this year,” he said.</p>\n<p>Tesla Inc. CEO Elon Musk, considered the world’s richest person, with a net worth of about $270 billion, ridiculed a proposed tax on billionaires’ unrealized capital gains, saying on Twitter that eventually the government runs “out of other people’s money and then they come for you.” He has moved to sell more than $10 billion in Tesla stock over about a month—including roughly $4 billion to cover tax withholding on option exercises—in his first sale of company shares since 2010, other than sales designated as made solely to satisfy tax-withholding obligations.</p>\n<p>Microsoft Corp. CEO Satya Nadella last month sold half his total stake, for about $374 million before taxes. Analysts said the move could be related to Washington state instituting a 7% tax for long-term capital gains next year. A Microsoft spokesman said at the time that the sale was for “personal financial planning and diversification reasons.”</p>\n<p>Another spike in insider-stock sales occurred in May when company leaders sold off $13.12 billion in shares, following strong corporate earnings reports.</p>\n<p>The Journal examined data on company leaders’ stock transactions through Dec. 3, drawn from regulatory filings by InsiderScore. Sales marked as made solely to satisfy tax withholding requirements were excluded. Aggregate figures, through Nov. 30, exclude sales by major shareholders who aren’t also executives or directors.</p>\n<p>About a dozen high-profile founders and CEOs sold millions of dollars in company shares this year after selling none in all of 2020, in several cases selling for the first time in five or 10 years.</p>\n<p>Messrs. Page and Brin last sold stock in Google parent Alphabet Inc. GOOG -0.41% at about $800 a share in 2017, according to InsiderScore. When they returned to the market in May, shares had risen to $2,200. This year, they have each sold nearly 600,000 shares for about $1.5 billion before taxes. Each still owns about 6% of Alphabet, according to FactSet.</p>\n<p>The duo’s sales came as the company reported record revenues and profits more than doubled from a year earlier, and seven months after the Justice Department and state attorneys general filed a civil antitrust lawsuit against Google. The company’s share price reached an all-time high of $3,019.33 on Nov. 19, and has since pulled back to about $2,950.</p>\n<p>An Alphabet spokesman declined to comment. Messrs. Brin and Page didn’t respond to a request for comment.</p>\n<p>Mr. Lauder, the son of Estée Lauder Cos.’ founders, has shed just over two million shares this year, for more than $600 million before taxes in his first sales since 2016.</p>\n<p>Dell Technologies Inc.’s Michael Dell and the Carlyle Group’s David Rubenstein also came off the sidelines over the past year. Mr. Dell sold five million shares for nearly $253 million before taxes, his first since taking Dell public again in 2018. Mr. Rubenstein sold 11 million shares this year for $495 million before taxes, after making his first-ever sale in November 2020. His sales have followed him stepping aside as co-CEO and transitioning into a role as co-chairman.</p>\n<p>A spokesman for Mr. Lauder declined to comment. Spokespeople for Mr. Dell didn’t respond to requests for comment.</p>\n<p>Other insiders continued selling but at a faster clip this year. The Walton family quadrupled the number of shares its members sold, receiving $6.5 billion before taxes so far in 2021, from $1.5 billion in 2020. The sales came in a year when Walmart’s share price flirted with all-time highs, and the company posted higher sales in three quarters.</p>\n<p>Mr. Zuckerberg increased the number of Meta shares he sold nearly sevenfold from a year ago, collecting nearly $4.5 billion before taxes. His selling came as the company reported record sales and earnings, despite challenges presented by iPhone privacy changes and congressional hearings over harms from its platforms following the Journal’s Facebook Files series.</p>\n<p>Walmart and Meta spokespeople said the sales are generally governed by preset trading plans. They said the Walton family’s proceeds help fund nonprofit initiatives, and Mr. Zuckerberg’s fund the Chan Zuckerberg Initiative LLC, his family’s for-profit philanthropic company.</p>\n<p>Executives often sell shares under advance trading arrangements, dubbed 10b5-1 plans, that trigger sales on a fixed schedule or at price thresholds to avoid running afoul of insider-trading rules. The plans were used in almost two-thirds of stock sales last year—up from 30% in 2004—but some investors and regulators worry they can be abused. The Securities and Exchange Commission on Wednesday is scheduled to vote on a proposal that would change the rules governing the trading plans.</p>\n<p>Finance executive Charles Schwab sold the most shares since 2015 in the company he founded, Charles Schwab Corp.: 5.3 million shares for $361 million.</p>\n<p>“People are clearly being opportunistic,” said Ben Silverman, InsiderScore’s director of research. “These guys have been telling you all year that the market is overheated.”</p>\n<p>Soaring stock prices mean some executives raised the same amount of money, or more, selling fewer shares. Snap Inc. CEO Evan Spiegel set a price target to sell between $60 and $80, receiving a total of $710 million before taxes on 10 million shares—more than doubling his 2020 proceeds despite selling three million fewer shares.</p>\n<p>Amazon.com Inc. founder Jeff Bezos typically sells about $10 billion in stock annually to help fund his space venture, Blue Origin LLC. This year, he has sold 25% fewer shares while collecting roughly the same amount of money before taxes because the company’s share price has doubled over the past two years.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Elon Musk, Other Leaders Sell Stock at Historic Levels as Market Soars, Tax Changes Loom</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nElon Musk, Other Leaders Sell Stock at Historic Levels as Market Soars, Tax Changes Loom\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-10 07:58 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.wsj.com/articles/elon-musk-other-leaders-sell-stock-at-historic-levels-as-market-soars-tax-changes-loom-11639089782?mod=hp_lead_pos1><strong>The Wall Street Journal</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Company founders and leaders are unloading their stock at historic levels, with some selling shares in their businesses for the first time in years, amid soaring market valuations and ahead of ...</p>\n\n<a href=\"https://www.wsj.com/articles/elon-musk-other-leaders-sell-stock-at-historic-levels-as-market-soars-tax-changes-loom-11639089782?mod=hp_lead_pos1\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"DELL":"戴尔","WMT":"沃尔玛","MSFT":"微软","TSLA":"特斯拉","GOOG":"谷歌","AMZN":"亚马逊"},"source_url":"https://www.wsj.com/articles/elon-musk-other-leaders-sell-stock-at-historic-levels-as-market-soars-tax-changes-loom-11639089782?mod=hp_lead_pos1","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1113743057","content_text":"Company founders and leaders are unloading their stock at historic levels, with some selling shares in their businesses for the first time in years, amid soaring market valuations and ahead of possible changes in U.S. and some state tax laws.\nSo far this year, 48 top executives have collected more than $200 million each from stock sales, nearly four times the average number of insiders from 2016 through 2020, according to a Wall Street Journal analysis of data from the research firm InsiderScore.\nThe wave has included super sellers such as cosmetics billionaire Ronald Lauder and Google co-founders Larry Page and Sergey Brin, who have sold shares for the first time in four years or more as the economic recovery fueled strong growth in sales and profit. Other high-profile insiders—including the Walton family, heirs to the Walmart Inc. WMT 1.39% fortune, and Mark Zuckerberg, chief executive of Facebook parent Meta Platforms Inc. FB -0.22% —have accelerated sales and are on track to break recent records for the number of shares they have sold.\nAcross the S&P 500, insiders have sold a record $63.5 billion in shares through November, a 50% increase from all of 2020, driven both by stock-market gains and an increase in sales by some big holders. The technology sector has led with $41 billion in sales across the entire market, up by more than a third, with a smaller amount but an even bigger increase in financial services.\n“What you’re seeing is unprecedented” in recent years, said Daniel Taylor, an accounting professor at the University of Pennsylvania’s Wharton School who studies trading by executives and directors. He said 2021 marks the most sales he can recall by insiders in a decade, resembling waves of sales during the twilight of the early 2000s dot-com boom.\nInsiders have a long history of selling at peaks and buying in troughs, Mr. Taylor said.\nInvestors sometimes worry that large sales by insiders mean they don’t expect significant further share-price increases, and big, unexpected sales can weigh on share prices. Companies often require top executives to hold stakes equivalent to several times their annual salary, but many high-profile executives easily exceed those thresholds even after selling.\nExecutives aren’t required to say why they sold, and few do. The heaviest selling came as lawmakers in Washington hashed out potential tax increases as part of the Democrats’ Build Back Better legislative package, at times considering raising the long-term capital-gains tax rate. In November, insiders unloaded a collective $15.59 billion.\nThe legislation, pending in the Senate, imposes a 5% tax on adjusted gross income above $10 million beginning in 2022, and another 3% on income over $25 million, including capital gains from stock sales. Congressional revenue estimates assume taxpayers will accelerate capital gains in 2021. Wealthy taxpayers could save up to $8 million in taxes on every $100 million of shares sold ahead of the effective date, Mr. Taylor said. Such potential tax savings have been “a powerful incentive to sell this year,” he said.\nTesla Inc. CEO Elon Musk, considered the world’s richest person, with a net worth of about $270 billion, ridiculed a proposed tax on billionaires’ unrealized capital gains, saying on Twitter that eventually the government runs “out of other people’s money and then they come for you.” He has moved to sell more than $10 billion in Tesla stock over about a month—including roughly $4 billion to cover tax withholding on option exercises—in his first sale of company shares since 2010, other than sales designated as made solely to satisfy tax-withholding obligations.\nMicrosoft Corp. CEO Satya Nadella last month sold half his total stake, for about $374 million before taxes. Analysts said the move could be related to Washington state instituting a 7% tax for long-term capital gains next year. A Microsoft spokesman said at the time that the sale was for “personal financial planning and diversification reasons.”\nAnother spike in insider-stock sales occurred in May when company leaders sold off $13.12 billion in shares, following strong corporate earnings reports.\nThe Journal examined data on company leaders’ stock transactions through Dec. 3, drawn from regulatory filings by InsiderScore. Sales marked as made solely to satisfy tax withholding requirements were excluded. Aggregate figures, through Nov. 30, exclude sales by major shareholders who aren’t also executives or directors.\nAbout a dozen high-profile founders and CEOs sold millions of dollars in company shares this year after selling none in all of 2020, in several cases selling for the first time in five or 10 years.\nMessrs. Page and Brin last sold stock in Google parent Alphabet Inc. GOOG -0.41% at about $800 a share in 2017, according to InsiderScore. When they returned to the market in May, shares had risen to $2,200. This year, they have each sold nearly 600,000 shares for about $1.5 billion before taxes. Each still owns about 6% of Alphabet, according to FactSet.\nThe duo’s sales came as the company reported record revenues and profits more than doubled from a year earlier, and seven months after the Justice Department and state attorneys general filed a civil antitrust lawsuit against Google. The company’s share price reached an all-time high of $3,019.33 on Nov. 19, and has since pulled back to about $2,950.\nAn Alphabet spokesman declined to comment. Messrs. Brin and Page didn’t respond to a request for comment.\nMr. Lauder, the son of Estée Lauder Cos.’ founders, has shed just over two million shares this year, for more than $600 million before taxes in his first sales since 2016.\nDell Technologies Inc.’s Michael Dell and the Carlyle Group’s David Rubenstein also came off the sidelines over the past year. Mr. Dell sold five million shares for nearly $253 million before taxes, his first since taking Dell public again in 2018. Mr. Rubenstein sold 11 million shares this year for $495 million before taxes, after making his first-ever sale in November 2020. His sales have followed him stepping aside as co-CEO and transitioning into a role as co-chairman.\nA spokesman for Mr. Lauder declined to comment. Spokespeople for Mr. Dell didn’t respond to requests for comment.\nOther insiders continued selling but at a faster clip this year. The Walton family quadrupled the number of shares its members sold, receiving $6.5 billion before taxes so far in 2021, from $1.5 billion in 2020. The sales came in a year when Walmart’s share price flirted with all-time highs, and the company posted higher sales in three quarters.\nMr. Zuckerberg increased the number of Meta shares he sold nearly sevenfold from a year ago, collecting nearly $4.5 billion before taxes. His selling came as the company reported record sales and earnings, despite challenges presented by iPhone privacy changes and congressional hearings over harms from its platforms following the Journal’s Facebook Files series.\nWalmart and Meta spokespeople said the sales are generally governed by preset trading plans. They said the Walton family’s proceeds help fund nonprofit initiatives, and Mr. Zuckerberg’s fund the Chan Zuckerberg Initiative LLC, his family’s for-profit philanthropic company.\nExecutives often sell shares under advance trading arrangements, dubbed 10b5-1 plans, that trigger sales on a fixed schedule or at price thresholds to avoid running afoul of insider-trading rules. The plans were used in almost two-thirds of stock sales last year—up from 30% in 2004—but some investors and regulators worry they can be abused. The Securities and Exchange Commission on Wednesday is scheduled to vote on a proposal that would change the rules governing the trading plans.\nFinance executive Charles Schwab sold the most shares since 2015 in the company he founded, Charles Schwab Corp.: 5.3 million shares for $361 million.\n“People are clearly being opportunistic,” said Ben Silverman, InsiderScore’s director of research. “These guys have been telling you all year that the market is overheated.”\nSoaring stock prices mean some executives raised the same amount of money, or more, selling fewer shares. Snap Inc. CEO Evan Spiegel set a price target to sell between $60 and $80, receiving a total of $710 million before taxes on 10 million shares—more than doubling his 2020 proceeds despite selling three million fewer shares.\nAmazon.com Inc. founder Jeff Bezos typically sells about $10 billion in stock annually to help fund his space venture, Blue Origin LLC. This year, he has sold 25% fewer shares while collecting roughly the same amount of money before taxes because the company’s share price has doubled over the past two years.","news_type":1},"isVote":1,"tweetType":1,"viewCount":297,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3583106134648492","authorId":"3583106134648492","name":"Frosty4ever","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":3,"crmLevelSwitch":0,"idStr":"3583106134648492","authorIdStr":"3583106134648492"},"content":"Elon owns more shares then before. https://www.autoevolution.com/news/elon-musk-sold-10-million-tesla-shares-still-owns-more-than-before-175789.html","text":"Elon owns more shares then before. https://www.autoevolution.com/news/elon-musk-sold-10-million-tesla-shares-still-owns-more-than-before-175789.html","html":"Elon owns more shares then before. https://www.autoevolution.com/news/elon-musk-sold-10-million-tesla-shares-still-owns-more-than-before-175789.html"}],"imageCount":0,"langContent":"CN","totalScore":0},{"id":609685646,"gmtCreate":1638279520549,"gmtModify":1638279521000,"author":{"id":"3585001294737518","authorId":"3585001294737518","name":"Universe宇宙","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3585001294737518","authorIdStr":"3585001294737518"},"themes":[],"htmlText":"Powell, Yellen head to Congress as inflation, variant risks rise.&nbsp;[捂脸]&nbsp;","listText":"Powell, Yellen head to Congress as inflation, variant risks rise.&nbsp;[捂脸]&nbsp;","text":"Powell, Yellen head to Congress as inflation, variant risks rise. [捂脸]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":20,"repostSize":0,"link":"https://laohu8.com/post/609685646","repostId":"2187581408","repostType":4,"repost":{"id":"2187581408","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1638278227,"share":"https://www.laohu8.com/m/news/2187581408?lang=&edition=full","pubTime":"2021-11-30 21:17","market":"us","language":"en","title":"Powell, Yellen head to Congress as inflation, variant risks rise","url":"https://stock-news.laohu8.com/highlight/detail?id=2187581408","media":"Reuters","summary":"Nov 30 (Reuters) - U.S. lawmakers on Tuesday are expected to grill the heads of the Federal Reserve ","content":"<p>Nov 30 (Reuters) - U.S. lawmakers on Tuesday are expected to grill the heads of the Federal Reserve and Treasury Department over stubbornly high inflation and the possible impact of the new Omicron COVID-19 variant on what both officials view as a strong economy.</p>\n<p>Fed Chair Jerome Powell and Treasury Secretary Janet Yellen are due to testify before the U.S. Senate Banking Committee at 10 a.m. EST (1500 GMT) to discuss the economic recovery from the COVID-19 pandemic. They will also appear before the House of Representatives Financial Services Committee on Wednesday.</p>\n<p>Both released their prepared testimony late Monday, with Powell projecting 5% growth this year but noting the new variant poses downside risks to economic activity and jobs and raises uncertainty around inflation .</p>\n<p>Yellen warned lawmakers that failure to deal with the debt limit would \"eviscerate\" the recovery .</p>\n<p>With inflation at a 31-year high and the Fed's preferred measure of price pressures more than double its 2% goal, the U.S. central bank's promise to keep its benchmark overnight interest rate near zero until the labor market is fully healed is under threat.</p>\n<p>U.S. unemployment currently stands at 4.6% and businesses have nearly 5 million fewer people on their collective payrolls than they did pre-pandemic.</p>\n<p>The Fed this month began to reduce its support for the economy, and is currently on pace to fully taper its $120 billion in monthly purchases of Treasuries and mortgage-backed securities by next June. The program was introduced in early 2020 to help nurse the economy through the pandemic.</p>\n<p>With costs of everyday items like food, gas and rent rising quickly, Fed officials have indicated they could speed up the pace of the taper to give more scope for an earlier interest rate lift-off next year if required, according to the minutes</p>\n<p>of the central bank's last policy meeting published last week. The topic is on the agenda for the Fed's Dec. 14-15 policy meeting.</p>\n<p>That and other recent comments from officials have prompted analysts to place rising bets that the Fed could now raise rates as early as mid-2022.</p>\n<p>Goldman Sachs, in a note to clients, said there was \"a significant risk\" the timeline for the tapering of the central bank's asset purchases would be accelerated.</p>\n<p>In his prepared remarks Powell did not mention taper at all, but his comments on the variant suggest he is worried both about the economy slowing and the potential for further inflation pressure, a difficult situation that would tug Fed policy in opposite directions.</p>\n<p>\"The new COVID variant could complicate any plans to accelerate the taper at the December meeting, which is the direction momentum was heading ahead of the variant discovery,\" said Sam Bullard, senior economist at Wells Fargo.</p>\n<p><b>NEW VARIANT</b></p>\n<p>Health officials are racing to determine how transmissible and deadly the new variant is and to what extent current vaccines remain protective. The United States has imposed a travel ban on some southern African nations where the strain is prevalent.</p>\n<p>The now-dominant Delta variant of COVID-19 dented the U.S. economy over the summer, slowing employment gains amid workers' fears of contracting the virus and exacerbating supply chain snags that have driven up inflation.</p>\n<p>\"It is difficult to predict the persistence and effects of supply constraints, but it now appears that factors pushing inflation upward will linger well into next year,\" Powell said in his prepared remarks.</p>\n<p>Concern about the recent rise in COVID-19 cases and the emergence of the new Omicron variant, he said, \"could reduce people's willingness to work in person, which would slow progress in the labor market and intensify supply-chain disruptions.\"</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Powell, Yellen head to Congress as inflation, variant risks rise</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPowell, Yellen head to Congress as inflation, variant risks rise\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-11-30 21:17</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Nov 30 (Reuters) - U.S. lawmakers on Tuesday are expected to grill the heads of the Federal Reserve and Treasury Department over stubbornly high inflation and the possible impact of the new Omicron COVID-19 variant on what both officials view as a strong economy.</p>\n<p>Fed Chair Jerome Powell and Treasury Secretary Janet Yellen are due to testify before the U.S. Senate Banking Committee at 10 a.m. EST (1500 GMT) to discuss the economic recovery from the COVID-19 pandemic. They will also appear before the House of Representatives Financial Services Committee on Wednesday.</p>\n<p>Both released their prepared testimony late Monday, with Powell projecting 5% growth this year but noting the new variant poses downside risks to economic activity and jobs and raises uncertainty around inflation .</p>\n<p>Yellen warned lawmakers that failure to deal with the debt limit would \"eviscerate\" the recovery .</p>\n<p>With inflation at a 31-year high and the Fed's preferred measure of price pressures more than double its 2% goal, the U.S. central bank's promise to keep its benchmark overnight interest rate near zero until the labor market is fully healed is under threat.</p>\n<p>U.S. unemployment currently stands at 4.6% and businesses have nearly 5 million fewer people on their collective payrolls than they did pre-pandemic.</p>\n<p>The Fed this month began to reduce its support for the economy, and is currently on pace to fully taper its $120 billion in monthly purchases of Treasuries and mortgage-backed securities by next June. The program was introduced in early 2020 to help nurse the economy through the pandemic.</p>\n<p>With costs of everyday items like food, gas and rent rising quickly, Fed officials have indicated they could speed up the pace of the taper to give more scope for an earlier interest rate lift-off next year if required, according to the minutes</p>\n<p>of the central bank's last policy meeting published last week. The topic is on the agenda for the Fed's Dec. 14-15 policy meeting.</p>\n<p>That and other recent comments from officials have prompted analysts to place rising bets that the Fed could now raise rates as early as mid-2022.</p>\n<p>Goldman Sachs, in a note to clients, said there was \"a significant risk\" the timeline for the tapering of the central bank's asset purchases would be accelerated.</p>\n<p>In his prepared remarks Powell did not mention taper at all, but his comments on the variant suggest he is worried both about the economy slowing and the potential for further inflation pressure, a difficult situation that would tug Fed policy in opposite directions.</p>\n<p>\"The new COVID variant could complicate any plans to accelerate the taper at the December meeting, which is the direction momentum was heading ahead of the variant discovery,\" said Sam Bullard, senior economist at Wells Fargo.</p>\n<p><b>NEW VARIANT</b></p>\n<p>Health officials are racing to determine how transmissible and deadly the new variant is and to what extent current vaccines remain protective. The United States has imposed a travel ban on some southern African nations where the strain is prevalent.</p>\n<p>The now-dominant Delta variant of COVID-19 dented the U.S. economy over the summer, slowing employment gains amid workers' fears of contracting the virus and exacerbating supply chain snags that have driven up inflation.</p>\n<p>\"It is difficult to predict the persistence and effects of supply constraints, but it now appears that factors pushing inflation upward will linger well into next year,\" Powell said in his prepared remarks.</p>\n<p>Concern about the recent rise in COVID-19 cases and the emergence of the new Omicron variant, he said, \"could reduce people's willingness to work in person, which would slow progress in the labor market and intensify supply-chain disruptions.\"</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2187581408","content_text":"Nov 30 (Reuters) - U.S. lawmakers on Tuesday are expected to grill the heads of the Federal Reserve and Treasury Department over stubbornly high inflation and the possible impact of the new Omicron COVID-19 variant on what both officials view as a strong economy.\nFed Chair Jerome Powell and Treasury Secretary Janet Yellen are due to testify before the U.S. Senate Banking Committee at 10 a.m. EST (1500 GMT) to discuss the economic recovery from the COVID-19 pandemic. They will also appear before the House of Representatives Financial Services Committee on Wednesday.\nBoth released their prepared testimony late Monday, with Powell projecting 5% growth this year but noting the new variant poses downside risks to economic activity and jobs and raises uncertainty around inflation .\nYellen warned lawmakers that failure to deal with the debt limit would \"eviscerate\" the recovery .\nWith inflation at a 31-year high and the Fed's preferred measure of price pressures more than double its 2% goal, the U.S. central bank's promise to keep its benchmark overnight interest rate near zero until the labor market is fully healed is under threat.\nU.S. unemployment currently stands at 4.6% and businesses have nearly 5 million fewer people on their collective payrolls than they did pre-pandemic.\nThe Fed this month began to reduce its support for the economy, and is currently on pace to fully taper its $120 billion in monthly purchases of Treasuries and mortgage-backed securities by next June. The program was introduced in early 2020 to help nurse the economy through the pandemic.\nWith costs of everyday items like food, gas and rent rising quickly, Fed officials have indicated they could speed up the pace of the taper to give more scope for an earlier interest rate lift-off next year if required, according to the minutes\nof the central bank's last policy meeting published last week. The topic is on the agenda for the Fed's Dec. 14-15 policy meeting.\nThat and other recent comments from officials have prompted analysts to place rising bets that the Fed could now raise rates as early as mid-2022.\nGoldman Sachs, in a note to clients, said there was \"a significant risk\" the timeline for the tapering of the central bank's asset purchases would be accelerated.\nIn his prepared remarks Powell did not mention taper at all, but his comments on the variant suggest he is worried both about the economy slowing and the potential for further inflation pressure, a difficult situation that would tug Fed policy in opposite directions.\n\"The new COVID variant could complicate any plans to accelerate the taper at the December meeting, which is the direction momentum was heading ahead of the variant discovery,\" said Sam Bullard, senior economist at Wells Fargo.\nNEW VARIANT\nHealth officials are racing to determine how transmissible and deadly the new variant is and to what extent current vaccines remain protective. The United States has imposed a travel ban on some southern African nations where the strain is prevalent.\nThe now-dominant Delta variant of COVID-19 dented the U.S. economy over the summer, slowing employment gains amid workers' fears of contracting the virus and exacerbating supply chain snags that have driven up inflation.\n\"It is difficult to predict the persistence and effects of supply constraints, but it now appears that factors pushing inflation upward will linger well into next year,\" Powell said in his prepared remarks.\nConcern about the recent rise in COVID-19 cases and the emergence of the new Omicron variant, he said, \"could reduce people's willingness to work in person, which would slow progress in the labor market and intensify supply-chain disruptions.\"","news_type":1},"isVote":1,"tweetType":1,"viewCount":89,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":876856647,"gmtCreate":1637294827814,"gmtModify":1637295096504,"author":{"id":"3585001294737518","authorId":"3585001294737518","name":"Universe宇宙","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3585001294737518","authorIdStr":"3585001294737518"},"themes":[],"htmlText":"The S&amp;P 500 and Nasdaq notched record closing highs on Thursday, boosted by upbeat corporate earnings news","listText":"The S&amp;P 500 and Nasdaq notched record closing highs on Thursday, boosted by upbeat corporate earnings news","text":"The S&P 500 and Nasdaq notched record closing highs on Thursday, boosted by upbeat corporate earnings news","images":[],"top":1,"highlighted":2,"essential":1,"paper":1,"likeSize":6,"commentSize":19,"repostSize":0,"link":"https://laohu8.com/post/876856647","repostId":"1185082595","repostType":4,"repost":{"id":"1185082595","pubTimestamp":1637276340,"share":"https://www.laohu8.com/m/news/1185082595?lang=&edition=full","pubTime":"2021-11-19 06:59","market":"us","language":"en","title":"S&P 500, Nasdaq hit record closing highs","url":"https://stock-news.laohu8.com/highlight/detail?id=1185082595","media":"Reuters","summary":"(Reuters) - The S&P 500 and Nasdaq notched record closing highs on Thursday, boosted by upbeat corpo","content":"<p>(Reuters) - The S&amp;P 500 and Nasdaq notched record closing highs on Thursday, boosted by upbeat corporate earnings news from companies including <a href=\"https://laohu8.com/S/NVDA\">Nvidia</a>, while Turkey's lira weakened further after its central bank cut rates.</p>\n<p>MSCI's gauge of stocks across the globe was flat, and the Dow Jones industrial average ended lower.Nvidia's stock jumped and was among the biggest supports for the S&amp;P 500 and Nasdaq after it beat quarterly estimates and forecast strong fourth-quarter revenue. Macy's(M.N)shares shot up 21.2% after it raised its earnings outlook.</p>\n<p>On the flip side, <a href=\"https://laohu8.com/S/CSCO\">Cisco Systems</a>&nbsp;shares fell 5.5%, a day after it forecast current-quarter revenue below expectations due to supply chain shortages and delays. It was the latest in a growing list of U.S. companies citing supply chain problems.</p>\n<p>Investors have been concerned over further increases in price pressures. Retail giant <a href=\"https://laohu8.com/S/TGT\">Target</a>&nbsp;warned of higher costs earlier this week.</p>\n<p>New York Federal Reserve Bank President John Williams said Thursday that inflation is becoming more broad-based and that expectations for future price increases are rising.</p>\n<p>The Dow Jones Industrial Average(.DJI)&nbsp;fell 60.1 points, or 0.17%, to 35,870.95, the S&amp;P 500(.SPX)gained 15.87 points, or 0.34%, to 4,704.54 and the Nasdaq Composite(.IXIC)&nbsp;added 72.14 points, or 0.45%, to 15,993.71.</p>\n<p>The pan-European STOXX 600 index(.STOXX)lost 0.46% and MSCI's gauge of stocks across the globe(.MIWD00000PUS)gained 0.03%.</p>\n<p>Turkey's lira shed another 2.83% after its central bank cut rates by 100 basis points to 15%, even in the face of inflation near 20%, sending the Turkish currency hurtling southward.</p>\n<p>\"The lira remains a punching bag, and further weakness has no end in sight,\" said Edward Moya, senior market analyst at Oanda.</p>\n<p>The lira has lost around 11.5% of its value this month amid President Tayyip Erdogan's renewed criticism of interest rates and calls for stimulus despite the risks. It was last at 10.909, having earlier hit a record low of 11.30 per dollar.</p>\n<p>The dollar edged back from a 16-month high as traders weighed whether the U.S. currency's recent surge had gone too far.</p>\n<p>The dollar index , which measures the currency against a basket of six rivals, was last down 0.3%.</p>\n<p>In the U.S. Treasury market, yields fell after the relative success of a 20-year bond auction on Wednesday reduced fears about further rapid yield increases.</p>\n<p>Benchmark 10-year notes were last at 1.587%. They have jumped from a low of 1.415% last week and are holding below five-month highs of 1.705% reached on Oct. 21.</p>\n<p>Oil prices rose slightly after dropping to six-week lows.</p>\n<p>Brent crude settled up 96 cents, or 1.2%, at $81.24 a barrel, while U.S. West Texas Intermediate crude futures closed 65 cents, or 0.8%, higher at $79.01.</p>\n<p>U.S. gold futures settled down 0.5% at $1,861.4.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>S&P 500, Nasdaq hit record closing highs</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nS&P 500, Nasdaq hit record closing highs\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-19 06:59 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.reuters.com/markets/us/global-markets-wrapup-6-graphics-2021-11-18/><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>(Reuters) - The S&P 500 and Nasdaq notched record closing highs on Thursday, boosted by upbeat corporate earnings news from companies including Nvidia, while Turkey's lira weakened further after its ...</p>\n\n<a href=\"https://www.reuters.com/markets/us/global-markets-wrapup-6-graphics-2021-11-18/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".DJI":"道琼斯",".IXIC":"NASDAQ Composite",".SPX":"S&P 500 Index"},"source_url":"https://www.reuters.com/markets/us/global-markets-wrapup-6-graphics-2021-11-18/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1185082595","content_text":"(Reuters) - The S&P 500 and Nasdaq notched record closing highs on Thursday, boosted by upbeat corporate earnings news from companies including Nvidia, while Turkey's lira weakened further after its central bank cut rates.\nMSCI's gauge of stocks across the globe was flat, and the Dow Jones industrial average ended lower.Nvidia's stock jumped and was among the biggest supports for the S&P 500 and Nasdaq after it beat quarterly estimates and forecast strong fourth-quarter revenue. Macy's(M.N)shares shot up 21.2% after it raised its earnings outlook.\nOn the flip side, Cisco Systems shares fell 5.5%, a day after it forecast current-quarter revenue below expectations due to supply chain shortages and delays. It was the latest in a growing list of U.S. companies citing supply chain problems.\nInvestors have been concerned over further increases in price pressures. Retail giant Target warned of higher costs earlier this week.\nNew York Federal Reserve Bank President John Williams said Thursday that inflation is becoming more broad-based and that expectations for future price increases are rising.\nThe Dow Jones Industrial Average(.DJI) fell 60.1 points, or 0.17%, to 35,870.95, the S&P 500(.SPX)gained 15.87 points, or 0.34%, to 4,704.54 and the Nasdaq Composite(.IXIC) added 72.14 points, or 0.45%, to 15,993.71.\nThe pan-European STOXX 600 index(.STOXX)lost 0.46% and MSCI's gauge of stocks across the globe(.MIWD00000PUS)gained 0.03%.\nTurkey's lira shed another 2.83% after its central bank cut rates by 100 basis points to 15%, even in the face of inflation near 20%, sending the Turkish currency hurtling southward.\n\"The lira remains a punching bag, and further weakness has no end in sight,\" said Edward Moya, senior market analyst at Oanda.\nThe lira has lost around 11.5% of its value this month amid President Tayyip Erdogan's renewed criticism of interest rates and calls for stimulus despite the risks. It was last at 10.909, having earlier hit a record low of 11.30 per dollar.\nThe dollar edged back from a 16-month high as traders weighed whether the U.S. currency's recent surge had gone too far.\nThe dollar index , which measures the currency against a basket of six rivals, was last down 0.3%.\nIn the U.S. Treasury market, yields fell after the relative success of a 20-year bond auction on Wednesday reduced fears about further rapid yield increases.\nBenchmark 10-year notes were last at 1.587%. They have jumped from a low of 1.415% last week and are holding below five-month highs of 1.705% reached on Oct. 21.\nOil prices rose slightly after dropping to six-week lows.\nBrent crude settled up 96 cents, or 1.2%, at $81.24 a barrel, while U.S. West Texas Intermediate crude futures closed 65 cents, or 0.8%, higher at $79.01.\nU.S. gold futures settled down 0.5% at $1,861.4.","news_type":1},"isVote":1,"tweetType":1,"viewCount":51,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":846768090,"gmtCreate":1636115043017,"gmtModify":1636115335261,"author":{"id":"3585001294737518","authorId":"3585001294737518","name":"Universe宇宙","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3585001294737518","authorIdStr":"3585001294737518"},"themes":[],"htmlText":"Why covid pill, not covid syrup?","listText":"Why covid pill, not covid syrup?","text":"Why covid pill, not covid syrup?","images":[],"top":1,"highlighted":2,"essential":1,"paper":1,"likeSize":1,"commentSize":19,"repostSize":0,"link":"https://laohu8.com/post/846768090","repostId":"1166866310","repostType":4,"repost":{"id":"1166866310","pubTimestamp":1636112660,"share":"https://www.laohu8.com/m/news/1166866310?lang=&edition=full","pubTime":"2021-11-05 19:44","market":"us","language":"en","title":"Pfizer Develops Covid Pill That Cuts Hospitalizations and Deaths by 89%","url":"https://stock-news.laohu8.com/highlight/detail?id=1166866310","media":"Bloomberg","summary":"Drug reduced Covid hospitalizations by 89% in clinical trial\nPfizer shares surge 11%; Merck pill awa","content":"<ul>\n <li>Drug reduced Covid hospitalizations by 89% in clinical trial</li>\n <li>Pfizer shares surge 11%; Merck pill awaiting U.S. approval</li>\n</ul>\n<p>Pfizer Inc.&nbsp;said its Covid-19 pill reduced hospitalizations and deaths in high-risk patients by 89%, a result that has the potential to upend how the disease caused by the coronavirus is treated and alter the course of the pandemic. The shares surged 11%.</p>\n<p>The drugmaker said in a statement on Friday that it was no longer taking new patients in a clinical trial of the treatment “due to the overwhelming efficacy” and planned to submit the findings to U.S. regulatory authorities for emergency authorization as soon as possible.</p>\n<p>The results mean there are now two promising candidates for treating Covid-19 patients early in the course of the disease. Last month,Merck &amp; Co.&nbsp;and partner Ridgeback Biotherapeutics LP submitted their experimental pill to regulators after a study showed it slashed the risk of getting seriously ill or dying&nbsp;by half&nbsp;in patients with mild-to-moderate Covid-19.</p>\n<p>Pfizer gained 11% in premarket U.S. trading, while Merck fell 6.6%. Some vaccine makers lost ground, with&nbsp;Moderna Inc&nbsp;.down 4.5% and Pfizer partner&nbsp;BioNTech&nbsp;SE slipping 4% in German trading.</p>\n<p>A pill that could be taken at home at the first sign of symptoms is a crucial tool for taming the Covid-19 crisis globally, so long as it’s widely available. A Pfizer spokesperson said submissions to other regulatory agencies will occur shortly after the U.S. filing.</p>\n<p>In Pfizer’s trial of 1,219 unvaccinated adults, five days of treatment with its drug dramatically reduced the rate of hospitalization when it was started within either three days or five days of symptom onset, the company said. The drug, Paxlovid, binds to an enzyme called a protease to stop the virus from replicating itself. Some drugs for HIV work in a similar way.</p>\n<p>Overall, just 0.8% of people who started treatment within three days of getting sick ended up in the hospital and no one died, while 7% of people who got a placebo in that window were later hospitalized or died. Similar results were found when the drug was started within five days of symptom onset. The result, which hasn’t been published in a medical journal, was highly statistically significant, Pfizer said.</p>\n<p><b>Acute Need</b></p>\n<p>Current treatment options for Covid aren’t ideal. Monoclonal antibodies from companies like&nbsp;Regeneron Pharmaceuticals Inc.&nbsp;and&nbsp;Eli Lilly &amp; Co.&nbsp;reduce hospitalizations, but the infusions are hard to manufacture and must be given in a medical office, adding to the strain on health systems.</p>\n<p>Other medications like&nbsp;Gilead Sciences Inc.’s remdesivir are used to treat much sicker people who are already in the hospital. Low-cost steroid dexamethasone, while very effective, is usually only given to gravely ill patients.</p>\n<p>The need for a pill is so acute that Merck has&nbsp;already agreed&nbsp;to allow generic drugmakers to apply for licenses to make its treatment for more than 100 low- and middle-income nations, before it has even been cleared in the U.S. The U.K.’s drug regulators became the first in the world&nbsp;to greenlight&nbsp;Merck’s drug Thursday after a swift review.</p>\n<p>Now Pfizer’s pill, which works by a different mechanism, appears to have produced even better results in high-risk patients. The trial was stopped early by independent monitors because the effect was so impressive.</p>\n<p>“We are really over the moon that we did see such high efficacy in this study. It has tremendous implications for patients globally,” said Annaliesa Anderson, chief scientific officer for Pfizer’s hospitals business unit, which includes its antiviral work.</p>\n<p>In addition to the current trial in high-risk patients, Pfizer is also testing the drug in standard-risk patients, a study that included some vaccinated people who had breakthrough infections.</p>\n<p>In a third large trial, Pfizer is exploring if the drug could be used as a prophylactic medicine for people who live with someone who has come down with Covid-19, meaning a person would take the drug to avoid contracting the virus.</p>\n<p><b>Old Molecule</b></p>\n<p>The pill was internally developed by Pfizer researchers in the U.S. and U.K. During the early pandemic shutdowns, the scientists agreed to come back to their labs in an urgent effort to develop anti-Covid pills, Anderson said. Company researchers “worked around the clock to design this molecule” in a highly-compressed timeframe, she said.</p>\n<p>They dusted off an old experimental antiviral drug that Pfizer had developed after the original SARS epidemic, a coronavirus cousin to Covid-19 that killed about 800 people starting in late 2002. The old drug needed to be administered intravenously. But by July of last year, the Pfizer researchers tweaked the original molecule and came up with a new compound that turned out to be highly potent against Covid-19 and other coronaviruses in the test tube -- and could be used as a pill.</p>\n<p>The Pfizer drug works to block a crucial enzyme that the Covid-19 virus needs to replicate. It is taken twice a day for five days and used in combination with a second medicine called ritonavir that helps the Pfizer compound stay in the bloodstream longer.</p>\n<p>Pfizer said it planned to offer the antiviral therapy through a tiered pricing approach during the pandemic. High and upper-middle income countries will pay more than lower income countries, it said. The drugmaker didn’t say exactly how much it would charge.</p>\n<p>A Pfizer spokesperson said the company currently expects to produce more than 180,000 packs of the drug by the end of this year, and anticipates making at least 50 million packs by the end of 2022, with 21 million produced in the first half of the year.</p>\n<p></p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pfizer Develops Covid Pill That Cuts Hospitalizations and Deaths by 89%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPfizer Develops Covid Pill That Cuts Hospitalizations and Deaths by 89%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-05 19:44 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-11-05/pfizer-to-seek-u-s-nod-for-covid-pill-after-strong-results?srnd=markets-vp><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Drug reduced Covid hospitalizations by 89% in clinical trial\nPfizer shares surge 11%; Merck pill awaiting U.S. approval\n\nPfizer Inc. said its Covid-19 pill reduced hospitalizations and deaths in high-...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-11-05/pfizer-to-seek-u-s-nod-for-covid-pill-after-strong-results?srnd=markets-vp\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.bloomberg.com/news/articles/2021-11-05/pfizer-to-seek-u-s-nod-for-covid-pill-after-strong-results?srnd=markets-vp","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1166866310","content_text":"Drug reduced Covid hospitalizations by 89% in clinical trial\nPfizer shares surge 11%; Merck pill awaiting U.S. approval\n\nPfizer Inc. said its Covid-19 pill reduced hospitalizations and deaths in high-risk patients by 89%, a result that has the potential to upend how the disease caused by the coronavirus is treated and alter the course of the pandemic. The shares surged 11%.\nThe drugmaker said in a statement on Friday that it was no longer taking new patients in a clinical trial of the treatment “due to the overwhelming efficacy” and planned to submit the findings to U.S. regulatory authorities for emergency authorization as soon as possible.\nThe results mean there are now two promising candidates for treating Covid-19 patients early in the course of the disease. Last month,Merck & Co. and partner Ridgeback Biotherapeutics LP submitted their experimental pill to regulators after a study showed it slashed the risk of getting seriously ill or dying by half in patients with mild-to-moderate Covid-19.\nPfizer gained 11% in premarket U.S. trading, while Merck fell 6.6%. Some vaccine makers lost ground, with Moderna Inc .down 4.5% and Pfizer partner BioNTech SE slipping 4% in German trading.\nA pill that could be taken at home at the first sign of symptoms is a crucial tool for taming the Covid-19 crisis globally, so long as it’s widely available. A Pfizer spokesperson said submissions to other regulatory agencies will occur shortly after the U.S. filing.\nIn Pfizer’s trial of 1,219 unvaccinated adults, five days of treatment with its drug dramatically reduced the rate of hospitalization when it was started within either three days or five days of symptom onset, the company said. The drug, Paxlovid, binds to an enzyme called a protease to stop the virus from replicating itself. Some drugs for HIV work in a similar way.\nOverall, just 0.8% of people who started treatment within three days of getting sick ended up in the hospital and no one died, while 7% of people who got a placebo in that window were later hospitalized or died. Similar results were found when the drug was started within five days of symptom onset. The result, which hasn’t been published in a medical journal, was highly statistically significant, Pfizer said.\nAcute Need\nCurrent treatment options for Covid aren’t ideal. Monoclonal antibodies from companies like Regeneron Pharmaceuticals Inc. and Eli Lilly & Co. reduce hospitalizations, but the infusions are hard to manufacture and must be given in a medical office, adding to the strain on health systems.\nOther medications like Gilead Sciences Inc.’s remdesivir are used to treat much sicker people who are already in the hospital. Low-cost steroid dexamethasone, while very effective, is usually only given to gravely ill patients.\nThe need for a pill is so acute that Merck has already agreed to allow generic drugmakers to apply for licenses to make its treatment for more than 100 low- and middle-income nations, before it has even been cleared in the U.S. The U.K.’s drug regulators became the first in the world to greenlight Merck’s drug Thursday after a swift review.\nNow Pfizer’s pill, which works by a different mechanism, appears to have produced even better results in high-risk patients. The trial was stopped early by independent monitors because the effect was so impressive.\n“We are really over the moon that we did see such high efficacy in this study. It has tremendous implications for patients globally,” said Annaliesa Anderson, chief scientific officer for Pfizer’s hospitals business unit, which includes its antiviral work.\nIn addition to the current trial in high-risk patients, Pfizer is also testing the drug in standard-risk patients, a study that included some vaccinated people who had breakthrough infections.\nIn a third large trial, Pfizer is exploring if the drug could be used as a prophylactic medicine for people who live with someone who has come down with Covid-19, meaning a person would take the drug to avoid contracting the virus.\nOld Molecule\nThe pill was internally developed by Pfizer researchers in the U.S. and U.K. During the early pandemic shutdowns, the scientists agreed to come back to their labs in an urgent effort to develop anti-Covid pills, Anderson said. Company researchers “worked around the clock to design this molecule” in a highly-compressed timeframe, she said.\nThey dusted off an old experimental antiviral drug that Pfizer had developed after the original SARS epidemic, a coronavirus cousin to Covid-19 that killed about 800 people starting in late 2002. The old drug needed to be administered intravenously. But by July of last year, the Pfizer researchers tweaked the original molecule and came up with a new compound that turned out to be highly potent against Covid-19 and other coronaviruses in the test tube -- and could be used as a pill.\nThe Pfizer drug works to block a crucial enzyme that the Covid-19 virus needs to replicate. It is taken twice a day for five days and used in combination with a second medicine called ritonavir that helps the Pfizer compound stay in the bloodstream longer.\nPfizer said it planned to offer the antiviral therapy through a tiered pricing approach during the pandemic. High and upper-middle income countries will pay more than lower income countries, it said. The drugmaker didn’t say exactly how much it would charge.\nA Pfizer spokesperson said the company currently expects to produce more than 180,000 packs of the drug by the end of this year, and anticipates making at least 50 million packs by the end of 2022, with 21 million produced in the first half of the year.","news_type":1},"isVote":1,"tweetType":1,"viewCount":152,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":841727029,"gmtCreate":1635944850531,"gmtModify":1635945301132,"author":{"id":"3585001294737518","authorId":"3585001294737518","name":"Universe宇宙","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3585001294737518","authorIdStr":"3585001294737518"},"themes":[],"htmlText":"Please like, thanks.","listText":"Please like, thanks.","text":"Please like, thanks.","images":[],"top":1,"highlighted":2,"essential":1,"paper":1,"likeSize":6,"commentSize":17,"repostSize":0,"link":"https://laohu8.com/post/841727029","repostId":"1197682936","repostType":4,"repost":{"id":"1197682936","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1635941296,"share":"https://www.laohu8.com/m/news/1197682936?lang=&edition=full","pubTime":"2021-11-03 20:08","market":"us","language":"en","title":"Toplines Before US Market Open on Wednesday","url":"https://stock-news.laohu8.com/highlight/detail?id=1197682936","media":"Tiger Newspress","summary":"U.S. stock index futures were largely steady on Wednesday as investors refrained from making big bet","content":"<p>U.S. stock index futures were largely steady on Wednesday as investors refrained from making big bets ahead of the conclusion of the Federal Reserve's meeting, where policymakers are widely expected to signal the withdrawal of the pandemic-era support.</p>\n<p>At 8:00 a.m. ET, Dow e-minis were down 45 points, or 0.13%, S&amp;P 500 e-minis were down 2.75 points, or 0.06%, and Nasdaq 100 e-minis were up 20.5 points, or 0.13%.</p>\n<p><img src=\"https://static.tigerbbs.com/005a752484ce2a4a11470008800c9c2f\" tg-width=\"1080\" tg-height=\"411\" referrerpolicy=\"no-referrer\"></p>\n<p>U.S.&nbsp;private job creation popped higher in October thanks to a burst in hiring in the hospitality sector, payroll processing firm ADP reported Wednesday.</p>\n<p>Companies added 571,000 for the month, beating the 395,000 Dow Jones estimate and just ahead of September’s downwardly revised 523,000. It was the best month for jobs since June.</p>\n<p>Leisure and hospitality, a category that includes bars, restaurants, hotels and the like, saw a gain of 185,000 for a sector that remains well below its pre-pandemic employment level. The sector is seen as a proxy for an economic recovery that stalled over the summer due to a rise in the delta Covid variant and a massive clog in supply lines.</p>\n<p>The U.S. central bank will likely announce the tapering of its $120 billion-a-month asset purchase program in its policy statement due at 2 p.m. ET (1800 GMT).</p>\n<p>The statement will be followed by Chair Jerome Powell's news conference, which market participants will be closely watching for views on inflation and interest rate hikes.</p>\n<p><b>Stocks making the biggest moves premarket:</b></p>\n<p><b>Bed Bath &amp; Beyond(BBBY)</b> – Bed Bath &amp; Beyond rocketed 55% higher in premarket action after announcing an in-store partnership with&nbsp;Kroger&nbsp;(KR) and said its share buyback program was proceeding ahead of schedule. The buying spree was spurred by that positive news, combined with the fact that the housewares retailer’s stock is one of the most heavily shorted on Wall Street.</p>\n<p><b>Activision Blizzard(ATVI) </b>– Activision Blizzard saw its shares tank 12.6% in the premarket after it announced a delay in the launch of two games as well as issuing a weaker-than-expected outlook for the holiday quarter. The videogame maker did beat bottom-line forecasts for its latest quarter, coming in 2 cents ahead of estimates with an adjusted quarterly profit of 72 cents per share.</p>\n<p><b>Lyft(LYFT)</b> – Lyft shares surged 13.1% in premarket trading, after reporting earnings of an adjusted 5 cents per share for its latest quarter, compared to an expected loss of 3 cents per share. The ride-hailing service’s revenue also topped Wall Street forecasts, with Lyft benefitting from rising rider demand as well as higher prices.</p>\n<p><b>Zillow Group(ZG)</b> – Zillow is exiting its home-flipping business, saying its algorithm designed to profitably buy and sell homes doesn’t work as intended. The real estate firm also announced an unexpected quarterly loss and lower than expected revenue for its latest quarter. Zillow shares tumbled 17.5% in premarket trading.</p>\n<p><b>T-Mobile US(TMUS)</b> – T-Mobile came in 2 cents ahead of estimates with quarterly earnings of 55 cents per share, although the mobile service provider’s revenue missed Street forecasts. T-Mobile added 673,000 subscribers during the quarter, beating analyst forecasts but short of the numbers achieved by rivals like&nbsp;AT&amp;T(T). T-Mobile shares gained 2.8% in premarket action.</p>\n<p><b>Norwegian Cruise Line(NCLH)</b> – The cruise line operator’s stock slid 2.9% in the premarket after it reported a wider-than-expected loss and revenue that fell short of analyst estimates. Norwegian said it expects positive cash flow in the first quarter of 2022 and expects to be profitable in the second half of the year.</p>\n<p><b>New York Times(NYT)</b> – The newspaper publisher’s shares jumped 4.4% in the premarket after it beat estimates by 3 cents with an adjusted quarterly profit of 23 cents per share. Revenue also beat estimates amid rising advertising and digital sales.</p>\n<p><b>CVS Health(CVS)</b> – The drug store operator and pharmacy benefits manager beat estimates by 19 cents with adjusted quarterly earnings of $1.97 per share and revenue topping Wall Street forecasts as well. Results got a boost from increased demand for Covid testing and vaccinations.The&nbsp;shares&nbsp;fell&nbsp;1%&nbsp;in premarket trading.</p>\n<p><b>Humana(HUM)</b> – The health insurer reported adjusted quarterly earnings of $4.83 per share, beating the consensus estimate of $4.66, while revenue beat Street forecasts on strength in Humana’s Medicare Advantage business.The&nbsp;shares&nbsp;slid&nbsp;8.1%&nbsp;in premarket trading.</p>\n<p><b>Capri Holdings(CPRI) </b>– The company behind the Michael Kors and Versace brands saw its stock surge 9.9% in premarket trading, after beating earnings and revenue estimates for its latest quarter. Capri earned an adjusted $1.53 per share, well above the consensus estimate of 95 cents, and also raised its full-year outlook.</p>\n<p><b>Tupperware(TUP)</b> – Tupperware plummeted 16.1% in the premarket, as sales for the food storage products company came in well below Wall Street forecasts. The company points to persistent negative impact from the pandemic, among other factors.</p>\n<p><b>Mondelez International(MDLZ)</b> – Mondelez beat estimates by a penny with adjusted quarterly earnings of 70 cents per share, with the snack maker’s revenue beating forecasts as well. The company also said it would raise prices on snacks like Oreo cookies as it tries to keep up with rising commodity and labor costs. Mondelez rose 2.3% in the premarket.</p>\n<p><b>Camping World(CWH)</b> – The recreational vehicle retailer’s stock rallied 7.6% in the premarket after it reported quarterly earnings of $1.98 per share, well above the 55 cent consensus estimate, with revenue also well above Street forecasts.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Toplines Before US Market Open on Wednesday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nToplines Before US Market Open on Wednesday\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-11-03 20:08</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>U.S. stock index futures were largely steady on Wednesday as investors refrained from making big bets ahead of the conclusion of the Federal Reserve's meeting, where policymakers are widely expected to signal the withdrawal of the pandemic-era support.</p>\n<p>At 8:00 a.m. ET, Dow e-minis were down 45 points, or 0.13%, S&amp;P 500 e-minis were down 2.75 points, or 0.06%, and Nasdaq 100 e-minis were up 20.5 points, or 0.13%.</p>\n<p><img src=\"https://static.tigerbbs.com/005a752484ce2a4a11470008800c9c2f\" tg-width=\"1080\" tg-height=\"411\" referrerpolicy=\"no-referrer\"></p>\n<p>U.S.&nbsp;private job creation popped higher in October thanks to a burst in hiring in the hospitality sector, payroll processing firm ADP reported Wednesday.</p>\n<p>Companies added 571,000 for the month, beating the 395,000 Dow Jones estimate and just ahead of September’s downwardly revised 523,000. It was the best month for jobs since June.</p>\n<p>Leisure and hospitality, a category that includes bars, restaurants, hotels and the like, saw a gain of 185,000 for a sector that remains well below its pre-pandemic employment level. The sector is seen as a proxy for an economic recovery that stalled over the summer due to a rise in the delta Covid variant and a massive clog in supply lines.</p>\n<p>The U.S. central bank will likely announce the tapering of its $120 billion-a-month asset purchase program in its policy statement due at 2 p.m. ET (1800 GMT).</p>\n<p>The statement will be followed by Chair Jerome Powell's news conference, which market participants will be closely watching for views on inflation and interest rate hikes.</p>\n<p><b>Stocks making the biggest moves premarket:</b></p>\n<p><b>Bed Bath &amp; Beyond(BBBY)</b> – Bed Bath &amp; Beyond rocketed 55% higher in premarket action after announcing an in-store partnership with&nbsp;Kroger&nbsp;(KR) and said its share buyback program was proceeding ahead of schedule. The buying spree was spurred by that positive news, combined with the fact that the housewares retailer’s stock is one of the most heavily shorted on Wall Street.</p>\n<p><b>Activision Blizzard(ATVI) </b>– Activision Blizzard saw its shares tank 12.6% in the premarket after it announced a delay in the launch of two games as well as issuing a weaker-than-expected outlook for the holiday quarter. The videogame maker did beat bottom-line forecasts for its latest quarter, coming in 2 cents ahead of estimates with an adjusted quarterly profit of 72 cents per share.</p>\n<p><b>Lyft(LYFT)</b> – Lyft shares surged 13.1% in premarket trading, after reporting earnings of an adjusted 5 cents per share for its latest quarter, compared to an expected loss of 3 cents per share. The ride-hailing service’s revenue also topped Wall Street forecasts, with Lyft benefitting from rising rider demand as well as higher prices.</p>\n<p><b>Zillow Group(ZG)</b> – Zillow is exiting its home-flipping business, saying its algorithm designed to profitably buy and sell homes doesn’t work as intended. The real estate firm also announced an unexpected quarterly loss and lower than expected revenue for its latest quarter. Zillow shares tumbled 17.5% in premarket trading.</p>\n<p><b>T-Mobile US(TMUS)</b> – T-Mobile came in 2 cents ahead of estimates with quarterly earnings of 55 cents per share, although the mobile service provider’s revenue missed Street forecasts. T-Mobile added 673,000 subscribers during the quarter, beating analyst forecasts but short of the numbers achieved by rivals like&nbsp;AT&amp;T(T). T-Mobile shares gained 2.8% in premarket action.</p>\n<p><b>Norwegian Cruise Line(NCLH)</b> – The cruise line operator’s stock slid 2.9% in the premarket after it reported a wider-than-expected loss and revenue that fell short of analyst estimates. Norwegian said it expects positive cash flow in the first quarter of 2022 and expects to be profitable in the second half of the year.</p>\n<p><b>New York Times(NYT)</b> – The newspaper publisher’s shares jumped 4.4% in the premarket after it beat estimates by 3 cents with an adjusted quarterly profit of 23 cents per share. Revenue also beat estimates amid rising advertising and digital sales.</p>\n<p><b>CVS Health(CVS)</b> – The drug store operator and pharmacy benefits manager beat estimates by 19 cents with adjusted quarterly earnings of $1.97 per share and revenue topping Wall Street forecasts as well. Results got a boost from increased demand for Covid testing and vaccinations.The&nbsp;shares&nbsp;fell&nbsp;1%&nbsp;in premarket trading.</p>\n<p><b>Humana(HUM)</b> – The health insurer reported adjusted quarterly earnings of $4.83 per share, beating the consensus estimate of $4.66, while revenue beat Street forecasts on strength in Humana’s Medicare Advantage business.The&nbsp;shares&nbsp;slid&nbsp;8.1%&nbsp;in premarket trading.</p>\n<p><b>Capri Holdings(CPRI) </b>– The company behind the Michael Kors and Versace brands saw its stock surge 9.9% in premarket trading, after beating earnings and revenue estimates for its latest quarter. Capri earned an adjusted $1.53 per share, well above the consensus estimate of 95 cents, and also raised its full-year outlook.</p>\n<p><b>Tupperware(TUP)</b> – Tupperware plummeted 16.1% in the premarket, as sales for the food storage products company came in well below Wall Street forecasts. The company points to persistent negative impact from the pandemic, among other factors.</p>\n<p><b>Mondelez International(MDLZ)</b> – Mondelez beat estimates by a penny with adjusted quarterly earnings of 70 cents per share, with the snack maker’s revenue beating forecasts as well. The company also said it would raise prices on snacks like Oreo cookies as it tries to keep up with rising commodity and labor costs. Mondelez rose 2.3% in the premarket.</p>\n<p><b>Camping World(CWH)</b> – The recreational vehicle retailer’s stock rallied 7.6% in the premarket after it reported quarterly earnings of $1.98 per share, well above the 55 cent consensus estimate, with revenue also well above Street forecasts.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1197682936","content_text":"U.S. stock index futures were largely steady on Wednesday as investors refrained from making big bets ahead of the conclusion of the Federal Reserve's meeting, where policymakers are widely expected to signal the withdrawal of the pandemic-era support.\nAt 8:00 a.m. ET, Dow e-minis were down 45 points, or 0.13%, S&P 500 e-minis were down 2.75 points, or 0.06%, and Nasdaq 100 e-minis were up 20.5 points, or 0.13%.\n\nU.S. private job creation popped higher in October thanks to a burst in hiring in the hospitality sector, payroll processing firm ADP reported Wednesday.\nCompanies added 571,000 for the month, beating the 395,000 Dow Jones estimate and just ahead of September’s downwardly revised 523,000. It was the best month for jobs since June.\nLeisure and hospitality, a category that includes bars, restaurants, hotels and the like, saw a gain of 185,000 for a sector that remains well below its pre-pandemic employment level. The sector is seen as a proxy for an economic recovery that stalled over the summer due to a rise in the delta Covid variant and a massive clog in supply lines.\nThe U.S. central bank will likely announce the tapering of its $120 billion-a-month asset purchase program in its policy statement due at 2 p.m. ET (1800 GMT).\nThe statement will be followed by Chair Jerome Powell's news conference, which market participants will be closely watching for views on inflation and interest rate hikes.\nStocks making the biggest moves premarket:\nBed Bath & Beyond(BBBY) – Bed Bath & Beyond rocketed 55% higher in premarket action after announcing an in-store partnership with Kroger (KR) and said its share buyback program was proceeding ahead of schedule. The buying spree was spurred by that positive news, combined with the fact that the housewares retailer’s stock is one of the most heavily shorted on Wall Street.\nActivision Blizzard(ATVI) – Activision Blizzard saw its shares tank 12.6% in the premarket after it announced a delay in the launch of two games as well as issuing a weaker-than-expected outlook for the holiday quarter. The videogame maker did beat bottom-line forecasts for its latest quarter, coming in 2 cents ahead of estimates with an adjusted quarterly profit of 72 cents per share.\nLyft(LYFT) – Lyft shares surged 13.1% in premarket trading, after reporting earnings of an adjusted 5 cents per share for its latest quarter, compared to an expected loss of 3 cents per share. The ride-hailing service’s revenue also topped Wall Street forecasts, with Lyft benefitting from rising rider demand as well as higher prices.\nZillow Group(ZG) – Zillow is exiting its home-flipping business, saying its algorithm designed to profitably buy and sell homes doesn’t work as intended. The real estate firm also announced an unexpected quarterly loss and lower than expected revenue for its latest quarter. Zillow shares tumbled 17.5% in premarket trading.\nT-Mobile US(TMUS) – T-Mobile came in 2 cents ahead of estimates with quarterly earnings of 55 cents per share, although the mobile service provider’s revenue missed Street forecasts. T-Mobile added 673,000 subscribers during the quarter, beating analyst forecasts but short of the numbers achieved by rivals like AT&T(T). T-Mobile shares gained 2.8% in premarket action.\nNorwegian Cruise Line(NCLH) – The cruise line operator’s stock slid 2.9% in the premarket after it reported a wider-than-expected loss and revenue that fell short of analyst estimates. Norwegian said it expects positive cash flow in the first quarter of 2022 and expects to be profitable in the second half of the year.\nNew York Times(NYT) – The newspaper publisher’s shares jumped 4.4% in the premarket after it beat estimates by 3 cents with an adjusted quarterly profit of 23 cents per share. Revenue also beat estimates amid rising advertising and digital sales.\nCVS Health(CVS) – The drug store operator and pharmacy benefits manager beat estimates by 19 cents with adjusted quarterly earnings of $1.97 per share and revenue topping Wall Street forecasts as well. Results got a boost from increased demand for Covid testing and vaccinations.The shares fell 1% in premarket trading.\nHumana(HUM) – The health insurer reported adjusted quarterly earnings of $4.83 per share, beating the consensus estimate of $4.66, while revenue beat Street forecasts on strength in Humana’s Medicare Advantage business.The shares slid 8.1% in premarket trading.\nCapri Holdings(CPRI) – The company behind the Michael Kors and Versace brands saw its stock surge 9.9% in premarket trading, after beating earnings and revenue estimates for its latest quarter. Capri earned an adjusted $1.53 per share, well above the consensus estimate of 95 cents, and also raised its full-year outlook.\nTupperware(TUP) – Tupperware plummeted 16.1% in the premarket, as sales for the food storage products company came in well below Wall Street forecasts. The company points to persistent negative impact from the pandemic, among other factors.\nMondelez International(MDLZ) – Mondelez beat estimates by a penny with adjusted quarterly earnings of 70 cents per share, with the snack maker’s revenue beating forecasts as well. The company also said it would raise prices on snacks like Oreo cookies as it tries to keep up with rising commodity and labor costs. Mondelez rose 2.3% in the premarket.\nCamping World(CWH) – The recreational vehicle retailer’s stock rallied 7.6% in the premarket after it reported quarterly earnings of $1.98 per share, well above the 55 cent consensus estimate, with revenue also well above Street forecasts.","news_type":1},"isVote":1,"tweetType":1,"viewCount":209,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":849409395,"gmtCreate":1635770931356,"gmtModify":1635771085393,"author":{"id":"3585001294737518","authorId":"3585001294737518","name":"Universe宇宙","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3585001294737518","authorIdStr":"3585001294737518"},"themes":[],"htmlText":"Hit records high, hmmm...","listText":"Hit records high, hmmm...","text":"Hit records high, hmmm...","images":[],"top":1,"highlighted":2,"essential":1,"paper":1,"likeSize":6,"commentSize":18,"repostSize":0,"link":"https://laohu8.com/post/849409395","repostId":"1121087038","repostType":4,"repost":{"id":"1121087038","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1635768252,"share":"https://www.laohu8.com/m/news/1121087038?lang=&edition=full","pubTime":"2021-11-01 20:04","market":"us","language":"en","title":"Toplines Before US Market Open on Monday","url":"https://stock-news.laohu8.com/highlight/detail?id=1121087038","media":"Tiger Newspress","summary":"U.S. stock index futures hit record highs on Monday, led by gains in Tesla and economy-sensitive sto","content":"<p>U.S. stock index futures hit record highs on Monday, led by gains in Tesla and economy-sensitive stocks at the start of a week packed with economic data as well as the Federal Reserve’s potential move to slow down bond purchases.</p>\n<p>At 8:00 a.m. ET, Dow e-minis were up 154 points, or 0.43%, S&amp;P 500 e-minis were up 18.5 points, or 0.4%, and Nasdaq 100 e-minis were up 59 points, or 0.37%.</p>\n<p><img src=\"https://static.tigerbbs.com/5be444df098266771984b5e50296af07\" tg-width=\"1080\" tg-height=\"386\" referrerpolicy=\"no-referrer\"></p>\n<p>Tesla Inc rose 3.4% in premarket trading, pointing to a record open after it notched a trillion dollars in market capitalization last week.</p>\n<p>Other mega-cap technology stocks Google-owner Alphabet Inc , Meta Platforms, formerly Facebook Inc, Microsoft Corp, Amazon.com and Apple Inc traded mixed.</p>\n<p>Focus is now on the Fed’s policy meeting on Nov. 2-3, where the central bank is expected to announce the tapering of its $120 billion monthly bond buying program by $15 billion.</p>\n<p><b>Stocks making the biggest moves in the premarket:</b></p>\n<p><b>NIO(NIO)&nbsp;</b>–&nbsp;NIO delivered 3,667 vehicles in October, decreasing by 27.5% YoY.The stock turned&nbsp;to dived nearly 3%&nbsp;after rising 4%&nbsp;in premarket trading.</p>\n<p><b>Xpeng(XPEV)</b> – Xpeng shares jumped 4% in premarket trading after the Chinese electric vehicle maker said&nbsp;it delivered 10,138 cars in October, an increase of 233% over a year ago.</p>\n<p><b>Li Auto(LI)&nbsp;–</b>&nbsp;Li Auto delivered 7,649 Li ONEs in October, increasing 107.2% YoY.The stock fell more than 1% in premarket trading.</p>\n<p><b>Lucid Group(</b><b>LCID</b><b>)</b>&nbsp;<b>–</b>&nbsp;Lucid stock surged more&nbsp;than&nbsp;8% in premarket trading&nbsp;on automaker's first deliveries.Lucid Motors has&nbsp;held an event on October 30 called Dream Delivery where the first reservation-holding customers can pick up their&nbsp;Lucid Air Dream Edition&nbsp;EVs,which is the longest range electric car ever produced.</p>\n<p><b>AMC Entertainment(AMC)</b> – The movie theater operator’s stock rallied 2.1% in premarket action after AMC said its theater admissions revenue in October was the&nbsp;highest in any month since February 2020.</p>\n<p><b>Novavax(NVAX)</b>&nbsp;–&nbsp;Novavax,&nbsp;Inc.&nbsp;today announced the completion of its rolling submission to Health Canada for authorization of its COVID-19 vaccine candidate, the first filing of a protein-based COVID-19 vaccine inCanada. In addition, the company has completed the submission of all data and modules to the European Medicines Agency (EMA) to support the final regulatory review of its dossier.The&nbsp;stock surged 11.7% in premarket trading.</p>\n<p><b>Moderna(MRNA) </b>– Moderna said the Food and Drug Administration&nbsp;had delayed a decision&nbsp;on the use of its Covid-19 vaccine in adolescents aged 12 to 17, while the agency studies whether the shot increases the chance of myocarditis — an inflammation of the heart muscle. The drugmaker said a final decision from the FDA would likely not come until January. The stock lost 2.5% in the premarket.</p>\n<p><b>Spotify(SPOT)</b> – The music streaming service’s stock rose 2% in premarket trading after it was named a “top pick” at Morgan Stanley, on the prospects for accelerating growth in its Premium service and expanding profit margins.</p>\n<p><b>Crowdstrike(CRWD) </b>– The cloud computing company’s stock fell 2.3% in the premarket after it was downgraded to “neutral” from “buy” at BTIG. The firm points to increasing competition as well as the prospects for slowing growth.</p>\n<p><b>GameStop(GME)</b> – GameStop Chief Operating Officer Jenna Owens is leaving the videogame retailer after just seven months. GameStop did not give a reason for the departure of Owens, who had been a top executive at Amazon and Google before joining GameStop.</p>\n<p><b>Roblox(RBLX)</b> – Roblox is back online after the online gaming site suffered an outage that lasted from Thursday night through Sunday afternoon. The company did not give a specific cause of the outage but told The Wall Street Journal that there was no evidence of an external intrusion. Roblox shares rose 1% in premarket action.</p>\n<p><b>Trivago(TRVG)</b> – The travel services company saw its stock jump 4.2% in the premarket after it reported an unexpected profit and better-than-expected revenue for its latest quarter. Trivago cited improving travel trends as pandemic restrictions ease and vaccinations increase.</p>\n<p><b>Barclays(BCS) </b>– Barclays CEO Jes Staley&nbsp;will step down&nbsp;following an investigation into his relationship with disgraced financier Jeffrey Epstein by British regulators. Staley plans to contest the investigation’s findings, and has said in the past that he regrets any association with Epstein. Barclays fell 1.3% in premarket trading.</p>\n<p><b>Deere(DE)</b> – Deere&nbsp;reached a tentative contract agreement&nbsp;with striking workers, with a vote on the six-year pact set for Tuesday. The deal will give workers higher raises and bonuses and would end Deere’s first strike in 35 years. Deere shares gained 1.8% in premarket trading.</p>\n<p><b>Harley-Davidson(HOG)</b> – The motorcycle maker’s shares soared 7% in the premarket after the U.S. and the European Union&nbsp;ended a dispute involving steel and aluminum tariffs. Harley could have paid European tariffs of 56% if the dispute had not been resolved.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Toplines Before US Market Open on Monday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nToplines Before US Market Open on Monday\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-11-01 20:04</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>U.S. stock index futures hit record highs on Monday, led by gains in Tesla and economy-sensitive stocks at the start of a week packed with economic data as well as the Federal Reserve’s potential move to slow down bond purchases.</p>\n<p>At 8:00 a.m. ET, Dow e-minis were up 154 points, or 0.43%, S&amp;P 500 e-minis were up 18.5 points, or 0.4%, and Nasdaq 100 e-minis were up 59 points, or 0.37%.</p>\n<p><img src=\"https://static.tigerbbs.com/5be444df098266771984b5e50296af07\" tg-width=\"1080\" tg-height=\"386\" referrerpolicy=\"no-referrer\"></p>\n<p>Tesla Inc rose 3.4% in premarket trading, pointing to a record open after it notched a trillion dollars in market capitalization last week.</p>\n<p>Other mega-cap technology stocks Google-owner Alphabet Inc , Meta Platforms, formerly Facebook Inc, Microsoft Corp, Amazon.com and Apple Inc traded mixed.</p>\n<p>Focus is now on the Fed’s policy meeting on Nov. 2-3, where the central bank is expected to announce the tapering of its $120 billion monthly bond buying program by $15 billion.</p>\n<p><b>Stocks making the biggest moves in the premarket:</b></p>\n<p><b>NIO(NIO)&nbsp;</b>–&nbsp;NIO delivered 3,667 vehicles in October, decreasing by 27.5% YoY.The stock turned&nbsp;to dived nearly 3%&nbsp;after rising 4%&nbsp;in premarket trading.</p>\n<p><b>Xpeng(XPEV)</b> – Xpeng shares jumped 4% in premarket trading after the Chinese electric vehicle maker said&nbsp;it delivered 10,138 cars in October, an increase of 233% over a year ago.</p>\n<p><b>Li Auto(LI)&nbsp;–</b>&nbsp;Li Auto delivered 7,649 Li ONEs in October, increasing 107.2% YoY.The stock fell more than 1% in premarket trading.</p>\n<p><b>Lucid Group(</b><b>LCID</b><b>)</b>&nbsp;<b>–</b>&nbsp;Lucid stock surged more&nbsp;than&nbsp;8% in premarket trading&nbsp;on automaker's first deliveries.Lucid Motors has&nbsp;held an event on October 30 called Dream Delivery where the first reservation-holding customers can pick up their&nbsp;Lucid Air Dream Edition&nbsp;EVs,which is the longest range electric car ever produced.</p>\n<p><b>AMC Entertainment(AMC)</b> – The movie theater operator’s stock rallied 2.1% in premarket action after AMC said its theater admissions revenue in October was the&nbsp;highest in any month since February 2020.</p>\n<p><b>Novavax(NVAX)</b>&nbsp;–&nbsp;Novavax,&nbsp;Inc.&nbsp;today announced the completion of its rolling submission to Health Canada for authorization of its COVID-19 vaccine candidate, the first filing of a protein-based COVID-19 vaccine inCanada. In addition, the company has completed the submission of all data and modules to the European Medicines Agency (EMA) to support the final regulatory review of its dossier.The&nbsp;stock surged 11.7% in premarket trading.</p>\n<p><b>Moderna(MRNA) </b>– Moderna said the Food and Drug Administration&nbsp;had delayed a decision&nbsp;on the use of its Covid-19 vaccine in adolescents aged 12 to 17, while the agency studies whether the shot increases the chance of myocarditis — an inflammation of the heart muscle. The drugmaker said a final decision from the FDA would likely not come until January. The stock lost 2.5% in the premarket.</p>\n<p><b>Spotify(SPOT)</b> – The music streaming service’s stock rose 2% in premarket trading after it was named a “top pick” at Morgan Stanley, on the prospects for accelerating growth in its Premium service and expanding profit margins.</p>\n<p><b>Crowdstrike(CRWD) </b>– The cloud computing company’s stock fell 2.3% in the premarket after it was downgraded to “neutral” from “buy” at BTIG. The firm points to increasing competition as well as the prospects for slowing growth.</p>\n<p><b>GameStop(GME)</b> – GameStop Chief Operating Officer Jenna Owens is leaving the videogame retailer after just seven months. GameStop did not give a reason for the departure of Owens, who had been a top executive at Amazon and Google before joining GameStop.</p>\n<p><b>Roblox(RBLX)</b> – Roblox is back online after the online gaming site suffered an outage that lasted from Thursday night through Sunday afternoon. The company did not give a specific cause of the outage but told The Wall Street Journal that there was no evidence of an external intrusion. Roblox shares rose 1% in premarket action.</p>\n<p><b>Trivago(TRVG)</b> – The travel services company saw its stock jump 4.2% in the premarket after it reported an unexpected profit and better-than-expected revenue for its latest quarter. Trivago cited improving travel trends as pandemic restrictions ease and vaccinations increase.</p>\n<p><b>Barclays(BCS) </b>– Barclays CEO Jes Staley&nbsp;will step down&nbsp;following an investigation into his relationship with disgraced financier Jeffrey Epstein by British regulators. Staley plans to contest the investigation’s findings, and has said in the past that he regrets any association with Epstein. Barclays fell 1.3% in premarket trading.</p>\n<p><b>Deere(DE)</b> – Deere&nbsp;reached a tentative contract agreement&nbsp;with striking workers, with a vote on the six-year pact set for Tuesday. The deal will give workers higher raises and bonuses and would end Deere’s first strike in 35 years. Deere shares gained 1.8% in premarket trading.</p>\n<p><b>Harley-Davidson(HOG)</b> – The motorcycle maker’s shares soared 7% in the premarket after the U.S. and the European Union&nbsp;ended a dispute involving steel and aluminum tariffs. Harley could have paid European tariffs of 56% if the dispute had not been resolved.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1121087038","content_text":"U.S. stock index futures hit record highs on Monday, led by gains in Tesla and economy-sensitive stocks at the start of a week packed with economic data as well as the Federal Reserve’s potential move to slow down bond purchases.\nAt 8:00 a.m. ET, Dow e-minis were up 154 points, or 0.43%, S&P 500 e-minis were up 18.5 points, or 0.4%, and Nasdaq 100 e-minis were up 59 points, or 0.37%.\n\nTesla Inc rose 3.4% in premarket trading, pointing to a record open after it notched a trillion dollars in market capitalization last week.\nOther mega-cap technology stocks Google-owner Alphabet Inc , Meta Platforms, formerly Facebook Inc, Microsoft Corp, Amazon.com and Apple Inc traded mixed.\nFocus is now on the Fed’s policy meeting on Nov. 2-3, where the central bank is expected to announce the tapering of its $120 billion monthly bond buying program by $15 billion.\nStocks making the biggest moves in the premarket:\nNIO(NIO) – NIO delivered 3,667 vehicles in October, decreasing by 27.5% YoY.The stock turned to dived nearly 3% after rising 4% in premarket trading.\nXpeng(XPEV) – Xpeng shares jumped 4% in premarket trading after the Chinese electric vehicle maker said it delivered 10,138 cars in October, an increase of 233% over a year ago.\nLi Auto(LI) – Li Auto delivered 7,649 Li ONEs in October, increasing 107.2% YoY.The stock fell more than 1% in premarket trading.\nLucid Group(LCID) – Lucid stock surged more than 8% in premarket trading on automaker's first deliveries.Lucid Motors has held an event on October 30 called Dream Delivery where the first reservation-holding customers can pick up their Lucid Air Dream Edition EVs,which is the longest range electric car ever produced.\nAMC Entertainment(AMC) – The movie theater operator’s stock rallied 2.1% in premarket action after AMC said its theater admissions revenue in October was the highest in any month since February 2020.\nNovavax(NVAX) – Novavax, Inc. today announced the completion of its rolling submission to Health Canada for authorization of its COVID-19 vaccine candidate, the first filing of a protein-based COVID-19 vaccine inCanada. In addition, the company has completed the submission of all data and modules to the European Medicines Agency (EMA) to support the final regulatory review of its dossier.The stock surged 11.7% in premarket trading.\nModerna(MRNA) – Moderna said the Food and Drug Administration had delayed a decision on the use of its Covid-19 vaccine in adolescents aged 12 to 17, while the agency studies whether the shot increases the chance of myocarditis — an inflammation of the heart muscle. The drugmaker said a final decision from the FDA would likely not come until January. The stock lost 2.5% in the premarket.\nSpotify(SPOT) – The music streaming service’s stock rose 2% in premarket trading after it was named a “top pick” at Morgan Stanley, on the prospects for accelerating growth in its Premium service and expanding profit margins.\nCrowdstrike(CRWD) – The cloud computing company’s stock fell 2.3% in the premarket after it was downgraded to “neutral” from “buy” at BTIG. The firm points to increasing competition as well as the prospects for slowing growth.\nGameStop(GME) – GameStop Chief Operating Officer Jenna Owens is leaving the videogame retailer after just seven months. GameStop did not give a reason for the departure of Owens, who had been a top executive at Amazon and Google before joining GameStop.\nRoblox(RBLX) – Roblox is back online after the online gaming site suffered an outage that lasted from Thursday night through Sunday afternoon. The company did not give a specific cause of the outage but told The Wall Street Journal that there was no evidence of an external intrusion. Roblox shares rose 1% in premarket action.\nTrivago(TRVG) – The travel services company saw its stock jump 4.2% in the premarket after it reported an unexpected profit and better-than-expected revenue for its latest quarter. Trivago cited improving travel trends as pandemic restrictions ease and vaccinations increase.\nBarclays(BCS) – Barclays CEO Jes Staley will step down following an investigation into his relationship with disgraced financier Jeffrey Epstein by British regulators. Staley plans to contest the investigation’s findings, and has said in the past that he regrets any association with Epstein. Barclays fell 1.3% in premarket trading.\nDeere(DE) – Deere reached a tentative contract agreement with striking workers, with a vote on the six-year pact set for Tuesday. The deal will give workers higher raises and bonuses and would end Deere’s first strike in 35 years. Deere shares gained 1.8% in premarket trading.\nHarley-Davidson(HOG) – The motorcycle maker’s shares soared 7% in the premarket after the U.S. and the European Union ended a dispute involving steel and aluminum tariffs. Harley could have paid European tariffs of 56% if the dispute had not been resolved.","news_type":1},"isVote":1,"tweetType":1,"viewCount":46,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":691314184,"gmtCreate":1640136482157,"gmtModify":1640136576182,"author":{"id":"3585001294737518","authorId":"3585001294737518","name":"Universe宇宙","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":6,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3585001294737518","authorIdStr":"3585001294737518"},"themes":[],"htmlText":"First post 😉","listText":"First post 😉","text":"First post 😉","images":[],"top":1,"highlighted":2,"essential":1,"paper":1,"likeSize":1,"commentSize":20,"repostSize":0,"link":"https://laohu8.com/post/691314184","repostId":"2193695165","repostType":4,"isVote":1,"tweetType":1,"viewCount":596,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"lives":[]}